var title_f22_40_23168="TEE 4 chamber view";
var content_f22_40_23168=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F76441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F76441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 510px\">",
"   <div class=\"ttl\">",
"    Four-chamber transesophageal echocardiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 490px; height: 215px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Horizontal (0&deg;) imaging of the heart at 32 cm from the incisors (panel A) demonstrates the four-chamber view. Well seen are the body of the left atrium (LA), mitral valve (MV), foreshortened left ventricle (LV), right atrium (RA), tricuspid valve (TV), foreshortened right ventricle (RV), and Eustachian valve (EV). In panel B the probe is at a slightly more proximal location (28 cm from the incisors); seen are the LA, LV, RV, anterior (AML) and posterior mitral valve leaflets (PML), interventricular septum, left ventricular outflow tract (LVOT), aorta (Ao), and aortic valve (AoV). The LV is often foreshortened and the true apex is generally not seen in this orientation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Warren Manning, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23168=[""].join("\n");
var outline_f22_40_23168=null;
var title_f22_40_23169="Emergency pericardiocentesis subxiphoid approach";
var content_f22_40_23169=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Emergency pericardiocentesis subxiphoid approach",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 499px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23169=[""].join("\n");
var outline_f22_40_23169=null;
var title_f22_40_23170="Pathways of platelet activation";
var content_f22_40_23170=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57152&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57152&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 557px\">",
"   <div class=\"ttl\">",
"    Pathways of platelet activation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 537px; height: 281px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the interactions among platelet membrane receptors (glycoproteins Ia, Ib, and IIb/IIIa), adhesive macromolecules (such as von Willebrand factor, vWF), and the disrupted vessel wall. Platelet activation can occur via several pathways which are dependent upon collagen, thrombin, adenosine diphosphate (ADP) and serotonin, and thromboxane A2 (TxA2). The intrinsic and extrinsic systems of the coagulation cascade are noted at the right as are interactions between clotting factors and the platelet membrane.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Stein B, Fuster V, Israel DH, et al. J Am Coll Cardiol 1989; 14:813.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23170=[""].join("\n");
var outline_f22_40_23170=null;
var title_f22_40_23171="Patient information: Medicines for high blood pressure (The Basics)";
var content_f22_40_23171=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16234\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?32/6/32875\">",
"         Tips on taking medicines",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/10/27809\">",
"         Patient information: Coronary heart disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/58/34722\">",
"         Patient information: High blood pressure in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/19/41266\">",
"         Patient information: Low-sodium diet (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/27/21940\">",
"         Patient information: Medicines after a heart attack (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/37/36435\">",
"         Patient information: Medicines after an ischemic stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?8/62/9188\">",
"         Patient information: Medicines for chronic kidney disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/41/36499\">",
"         Patient information: Medicines for heart failure (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/55/24435\">",
"         Patient information: Stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/32/37380\">",
"         Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/61/32726\">",
"         Patient information: Reducing the costs of medicines (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Medicines for high blood pressure (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/medicines-for-high-blood-pressure-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H37202005\">",
"      <span class=\"h1\">",
"       Why do I need medicines to treat high blood pressure?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Having high blood pressure puts you at risk for heart attack, stroke, kidney damage, and other serious problems. The medicines your doctor or nurse prescribes to treat high blood pressure can help reduce the risk of these problems and even help you live longer.",
"     </p>",
"     <p>",
"      It&rsquo;s very important that you take your blood pressure medicines every day as directed. High blood pressure doesn't usually cause symptoms, so people sometimes don't take it seriously. Plus, blood pressure medicines can cause side effects and be expensive, so it&rsquo;s easy to understand why people don&rsquo;t like to take them. But if you are tempted to skip your medicines, remember, they can save your life!",
"     </p>",
"     <p>",
"      If your medicines cause unpleasant side effects, or if you can't afford your medicines, talk to your doctor or nurse. There are often ways to deal with these problems. The first step is to let your doctor or nurse know.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H37202012\">",
"      <span class=\"h1\">",
"       Which medicines might I need?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are lots of different medicines to treat high blood pressure. But some of the medicines have other health benefits besides lowering blood pressure.",
"     </p>",
"     <p>",
"      Your doctor or nurse will decide which medicine is best for you depending on:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        How high your blood pressure is",
"       </li>",
"       <li>",
"        Your other health problems, if you have any",
"       </li>",
"       <li>",
"        How well you do on the medicines you try",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your doctor or nurse might need to change your medicine or its dose a couple of times to find the medicine and dose that work best and cause the fewest side effects. Plus, you might need to take more than 1 medicine to get your blood pressure under control. Whatever your doctor or nurse prescribes, it's important to take your medicines exactly as prescribed (",
"      <a class=\"graphic graphic_table graphicRef59726 \" href=\"UTD.htm?32/6/32875\">",
"       table 1",
"      </a>",
"      ). But always let your doctor or nurse know if you have any problems with the medicines. That way he or she can make changes so that you are as comfortable possible and also get the most benefit. Never stop or make changes to the way you take your medicines without talking to your doctor or nurse first.",
"     </p>",
"     <p>",
"      Below is a list of the most common types of medicine given to people with high blood pressure:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Medicines called &ldquo;diuretics&rdquo;",
"       </li>",
"       <li>",
"        Medicines called &ldquo;angiotensin-converting enzyme inhibitors&rdquo; (&ldquo;ACE inhibitors&rdquo;) or &ldquo;angiotensin receptor blockers&rdquo; (&ldquo;ARBs&rdquo;)",
"       </li>",
"       <li>",
"        Medicines called &ldquo;calcium channel blockers&rdquo;",
"       </li>",
"       <li>",
"        Medicines called &ldquo;beta blockers&rdquo;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      This article has only some basic information on these medicines. For more detailed information about your medicines, ask your doctor or nurse for information from Lexicomp, available through UpToDate. The Lexicomp hand-outs explain how to use and store your medicines. They also list possible side effects and warn you if your medicines should not be taken with certain other medicines or foods.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H37202019\">",
"      <span class=\"h1\">",
"       Diuretics",
"      </span>",
"      &nbsp;&mdash;&nbsp;Diuretics are sometimes called &ldquo;water pills,&rdquo; because they make you urinate more than usual.",
"      <strong>",
"      </strong>",
"      Some examples of diuretics include",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?8/21/8533?source=see_link\">",
"       chlorthalidone",
"      </a>",
"      ,",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?10/20/10565?source=see_link\">",
"       hydrochlorothiazide",
"      </a>",
"      (also known as HCTZ), and",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?12/14/12518?source=see_link\">",
"       furosemide",
"      </a>",
"      (brand name: Lasix&reg;).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H37202026\">",
"      <span class=\"h1\">",
"       ACE inhibitors and ARBs",
"      </span>",
"      &nbsp;&mdash;&nbsp;ACE inhibitors and ARBs are often grouped together, because they work in similar ways. These medicines can help prevent kidney disease. Doctors often prescribe them for people with diabetes, because people with diabetes have a higher-than-average risk of kidney disease.",
"     </p>",
"     <p>",
"      Some examples of ACE inhibitors include",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?29/31/30197?source=see_link\">",
"       enalapril",
"      </a>",
"      ,",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?24/49/25365?source=see_link\">",
"       captopril",
"      </a>",
"      , and",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?9/32/9734?source=see_link\">",
"       lisinopril",
"      </a>",
"      . Some examples of ARBs include",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?4/50/4902?source=see_link\">",
"       candesartan",
"      </a>",
"      (brand name: Atacand&reg;) and",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?21/15/21749?source=see_link\">",
"       valsartan",
"      </a>",
"      (brand name: Diovan&reg;).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H37202033\">",
"      <span class=\"h1\">",
"       Calcium channel blockers",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some examples of calcium channel blockers include",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?4/13/4309?source=see_link\">",
"       amlodipine",
"      </a>",
"      (brand name: Norvasc&reg;),",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?1/12/1221?source=see_link\">",
"       felodipine",
"      </a>",
"      (brand name: Plendil&reg;), and",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?6/11/6326?source=see_link\">",
"       diltiazem",
"      </a>",
"      (brand name: Cardizem&reg;). These medicines also help prevent chest pain caused by heart disease.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H37202040\">",
"      <span class=\"h1\">",
"       Beta blockers",
"      </span>",
"      &nbsp;&mdash;&nbsp;Besides lowering blood pressure, beta blockers help reduce the amount of work the heart has to do. Studies show that people who take a beta blocker after a heart attack are less likely to have another heart attack or die than people who don&rsquo;t take a beta blocker. Studies also show that people with heart failure who take beta blockers live longer than people with heart failure who don&rsquo;t.",
"     </p>",
"     <p>",
"      When people first start taking beta-blockers, they sometimes feel tired. That is just while the body gets used to the medicine. But once the body gets used to beta blockers, the medicines can really help. If your doctor prescribes a beta blocker, give it a little time to start working.",
"     </p>",
"     <p>",
"      Some examples of beta blockers include",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?2/27/2486?source=see_link\">",
"       atenolol",
"      </a>",
"      (brand name: Tenormin&reg;),",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?24/28/25030?source=see_link\">",
"       metoprolol",
"      </a>",
"      (brand names: Lopressor&reg;, Toprol-XL&reg;), and",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?42/4/43077?source=see_link\">",
"       propranolol",
"      </a>",
"      (brand name: Inderal LA&reg;).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H37202153\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/58/34722?source=see_link\">",
"       Patient information: High blood pressure in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/19/41266?source=see_link\">",
"       Patient information: Low-sodium diet (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/10/27809?source=see_link\">",
"       Patient information: Coronary heart disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=see_link\">",
"       Patient information: Stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/27/21940?source=see_link\">",
"       Patient information: Medicines after a heart attack (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/41/36499?source=see_link\">",
"       Patient information: Medicines for heart failure (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/37/36435?source=see_link\">",
"       Patient information: Medicines after an ischemic stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/62/9188?source=see_link\">",
"       Patient information: Medicines for chronic kidney disease (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/32/37380?source=see_link\">",
"       Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       Patient information: Reducing the costs of medicines (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?22/40/23171?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16234 Version 4.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-9F549ED38C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23171=[""].join("\n");
var outline_f22_40_23171=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37202005\">",
"      Why do I need medicines to treat high blood pressure?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37202012\">",
"      Which medicines might I need?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37202019\">",
"      Diuretics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37202026\">",
"      ACE inhibitors and ARBs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37202033\">",
"      Calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37202040\">",
"      Beta blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37202153\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16234\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/6/32875\">",
"      Tips on taking medicines",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/10/27809?source=related_link\">",
"      Patient information: Coronary heart disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/58/34722?source=related_link\">",
"      Patient information: High blood pressure in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/32/37380?source=related_link\">",
"      Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/19/41266?source=related_link\">",
"      Patient information: Low-sodium diet (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/27/21940?source=related_link\">",
"      Patient information: Medicines after a heart attack (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/37/36435?source=related_link\">",
"      Patient information: Medicines after an ischemic stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/62/9188?source=related_link\">",
"      Patient information: Medicines for chronic kidney disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/41/36499?source=related_link\">",
"      Patient information: Medicines for heart failure (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=related_link\">",
"      Patient information: Stroke (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_40_23172="Barretts esophagus with low grade dysplasia Light";
var content_f22_40_23172=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Barrett's esophagus with low grade dysplasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of a biopsy specimen from the distal esophagus showing low grade dysplasia. The diagnosis of dysplasia is supported by the presence of glandular cells with enlarged and somewhat hyperchromatic nuclei that are confined to the basal half of the cell. Abnormal nuclei extend to the luminal surface of the specimen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Donald Antonioli, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23172=[""].join("\n");
var outline_f22_40_23172=null;
var title_f22_40_23173="Glucocorticoid-induced myopathy";
var content_f22_40_23173=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Glucocorticoid-induced myopathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/40/23173/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23173/contributors\">",
"     Marc L Miller, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/40/23173/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23173/contributors\">",
"     Ira N Targoff, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23173/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/40/23173/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23173/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/40/23173/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myopathy has been recognized as a side effect of glucocorticoid (corticosteroid) therapy since its introduction as a therapeutic agent in the 1950s [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/1\">",
"     1",
"    </a>",
"    ]. Myopathy can occur with any of the glucocorticoid preparations. The risk may be increased in older patients and in those with cancer or negative nitrogen balance prior to onset of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/2\">",
"     2",
"    </a>",
"    ]. Similar symptoms can occur in patients with Cushing's syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Cushing's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major aspects of glucocorticoid-induced myopathy will be reviewed here. Other side effects associated with glucocorticoid therapy, both oral and inhaled, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/60/7114?source=see_link\">",
"     \"Major side effects of inhaled glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids have a direct catabolic effect on skeletal muscle via effects on intermediary metabolism that provide amino acids as a substrate for gluconeogenesis. Activation of the glucocorticoid receptor appears to be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/3,4\">",
"     3,4",
"    </a>",
"    ], since myopathy can be prevented by a glucocorticoid receptor antagonist [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An additional mechanism in critical illness was suggested in an experimental model. Glucocorticoid therapy interfered with insulin-like growth factor-I (IGF-I) signaling, leading to increased myocyte apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Glucocorticoids and neuromuscular blocking agents'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    An intracellular signaling molecule with protein kinase activity known as Akt1 (a major isoform of Akt) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/6\">",
"     6",
"    </a>",
"    ] may play a central role in the atrophic and hypertrophic responses of muscle to glucocorticoids and IGF-I, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Glucocorticoid-induced suppression of Akt1 ultimately results in increased amounts of the ubiquitin-ligase atrogin-1 (MAFbx) that targets muscle proteins for degradation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/7,9\">",
"     7,9",
"    </a>",
"    ]. Conversely, IGF-I signaling leads to enhanced activity of Akt1 that suppresses muscle atrophy and that induces muscle hypertrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to increasing muscle degradation via ubiquitination, glucocorticoids also may reduce muscle differentiation. This effect appears to be mediated by enhanced degradation via ubiquitination of MyoD, which is a master transcriptional switch for muscle development and regeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with glucocorticoid myopathy typically present with gradual onset of proximal muscle weakness followed by atrophy of proximal muscle groups (",
"    <a class=\"graphic graphic_picture graphicRef64072 \" href=\"UTD.htm?0/38/623\">",
"     picture 1",
"    </a>",
"    ). Myalgias and muscle tenderness do not occur. Lower extremity weakness usually occurs before upper extremity weakness and is more severe. The myopathy may interfere with the activities of daily living, resulting in difficulties in getting up from a chair, climbing stairs, or performing overhead tasks.",
"   </p>",
"   <p>",
"    There is wide variability in the time course of symptom onset (from a few weeks to many months after therapy has begun) that is determined, in part, by the glucocorticoid dose. In one report of patients with primary brain tumors treated with daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    , two-thirds became symptomatic in the third to fourth months of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/10\">",
"     10",
"    </a>",
"    ]. Inactivity sensitizes skeletal muscle to the catabolic effect of steroids [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other features of Cushing's syndrome such as moon facies, diabetes, mood alteration, skin fragility, and osteoporosis are often (but not always) present [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Cushing's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Glucocorticoid myopathy in patients with a systemic malignancy may present somewhat differently, with involvement of the respiratory muscles. In one report of 15 adult cancer patients, nine developed proximal muscle weakness [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/13\">",
"     13",
"    </a>",
"    ]. Respiratory dysfunction developed in 10, including two of six without proximal muscle weakness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Relation to glucocorticoid dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is wide variation in the dose and duration of treatment prior to the onset of muscle weakness. Some patients become weak after a low dose of steroids for a few weeks, while others never develop myopathy despite receiving large doses of steroids for months or years. Despite this variability, there is a general dose relationship with systemic glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Glucocorticoid myopathy is unusual in patients treated with less than 10",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      or its equivalent.",
"     </li>",
"     <li>",
"      The higher the dose of glucocorticoid, the greater is the likelihood of developing myopathy and the more rapid is the onset of weakness. Daily doses in excess of 40 to 60",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      can induce clinically important weakness within two weeks and almost always result in some degree of muscle weakness when continued for more than one month.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk of developing glucocorticoid myopathy appears to be significantly lower in patients who are treated with both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/10\">",
"     10",
"    </a>",
"    ]. The reason for this is unclear but may be due to induction of hepatic metabolism of dexamethasone by phenytoin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Glucocorticoid preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The above observations refer to systemic glucocorticoid therapy. Inhaled glucocorticoids are rarely associated with muscle weakness. Patients who take high doses of inhaled glucocorticoids absorb 20 to 40 percent of the administered dose and can develop some systemic signs. However, only isolated case reports describe muscle weakness that resolves with cessation of glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/14\">",
"     14",
"    </a>",
"    ]. Myopathy after epidural glucocorticoid injection has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/60/7114?source=see_link\">",
"     \"Major side effects of inhaled glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Experimental and some clinical observations suggest that the risk of myopathy is increased with fluorinated preparations such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    compared with nonfluorinated preparations such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/2,10,16,17\">",
"     2,10,16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no definitive diagnostic test for glucocorticoid myopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/12\">",
"     12",
"    </a>",
"    ]. Muscle enzymes are normal [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/18\">",
"     18",
"    </a>",
"    ]; electromyography (EMG) is usually normal but may show low amplitude motor unit potentials; and muscle biopsy reveals nonspecific atrophy of type IIb fibers without signs of necrosis or inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/12,19\">",
"     12,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis is, therefore, based upon the history and timing of glucocorticoid exposure and upon the absence of other causes of myopathy. The diagnosis is generally established by demonstrating improved strength within",
"    <strong>",
"     three to four weeks",
"    </strong>",
"    after appropriate dose reduction.",
"   </p>",
"   <p>",
"    There are two settings in which the diagnosis may be particularly difficult: in patients with an underlying inflammatory myopathy and in those treated with neuromuscular blocking agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Glucocorticoid versus inflammatory myopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;When steroids are used in the treatment of inflammatory myopathy (eg, dermatomyositis, polymyositis, or HIV myopathy), the problem of distinguishing new or worsening muscle weakness due to glucocorticoid myopathy from exacerbation of the underlying myopathy often arises [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/22/11626?source=see_link\">",
"     \"Initial treatment of dermatomyositis and polymyositis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4695?source=see_link\">",
"     \"Muscle disease in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following factors can be used to establish the correct diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The onset of weakness one or more months after the initiation of or an increase in glucocorticoid therapy, the presence of other cushingoid features, and normal or decreasing serum muscle enzyme levels all favor glucocorticoid myopathy.",
"     </li>",
"     <li>",
"      The most definitive test is to decrease the glucocorticoid dose (if the underlying disease will allow it) and to observe the muscle strength response. Weakness due to glucocorticoid myopathy will begin to improve three to four weeks after a sufficient dose alteration, while symptoms due to an inflammatory myopathy should worsen.",
"     </li>",
"     <li>",
"      EMG and muscle biopsy can help distinguish between these disorders but are usually not necessary.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Glucocorticoids and neuromuscular blocking agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients requiring large doses of intravenous glucocorticoids and a neuromuscular blocking agent (often because of mechanical ventilation in status asthmaticus) may develop critical illness myopathy, which is characterized by severe diffuse proximal and distal weakness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/60/43976?source=see_link&amp;anchor=H6#H6\">",
"     \"Neuromuscular weakness related to critical illness\", section on 'Critical illness myopathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Major electrophysiologic findings of critical illness myopathy include normal to low amplitude motor responses and short-duration motor unit potentials coupled with normal or near-normal sensory potentials. Needle electromyography shows early or normal full recruitment. Some muscles exhibit electrical inexcitability to direct muscle stimulation. The major histopathologic findings are myopathy and myosin loss. Serum CK elevation is seen in approximately one-half of patients.",
"   </p>",
"   <p>",
"    Critical illness myopathy is usually reversible over weeks to months, but it leads to prolonged ICU stays and to increased length of hospital stays overall. Treatment is directed toward discontinuation or reduction of glucocorticoids as soon as possible.",
"   </p>",
"   <p>",
"    Of interest in this regard is a report of a 13-year-old girl with severe myasthenia gravis and respiratory failure requiring mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/20\">",
"     20",
"    </a>",
"    ]. Treatment with massive intravenous doses of glucocorticoids resulted in generalized muscle weakness and wasting. EMG suggested myopathy, and muscle biopsy showed diffuse muscle atrophy. The anti-acetylcholine receptor antibody titer was strongly positive. It was speculated that the neuromuscular blockade due to myasthenia gravis in this patient resembled the neuromuscular blocking agents in severe asthma in sensitizing skeletal muscle to high-dose corticosteroids and the development of an acute myopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Muscle strength begins to improve within three to four weeks after appropriate dose reduction and eventually resolves in virtually all patients if glucocorticoid therapy can be discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/12\">",
"     12",
"    </a>",
"    ]. In patients treated with a fluorinated preparation, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    , substituting a nonfluorinated preparation, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , can be tried if the patient cannot be weaned from glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23173/abstract/10\">",
"     10",
"    </a>",
"    ]. The lowest effective dose should be used, and, if symptoms persist, alternative therapies should be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H203934364\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Myopathy, a well-recognized side effect of glucocorticoid (corticosteroid) therapy, can occur with any of the glucocorticoid preparations. The risk may be increased in older or malnourished patients and in those with cancer. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Glucocorticoid-induced myopathy can occur with the initiation of systemic therapy as well as in chronic maintenance therapy when the dose is increased. Affected patients typically present with gradual onset over several weeks of proximal muscle weakness accompanied by muscle wasting. A common manifestation is difficulty getting up from a chair or climbing stairs. Myalgias and muscle tenderness are not observed. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although there is wide variation in the dose and duration of treatment prior to the onset of muscle weakness, there is a general dose relationship with systemic glucocorticoid therapy. Daily doses in excess of 40 to 60",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      can induce clinically important weakness within two weeks and almost always result in some degree of muscle weakness when continued for more than one month. By comparison, glucocorticoid myopathy is unusual in patients treated with less than 10",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      or its equivalent. Inhaled glucocorticoids are rarely associated with muscle weakness. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Relation to glucocorticoid dose'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Glucocorticoid preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of glucocorticoid-induced myopathy is one of exclusion, being based upon the history and timing of glucocorticoid exposure and upon the absence of other causes of myopathy. The diagnosis is generally established by demonstrating improved strength within",
"      <strong>",
"       three to four weeks",
"      </strong>",
"      after appropriate dose reduction. There are two settings in which the diagnosis may be particularly difficult: in patients with an underlying inflammatory myopathy and in those treated with neuromuscular blocking agents. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Glucocorticoid versus inflammatory myopathy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Glucocorticoids and neuromuscular blocking agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Muscle strength begins to improve within three to four weeks after appropriate dose reduction and eventually resolves in virtually all patients if glucocorticoid therapy can be discontinued. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Course'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/1\">",
"      BUNIM JJ, ZIFF M, McEWEN C. Evaluation of prolonged cortisone therapy in rheumatiod arthritis: a four-year study. Am J Med 1955; 18:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/2\">",
"      Afifi AK, Bergman RA, Harvey JC. Steroid myopathy. Clinical, histologic and cytologic observations. Johns Hopkins Med J 1968; 123:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/3\">",
"      Konagaya M, Bernard PA, Max SR. Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist. Endocrinology 1986; 119:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/4\">",
"      Sun L, Trausch-Azar JS, Muglia LJ, Schwartz AL. Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism. Proc Natl Acad Sci U S A 2008; 105:3339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/5\">",
"      Singleton JR, Baker BL, Thorburn A. Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis. Endocrinology 2000; 141:2945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/6\">",
"      Hoffman EP, Nader GA. Balancing muscle hypertrophy and atrophy. Nat Med 2004; 10:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/7\">",
"      Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/8\">",
"      Stitt TN, Drujan D, Clarke BA, et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004; 14:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/9\">",
"      Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294:1704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/10\">",
"      Dropcho EJ, Soong SJ. Steroid-induced weakness in patients with primary brain tumors. Neurology 1991; 41:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/11\">",
"      Ferrando AA, Stuart CA, Sheffield-Moore M, Wolfe RR. Inactivity amplifies the catabolic response of skeletal muscle to cortisol. J Clin Endocrinol Metab 1999; 84:3515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/12\">",
"      Bowyer SL, LaMothe MP, Hollister JR. Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol 1985; 76:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/13\">",
"      Batchelor TT, Taylor LP, Thaler HT, et al. Steroid myopathy in cancer patients. Neurology 1997; 48:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/14\">",
"      Herzog AG. Proximal myopathy associated with inhaled steroids. JAMA 1999; 281:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/15\">",
"      Boonen S, Van Distel G, Westhovens R, Dequeker J. Steroid myopathy induced by epidural triamcinolone injection. Br J Rheumatol 1995; 34:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/16\">",
"      Braunstein PW Jr, DeGirolami U. Experimental corticosteroid myopathy. Acta Neuropathol 1981; 55:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/17\">",
"      Kelly FJ, McGrath JA, Goldspink DF, Cullen MJ. A morphological/biochemical study on the actions of corticosteroids on rat skeletal muscle. Muscle Nerve 1986; 9:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/18\">",
"      Askari A, Vignos PJ Jr, Moskowitz RW. Steroid myopathy in connective tissue disease. Am J Med 1976; 61:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/19\">",
"      Khaleeli AA, Edwards RH, Gohil K, et al. Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol (Oxf) 1983; 18:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23173/abstract/20\">",
"      Panegyres PK, Squier M, Mills KR, Newsom-Davis J. Acute myopathy associated with large parenteral dose of corticosteroid in myasthenia gravis. J Neurol Neurosurg Psychiatry 1993; 56:702.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5171 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-60.18.131.125-10F4DE3033-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23173=[""].join("\n");
var outline_f22_40_23173=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H203934364\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Relation to glucocorticoid dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Glucocorticoid preparation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Glucocorticoid versus inflammatory myopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Glucocorticoids and neuromuscular blocking agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H203934364\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/5171\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5171|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/38/623\" title=\"picture 1\">",
"      Proximal wasting in Cushings",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=related_link\">",
"      Epidemiology and clinical manifestations of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/22/11626?source=related_link\">",
"      Initial treatment of dermatomyositis and polymyositis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/60/7114?source=related_link\">",
"      Major side effects of inhaled glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4695?source=related_link\">",
"      Muscle disease in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/60/43976?source=related_link\">",
"      Neuromuscular weakness related to critical illness",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_40_23174="Type 4 breast lobule";
var content_f22_40_23174=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F51142&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F51142&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Type 4 breast lobule",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 354px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is a type 4 breast lobule type 4 obtained at beginning of lactation as viewed by light microscopy.",
"    <br>",
"     <br>",
"      Microscopic sections fixed and stained with hematoxylin and eosin (H &amp; E). Photographs at 2.5x, and 40x respectively.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Russo, J, Hu, Y-F, Silva, IDCG, and Russo, IH. Cancer risk related to mammary gland structure and development. Microscopy Research and Technique 2001; 52:204. Copyright &copy; 2001 American Cancer Society.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23174=[""].join("\n");
var outline_f22_40_23174=null;
var title_f22_40_23175="Dietary and nutritional assessment in adults";
var content_f22_40_23175=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Dietary and nutritional assessment in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/40/23175/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23175/contributors\">",
"     Barbara Olendzki, RD, MPH, LDN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/40/23175/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23175/contributors\">",
"     Timothy O Lipman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/40/23175/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23175/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/40/23175/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over the past few decades conflicting principles of healthy eating have been proposed, generating diverse opinions on what constitutes healthy food choices. Clinicians find their patients informing them of new diets they would like to try which may conflict with national guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/1\">",
"     1",
"    </a>",
"    ]. There is confusion in the general population, including the medical profession, as to which dietary components may be most important, and how to integrate these changes within the patient&rsquo;s current lifestyle.",
"   </p>",
"   <p>",
"    This confusion has consequences. Clinicians continue to be the most respected source of lifestyle modification information [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/2\">",
"     2",
"    </a>",
"    ] and are exposed to 60 to 70 percent of the United States adult population each year [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/3\">",
"     3",
"    </a>",
"    ]. As an example, a study of clinician attitudes highlights these concerns in the delivery of nutrition advice to their patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Nearly all clinicians were aware of the obesity epidemic and 60 percent of them felt capable of assuming a major role in obesity control, but only 36 percent agreed that they had effective weight-management practices.",
"   </p>",
"   <p>",
"    Clinicians use several strategies, but there are barriers to nutritional counseling which include skepticism about the effectiveness of nutritional interventions, concerns about patient response and compliance, lack of specific knowledge and training about nutrition as it relates to disease, and the perceived unpalatability of nutritional changes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. Clinicians are able to identify patients at risk, but encounter time constraints, lack of specialty clinics, absence of guidelines, and an inadequate number of dietitians [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. In addition to appropriate training, physicians need effective nutritional tools and information that can be used in the clinical setting [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dietary choices may help reverse or lessen some common risk factors for the main contributors to morbidity and mortality in the United States, including obesity, coronary heart disease, diabetes, some cancers, and stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. The dissemination of accurate dietary information within a medical setting has become an increasing priority both to the clinician and the patient. Many people believe that a comprehensive plan of complete dietary change is necessary to accomplish goals; however, this is not always the case. Indeed, sometimes simple changes in one area of the diet (such as increasing fiber, or decreasing white flour products) may have a beneficial impact on other areas of the diet [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The balance of protective foods is just as important as the avoidance of foods containing excess calories, sugars, saturated or trans fat. Making simple recommendations directed at modifying appropriate risk factors for chronic disease, and providing flexibility within the plan can be more effective over the long term [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/15\">",
"     15",
"    </a>",
"    ]. The goal of nutrition assessment is to identify appropriate and actionable areas of change in the dietary lifestyle.",
"   </p>",
"   <p>",
"    A primary care nutritional consultation can be expected to take 5 to 15 minutes. When prescribing nutritional therapy, it is helpful for the provider to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obtain relevant laboratory and anthropometric data",
"     </li>",
"     <li>",
"      Determine what prior attempts the patient has made at dietary change",
"     </li>",
"     <li>",
"      Identify pertinent components of the patient's current diet",
"     </li>",
"     <li>",
"      Understand the key psychosocial constraints faced by the patient in making lifestyle changes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review these steps and discuss some of the evidence on modifying diets to prevent disease. The specific components of a healthy diet and dietary therapy for specific populations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31641?source=see_link\">",
"     \"Healthy diet in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=see_link\">",
"     \"Dietary therapy for obesity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42679?source=see_link\">",
"     \"Diet in the treatment and prevention of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIET AND DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic evidence suggests that \"Western\" style diets rich in red meats, fatty foods, added fats, desserts, and sweets are associated with a substantially increased risk for obesity, type 2 diabetes, and heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=see_link\">",
"     \"Dietary fat\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31641?source=see_link\">",
"     \"Healthy diet in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=see_link\">",
"     \"Prediction and prevention of type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dietary patterns that are characterized by a \"prudent\" diet high in fruit, vegetables, whole grains, fish, poultry, and low-fat dairy products are associated with a lower risk of these diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. These associations are stronger for dietary patterns than for individual foods, highlighting the importance of identifying and changing foods that are in excess and adding to protective foods that are too limited in the diet [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lifestyle interventions can have results comparable or superior to drug therapy. As an example, in the Diabetes Prevention Study, diet and exercise were more effective than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    in preventing people with impaired glucose tolerance from progressing to diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=see_link\">",
"     \"Prediction and prevention of type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinicians can be effective at assisting their patients with improving quality of life and in achieving substantial improvements in cardiovascular risk factors through attentive follow-up and referral to a dietitian when necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. In addition to improvements to patient health, lifestyle-oriented change can be cost-effective, especially in high-risk groups [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     LABORATORY AND ANTHROPOMETRIC DATA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data to be collected include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Body mass index (BMI). BMI = body weight (in kg) &divide; stature (height, in meters) squared. The BMI can also be obtained from a nomogram or a table (",
"      <a class=\"graphic graphic_figure graphicRef65305 \" href=\"UTD.htm?12/3/12351\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef63600 graphicRef74762 \" href=\"UTD.htm?28/43/29361\">",
"       table 1A-B",
"      </a>",
"      ). BMI is correlated with body fat and is relatively unaffected by height. Overweight is defined as a BMI between 25 and 29.9",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      and obesity is defined as a BMI of 30",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      or more. Severe obesity is defined as a BMI greater than 40",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      or greater than 35",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      with comorbidities. Attention should also be paid to whether obesity is predominantly abdominal, since this may increase the risk of complications such as the metabolic syndrome and coronary heart disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=see_link\">",
"       \"Screening for and clinical evaluation of obesity in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=see_link\">",
"       \"Health hazards associated with obesity in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fasting lipid profile (total cholesterol, HDL, triglycerides, LDL). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33241?source=see_link\">",
"       \"Screening guidelines for dyslipidemia\"",
"      </a>",
"      .) According to the third report of the National Cholesterol Education Program guidelines [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/27\">",
"       27",
"      </a>",
"      ], LDL response is determined after six weeks with either drug or lifestyle therapy; however, many physicians prefer to reassess changes every three to six months. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26122?source=see_link&amp;anchor=H28#H28\">",
"       \"Treatment of lipids (including hypercholesterolemia) in secondary prevention\", section on 'Monitoring therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Labs that may be appropriate in assessing the nutritional state of selected patients include blood glucose, glycosylated hemoglobin (A1C), C-reactive protein, hematocrit, albumin, measurements of liver and renal function, and electrolytes. Patients with unexplained gastrointestinal distress, anemia, or weight loss should also be screened for celiac disease, or other disorders that require specialized dietary consideration (Crohn's disease, colitis, diverticular disease, renal disease, etc). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=see_link&amp;anchor=H2#H2\">",
"       \"Diagnosis of celiac disease\", section on 'Who should be tested'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/16/2312?source=see_link\">",
"       \"Screening for diabetes mellitus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=see_link\">",
"       \"Overview of homocysteine\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIETARY AND NUTRITIONAL ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The purpose of the dietary assessment is to obtain relevant information from the current diet to identify dietary components that may raise or lower health risks. This will help determine which dietary lifestyle changes are reasonable for a given patient, and any beneficial dietary habits that may be increased.",
"   </p>",
"   <p>",
"    Patients with complex nutritional concerns should receive a comprehensive nutritional assessment and increased support and recommendations for change. This typically requires referral to a dietitian. Such a complete nutritional assessment will also examine:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The physical ability to digest food including chewing, swallowing, absorption, and elimination",
"     </li>",
"     <li>",
"      Food intolerances, including gastrointestinal disorders (eg, inflammatory and irritable bowel)",
"     </li>",
"     <li>",
"      Eating disorders and appetite fluctuations",
"     </li>",
"     <li>",
"      Unintentional weight loss or gain",
"     </li>",
"     <li>",
"      Taste changes",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Food/drug",
"      </span>",
"      interactions",
"     </li>",
"     <li>",
"      Skills and ability to comply with dietary lifestyle changes",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Initial approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Simply asking patients, &ldquo;What can you do to improve your diet?&rdquo; can reduce time spent in assessment by highlighting areas the patient is willing to consider changing. Patients often can inform the clinician of the areas of weakness in their diet, and which behaviors contribute to body weight or other adverse health risk (such as elevated blood sugars). It is just as important to identify strengths in the diet (fruit, vegetables, other healthy options) in order to build on positive dietary foundations. The clinician may then follow-up in subsequent visits to assess patient changes. This follow-up is often important for patient motivation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     24-Hour dietary recall",
"    </span>",
"    &nbsp;&mdash;&nbsp;A brief nutritional assessment tool commonly used is the 24-hour dietary recall. The goal of the 24-hour dietary recall is to identify the day-to-day pattern of eating with a minimum of reporting bias. Most people have little variability in dietary patterns and are remarkably consistent with caloric intake and food choices.",
"   </p>",
"   <p>",
"    An abbreviated assessment may be performed by obtaining only the previous evening's intake, which can then be combined with the food frequency assessment. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Food frequency questionnaire'",
"    </a>",
"    below.) Typically, the majority of calories are consumed in the evening. The dietician will ask what the patient consumed for the evening meal and any snacks afterward, including beverages and the portion sizes of the meals. For patients with diabetes, timing of intake is also important to keep blood sugars from going too high or too low.",
"   </p>",
"   <p>",
"    If time allows, ask the patient to report the previous day's intake, separating meal occurrences: \"What is the first thing you had to eat or drink yesterday?\"; \"Did you have anything else at the time?\"; \"What was the next thing you had to eat or drink?\" Continue through to snacks before bedtime and determine the time the patient went to bed, so as to calculate when they ate their last meal. This exercise can also elicit behaviors and lifestyle factors that underlie dietary choices.",
"   </p>",
"   <p>",
"    Patients frequently will fail to report beverage consumption and most patients will require regular prompting such as, \"What did you have to drink with that?\" Beverages and snacks often contribute greatly to poor nutrition and health [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Be sure to ask about combined foods such as cream in coffee and butter on bread. As in other settings, avoid leading questions: ask if the patient had anything on or with the bread, rather than if he had butter on the bread.",
"   </p>",
"   <p>",
"    Mixed dishes such as casseroles will likely require additional prompting, and a number of other food responses may require follow-up questions to have a clear picture of what was eaten; \"Was there a sauce, cheese, or gravy with that?\" \"What type of beef?\" \"What percentage of fat in the hamburger?\" \"What percentage milk?\" Be sure to ask about alcohol consumption. As far as assessing trans fatty acids (partially hydrogenated oils), remember that 40 percent of intake of these detrimental fats comes from cakes, cookies, crackers, pies and breads (processed foods) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/19\">",
"     19",
"    </a>",
"    ]. Small adjustments in daily living can add up to large changes over time.",
"   </p>",
"   <p>",
"    Be aware that many patients have difficulties with accurately reporting portion sizes with underreporting of larger portion sizes occurring with almost mathematical predictability [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Use comparisons such as a deck of cards (3 ounces), 1 cup of broccoli is about the size of a fist, 1 cup of ice cream is about the size of a tennis or racquetball (",
"    <a class=\"graphic graphic_figure graphicRef56956 \" href=\"UTD.htm?38/60/39878\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Food frequency questionnaire",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the clinician is especially short on time, another assessment tool is the food frequency questionnaire, which is the quickest way to identify dietary patterns. Used in combination with the 24-hour recall, this is the best way to identify protective and detrimental components of the patient diet.",
"   </p>",
"   <p>",
"    The food frequency questionnaire will cover typical intake over a period of time (usually one month). A brief food frequency assessment can be found in the table (",
"    <a class=\"graphic graphic_table graphicRef69381 \" href=\"UTD.htm?6/43/6845\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Focus on one or more key areas that are correlated with your patient's health concerns. Ask how often the patient consumes the food and then probe for greater detail. As an example, if the patient has a high LDL cholesterol level, you may want to explore sources of saturated fat and hydrogenated fats (trans fats), such as meats, cheese, processed foods, snacks, and dairy products including 2 percent milk, whole milk, and ice cream.",
"   </p>",
"   <p>",
"    What is missing in the diet is equally important to what may be in excess. Food frequency assessments can reveal that a patient is not eating a variety of fruit, vegetables, whole grains, and fish. You will also want to look at soluble fiber (eg, barley, legumes, ground flax seeds, oats), which may be missing from the diet. In fact, a simple dietary recommendation of increasing fiber, or lowering saturated fat can also have a beneficial impact on other areas of the diet that are not specifically addressed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Food diary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another option for assessment is to ask the patient to bring in a three or four-day diary that contains a complete record of foods and beverages consumed over those days. This transfers much of the time burden from the clinician to the patient. Quickly highlight foods that need to be changed, in addition to any beneficial choices that should be continued.",
"   </p>",
"   <p>",
"    The diary itself is an intervention: patients will alter what they consume because they are required to write it down. A diary can be an excellent tool to help patients increase awareness of their eating habits and to encourage compliance with recommended dietary changes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23175/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional questions are likely to be needed to clarify particular components of the patient's diet around areas of concern. Similar questions as described above (see",
"    <a class=\"local\" href=\"#H6\">",
"     '24-Hour dietary recall'",
"    </a>",
"    above) are used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other assessment tools",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several web sites supply useful dietary and energy assessment tools that you or your patient may visit to assist you. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Food and Nutrition Information",
"      <span class=\"nowrap\">",
"       Center",
"       <br/>",
"       <br/>",
"       (file://fnic.nal.usda.gov/nal_display/index.php?info_center=4&amp;tax_level=1)",
"      </span>",
"     </li>",
"     <li>",
"      Nutrition Analysis Tool at the University of Illinois",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.nat.uiuc.edu/mainnat.html\">",
"     www.nat.uiuc.edu/mainnat.html",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      American Heart Association",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.americanheart.org/\">",
"     www.americanheart.org",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      University of Massachusetts Division of Preventive and Behavioral Medicine",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://umassmed.edu/nutrition/index.aspx?linkidentifier=id&amp;itemid=138272\">",
"     file://umassmed.edu/nutrition/index.aspx?linkidentifier=id&amp;itemid=138272",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oldways Preservation and Exchange Trust",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.oldwayspt.org/\">",
"     www.oldwayspt.org",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Institute of Medicine",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://iom.edu/global/topics/food-nutrition.aspx\">",
"     file://iom.edu/Global/Topics/Food-Nutrition.aspx",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nutrition and Your Health: Dietary guidelines for Americans",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; (",
"    <a class=\"external\" href=\"file://health.gov/dietaryguidelines/dga2010/DietaryGuidelines2010.pdf\">",
"     file://health.gov/dietaryguidelines/dga2010/DietaryGuidelines2010.pdf",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To calculate your patient's 10-year risk of developing heart disease according to the Framingham Heart Study:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://hp2010.nhlbihin.net/atpiii/calculator.asp?usertype=prof\">",
"     file://hp2010.nhlbihin.net/atpiii/calculator.asp?usertype=prof",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    For facilitating patient tracking of dietary intake, there are many websites and smart phone applications to recommend to patients, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      www.sparkpeople.com",
"     </li>",
"     <li>",
"      www.calorieking.com",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       www.livestrong.com/thedailyplate/iphone-calorie-tracker/",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       www.myfitnesspal.com/iphone",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       www.nexercise.com/",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       www.loseit.com/",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following figure can be used as a nutritional consultation form featuring information you may wish to obtain from the patient in order to provide adequate guidance, and it has the structure of a 24-hour recall",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    food frequency questionnaire to assist with nutritional assessment (",
"    <a class=\"graphic graphic_form graphicRef50919 \" href=\"UTD.htm?15/3/15423\">",
"     form 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     BEHAVIORAL ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to biochemical and anthropometrical indicators of health, it is important to assess the key behavioral factors that are pertinent to a patient's food choices. Work and other time constraints, weekend differences, timing of intake (does the patient go for hours without eating and then increase intake in the evening?; in diabetics, how does timing relate to blood glucose levels and diabetic medications?), regularity of",
"    <span class=\"nowrap\">",
"     takeout/restaurant",
"    </span>",
"    meals, travel, age and number of children, who cooks, who purchases food, the health of other family members, exercise habits, cultural and religious practices, personal stress and depression, and the patient's personal health goals and motivators are all factors to consider in this assessment stage.",
"   </p>",
"   <p>",
"    Lifestyle changes, including diet and physical activity, are best accomplished with support from friends and family. Change is likely to take place incrementally, building upon increasing knowledge about the impact of nutrition upon health concerns, and skills developed to meet those concerns.",
"   </p>",
"   <p>",
"    Food is often a conduit through which patients express emotions in good and bad times, interspersed through the broad sphere of social interaction. Any change in dietary lifestyle may create difficulties. Support of friends and family is paramount in the process. Many patients will require an in-depth, comprehensive consult by a dietitian or behaviorist to assist with the accomplishment of dietary and lifestyle changes.",
"   </p>",
"   <p>",
"    Patients with eating disorders as well as some patients with very low or very high BMIs should be referred to a psychologist or other counselor for behavioral counseling in conjunction with a referral to a dietitian. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link\">",
"     \"Eating disorders: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/35/11827?source=see_link\">",
"       \"Patient information: Diet and health (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28642?source=see_link\">",
"       \"Patient information: Diet and health (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before prescribing dietary change, it is helpful to assess a number of aspects of a patient's current eating habits and nutritional status. Although complex patients may be referred to a dietitian for such an assessment, many patients will be adequately assessed and counseled in a primary care setting.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Determine the patient's body mass index (BMI). BMI = body weight (in kg) &divide; stature (height, in meters) squared. The BMI can also be obtained from a nomogram or a table (",
"      <a class=\"graphic graphic_figure graphicRef65305 \" href=\"UTD.htm?12/3/12351\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef63600 graphicRef74762 \" href=\"UTD.htm?28/43/29361\">",
"       table 1A-B",
"      </a>",
"      ). Attention should also be paid to whether obesity is predominantly abdominal, since this may particularly increase the risk of complications such as metabolic syndrome and coronary heart disease. Measuring BMI is a way to assess patient risks; it is not necessarily a goal to normalize BMI. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Laboratory and anthropometric data'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Obtain a fasting lipid profile. Other labs that may be appropriate in assessing the nutritional state of selected patients include blood glucose, glycosylated hemoglobin (A1C), C-reactive protein, hematocrit, albumin, measurements of liver and renal function, and electrolytes. Patients with unexplained gastrointestinal distress, anemia, or weight loss should also be screened for celiac disease, or other disorders that require specialized dietary consideration (Crohn's disease, colitis, diverticular disease, renal disease, irritable bowel syndrome, etc). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=see_link&amp;anchor=H2#H2\">",
"       \"Diagnosis of celiac disease\", section on 'Who should be tested'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/16/2312?source=see_link\">",
"       \"Screening for diabetes mellitus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=see_link\">",
"       \"Overview of homocysteine\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H3\">",
"       'Laboratory and anthropometric data'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Assess current dietary habits with some combination of a 24-hour dietary recall, a food frequency questionnaire, and a food diary, depending upon the time available. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Dietary and nutritional assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Assess behavioral and life factors that will impact the patient's ability to implement dietary change, and ask about prior attempts at dietary change. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Behavioral assessment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Dietary Guidelines for Americans, 2010. US Government Printing Office; US Department of Agriculture and US Department of Health and Human Services, Washington, DC 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/2\">",
"      Hiddink GJ, Hautvast JG, van Woerkum CM, et al. Consumers' expectations about nutrition guidance: the importance of primary care physicians. Am J Clin Nutr 1997; 65:1974S.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. National Ambulatory Medical Care Survey: 2000 Summary. Centers for Disease Control and Prevention, National Center for Health Statistics. Available at: www.cdc.gov/nchs/ (Accessed on March 07, 2005).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/4\">",
"      Vetter ML, Herring SJ, Sood M, et al. What do resident physicians know about nutrition? An evaluation of attitudes, self-perceived proficiency and knowledge. J Am Coll Nutr 2008; 27:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/5\">",
"      Ampt AJ, Amoroso C, Harris MF, et al. Attitudes, norms and controls influencing lifestyle risk factor management in general practice. BMC Fam Pract 2009; 10:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/6\">",
"      Wynn K, Trudeau JD, Taunton K, et al. Nutrition in primary care: current practices, attitudes, and barriers. Can Fam Physician 2010; 56:e109.",
"     </a>",
"    </li>",
"    <li>",
"     US Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Office of Disease Prevention and Health Promotion; U.S. Department of Health and Human Services, Washington, DC 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/8\">",
"      Truswell AS. Family physicians and patients: is effective nutrition interaction possible? Am J Clin Nutr 2000; 71:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/9\">",
"      Goldberg RJ, Rosen J, Roselli A, Lewis B. Survey of physician's attitudes and practices toward lipid-lowering management strategies. Cardiology 2007; 107:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/10\">",
"      Hyman DJ, Maibach EW, Flora JA, Fortmann SP. Cholesterol treatment practices of primary care physicians. Public Health Rep 1992; 107:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/11\">",
"      Al-Ghawi A, Uauy R. Study of the knowledge, attitudes and practices of physicians towards obesity management in primary health care in Bahrain. Public Health Nutr 2009; 12:1791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/12\">",
"      Ma Y, Olendzki BC, Pagoto SL, et al. What are patients actually eating: the dietary practices of cardiovascular disease patients. Curr Opin Cardiol 2010; 25:518.",
"     </a>",
"    </li>",
"    <li>",
"     National Center for Health Statistics. www.cdc.gov/nchs/fastats/lcod.htm (Accessed on February 04, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/14\">",
"      Olendzki BC, Ma Y, Schneider KL, et al. A simple dietary message to improve dietary quality: Results from a pilot investigation. Nutrition 2009; 25:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/15\">",
"      Swain JF, McCarron PB, Hamilton EF, et al. Characteristics of the diet patterns tested in the optimal macronutrient intake trial to prevent heart disease (OmniHeart): options for a heart-healthy diet. J Am Diet Assoc 2008; 108:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/16\">",
"      Fung TT, Rimm EB, Spiegelman D, et al. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001; 73:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/17\">",
"      van Dam RM, Rimm EB, Willett WC, et al. Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 2002; 136:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/18\">",
"      Millen BE, Quatromoni PA, Copenhafer DL, et al. Validation of a dietary pattern approach for evaluating nutritional risk: the Framingham Nutrition Studies. J Am Diet Assoc 2001; 101:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/19\">",
"      Katcher HI, Hill AM, Lanford JL, et al. Lifestyle approaches and dietary strategies to lower LDL-cholesterol and triglycerides and raise HDL-cholesterol. Endocrinol Metab Clin North Am 2009; 38:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/20\">",
"      Zarraga IG, Schwarz ER. Impact of dietary patterns and interventions on cardiovascular health. Circulation 2006; 114:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/21\">",
"      Park Y, Subar AF, Hollenbeck A, Schatzkin A. Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med 2011; 171:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/22\">",
"      Sacks FM. Dietary fat, the Mediterranean diet, and health: reports from scientific exchanges, 1998 and 2000. Introduction. Am J Med 2002; 113 Suppl 9B:1S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/23\">",
"      Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/24\">",
"      Spellman CW. Aggressively managing type 2 diabetes mellitus, hyperlipidemia, and bone loss. J Am Osteopath Assoc 2008; 108:S20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/25\">",
"      Eriksson KM, Westborg CJ, Eliasson MC. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors. Scand J Public Health 2006; 34:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/26\">",
"      Gordon L, Graves N, Hawkes A, Eakin E. A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol. Chronic Illn 2007; 3:101.",
"     </a>",
"    </li>",
"    <li>",
"     National Heart, Lung, and Blood Institute. The Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health; Washington, DC 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/28\">",
"      Feig DI. Sugar-sweetened beverages and hypertension. Future Cardiol 2010; 6:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/29\">",
"      Stookey JD, Constant F, Gardner CD, Popkin BM. Replacing sweetened caloric beverages with drinking water is associated with lower energy intake. Obesity (Silver Spring) 2007; 15:3013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/30\">",
"      Olendzki BC, Ma Y, H&eacute;bert JR, et al. Underreporting of energy intake and associated factors in a Latino population at risk of developing type 2 diabetes. J Am Diet Assoc 2008; 108:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/31\">",
"      Wansink B, van Ittersum K. Portion size me: downsizing our consumption norms. J Am Diet Assoc 2007; 107:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23175/abstract/32\">",
"      Schusdziarra V, Hausmann M, Wiedemann C, et al. Successful weight loss and maintenance in everyday clinical practice with an individually tailored change of eating habits on the basis of food energy density. Eur J Nutr 2011; 50:351.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5366 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9F1D191359-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23175=[""].join("\n");
var outline_f22_40_23175=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIET AND DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      LABORATORY AND ANTHROPOMETRIC DATA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIETARY AND NUTRITIONAL ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Initial approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      24-Hour dietary recall",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Food frequency questionnaire",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Food diary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other assessment tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      BEHAVIORAL ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/5366\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/5366|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/3/12351\" title=\"figure 1\">",
"      Nomogram for BMI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/60/39878\" title=\"figure 2\">",
"      Portion-size estimator",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/5366|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?15/3/15423\" title=\"form 1\">",
"      Nutrition consult form",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/5366|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/22/367\" title=\"table 1A\">",
"      Determining BMI A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/9/157\" title=\"table 1B\">",
"      Determining BMI B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/43/6845\" title=\"table 2\">",
"      Food frequency questionnaire",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=related_link\">",
"      Diagnosis of celiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42679?source=related_link\">",
"      Diet in the treatment and prevention of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=related_link\">",
"      Dietary fat",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=related_link\">",
"      Dietary therapy for obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=related_link\">",
"      Eating disorders: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=related_link\">",
"      Health hazards associated with obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31641?source=related_link\">",
"      Healthy diet in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=related_link\">",
"      Overview of homocysteine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28642?source=related_link\">",
"      Patient information: Diet and health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/35/11827?source=related_link\">",
"      Patient information: Diet and health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=related_link\">",
"      Prediction and prevention of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=related_link\">",
"      Screening for and clinical evaluation of obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/16/2312?source=related_link\">",
"      Screening for diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33241?source=related_link\">",
"      Screening guidelines for dyslipidemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26122?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in secondary prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_40_23176="AV sequential pacing tutorial";
var content_f22_40_23176=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78036&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78036&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1046px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dual chamber atrioventricular sequential pacing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 344px; height: 189px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Two pacemaker spikes are seen within each complex; there is an atrial spike (marked by red lines) and an associated P wave, followed by a ventricular spike (marked by green lines) and an associated paced QRS complex. The P wave morphology is variable, depending upon the location of the wire within the right atrium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 456px\">",
"   <div class=\"ttl\">",
"    Sinus rhythm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 103px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The normal P wave in sinus rhythm is slightly notched since activation of the right atrium precedes that of the left atrium. The P wave is upright in a positive direction in leads I and II. A P wave with a uniform morphology precedes each QRS complex. The rate is between 60 and 100 beats per minute and the cycle length is uniform between sequential P waves and QRS complexes. In addition, the P wave morphology and PR intervals are identical from beat to beat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23176=[""].join("\n");
var outline_f22_40_23176=null;
var title_f22_40_23177="Thyroid nerves variants";
var content_f22_40_23177=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F61802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F61802&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Variations in nerve supply of the thyroid gland",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 659px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAKTAh4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6porK8T61H4f0hr+W1ubv99BbpBbbPMkkmlSJAN7Ko+aReSwAGayv+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KoA6qiuV/4SjV/wDoRPEn/f8A07/5Ko/4SjV/+hE8Sf8Af/Tv/kqgDqqK5X/hKNX/AOhE8Sf9/wDTv/kqj/hKNX/6ETxJ/wB/9O/+SqAOqorj7jxndWbWzan4Q8QWNtNdQWn2iWSyZI3mlWJCwS4ZsbnXOFNdhQByvxL/AORcs/8AsNaT/wCnG3rqq5X4l/8AIuWf/Ya0n/0429dVQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHK/Ev/kXLP8A7DWk/wDpxt66quV+Jf8AyLln/wBhrSf/AE429dVQByvxL/5Fyz/7DWk/+nG3rqq5X4l/8i5Z/wDYa0n/ANONvXVUAeZfG34o/wDCtrTSvsumf2pfXzyMLfzCm2GJN0j5APTI/DPpXoml31vqmmWmoWT+Za3UKTxP/eRlDKfyIrzbxf8ACgeMviDca1r+q3SaWunf2fa2tjM0Eihs+YXYdQwZgR0IIBq14C8IeLPC2i+FNHOv2c2n6W08d6v2clrqE8wqpP3SmSOOoxQB1/jXVpdB8Ha9rFtGkk+n2E93GkmdrNHGzAHHOMivKvhZ8WdY8VzrLfz+Fp4RYveSafpL3EmoJgA7djDaSM4IDH2zXrPizSP+Eg8K6zo3n/Z/7RsprPztm/y/MQpu25GcZzjIz61wvgX4feKfCdlDZR+M7K6s7aza1tozoUcZRtuEdnEm5sdcE8+tACf8Lp8N6jpN/ceGvteq3NrpkmpPHDbsRCFyAsp/hbcOnXHPTmjw98X9OvPBmlaxqmmatb31+Y4YLKKxkZ7qVl3EW4I/eIACd/T35FUfBnwak8LnWEh8TXF1ba5YyW+qpLajdPO2/wDfo275CN5+Uhvr6Urr4L3+peDtD0fV9e0+7n0CQf2bI+mBojEF2mOaNnO/OF5BGMDrQB1B+L3hdNGt9RnOowiXUG0p7Z7N/PhuVG4xvGMkHHpnrVfVPjN4c03zllstfkmhtUvZootMkLwwtn55P7gGOd2Kz9K+EMttDovnajpdu+na1HrHlabpIt4n2ps8vAcnJ67yT6Yrc1v4df2prvjDUv7U8r/hIdG/sjy/s+77P8rL5mdw3fe+7gdOtAE/iL4laVomnWeo/wBna3f6Zc2aX4vLGyaWGOFhkM7ZGOOcdcVTsPHcmq/E7Q9K0uSCbQNT0A6tHKYyJGbzAF5J4G09CM5rm9f+Cc2qLokR1y0lt9P0KPRTHfaaLlFKJt+0QoZAI5DxzyRjrXR+Evhp/wAI9r/hzU/7W+0f2PoQ0Xy/s2zzvnDebnedvTG3B+tAEHjD4hXnhz4o2ehnT7q/0yXSHvWhsLRp7kyiXaMYOAuM5z+fIFWH+MPhQWGh3cUt/cJrMMs1olvZvLI3lHDoUUEhgePTjrjmpPF/gjWNR8b2/irw7r1tpmoQaa2nLHcWH2hSGk3l8+YuD7YPSqHhL4SweGtR8HXVtq0kw0CG7SQSQfNdyXHLPnd8mCTgYPGBnvQBoa38VNG0O/hh1bTdetLSSSOIahLp7LbBnAIBfr/EASBweOtQeJPjD4a8P6nqllexavIdLljivpreweSG28wAqzyDgDke5PQGuY8W/A2bxHr+uX0+vWmzUbqO6jluNME91bbCD5SSmQbY8LjAA6/XO9r/AMKP7XtfiBD/AGz5P/CVvbPn7Lu+y+UAMffG/OP9nHvQBr6z8TNF07X59HgtdW1S8tUjku/7NsmnS1SQZUyMOmRzxnjmuT0v4zW9hr3iSy8VW92ttZ64+mwXdrYyNBDH8oTzpPuhiSenPtWyfh/rml+KNT1bwl4lg06PV0gW+hudPFwQ8SbBJEd4wSvYgjP5Crq3wj/tDQfFmm/235f9va0ur+Z9kz5GGRvLxv8Am+597I69KAO+8WeItN8KaDc6vrU5hsoNoJVS7MzEKqqo5JJIGK4DxH8ZLCy8JeIr2w0vVYtb0qBZDpuo2TxSKH4SR1H/ACzz1IPHQ4yK6/4j+EovGvhebSHu3spfNjuILlEDmGWNgyttPDDjBHoe1cZd/CjUdbg8UXPiXxFDca1rWnppi3FtY+XFbQq27iPeSxLcklhQB03gHxFe3Hw4i8ReLpkhPkSXc7mzktfKiUEkmNiWwApIP8QwQOao2HxZ0O70O+1h7DXLXS7W1+2i6ubFkjni3Abo2zhvvA44OD0rqpdHc+EH0WG5RZTYmzW4kgWVQfL2BzG3DDvtPB6GvJ9C+BAs7TxNFdavbW41nTjYGDTLNoIEO4MJmjaRtz5AGBtGMjvmgD0K++IWhWV7cWs8lwJYNDbxC+IiR9kU4J/3uPu1n6P8V/Dmp6ha2rrqVgt3ZNqFrcX9o0EVxCqb3ZGbrtXknpgZBIxXIXvwu1+10zxDquo68muaq/hC58P29rBYCDcCCyYIc5ORjGOrdR0p3hL4Vanq+leGZvHOqCSDTtBbTbXTbe18hrbz7YRS+Y5Ztzhfl4AGRnA6UAdVovxZ8ParexW6wataLc20t5ZTXlk0Ud7FGu52hJ+9hfm5xwRWZf8Axb0rUfDkWpaBc3drAbi2j+1XmlytFIJXK7EyVDHjBIJC+9ZPhH4Jy+H7uADUNDa3t4JoEni0RI7yVZIXjG+XeeRvySAC2ME8mugufhd5/wAL9B8H/wBsbf7Lmt5vtf2bPm+U+7Gzfxnp94496ALOsfFvw3pOq31pcLqb2un3C2t9qUNm72lpKxA2SSjoQSAcA4JGa0IviLoc3jC58MwLqE2qW06QTeVZu8UZdNwLSAbVXHckVyOufCG/vj4j0uy8SLaeF/EOoHUr+zNkHnEjMrSCOXcAAxQdVOPfnPZ+EfBq+HPFHinV47zzk1uWCRYPK2/ZxFHsxu3HdnrnA/GgCp4h8UX+n/FXwl4dgWA2GqW93LcFkJcGJAV2nPHXng1HoPxO0jVvE1poMun63pWo3sbyWi6lYtALgINzbcnqFGcHHFW/Engs61430PxCupPatpdtdWwijiyz+cgXcHz8pXGehz7Vw/gX4JSeGvFHhzWZ9ZsLiXRmustDpYimvRNGUDTS+YSzLnPIPccZJoA3LX41+E7rQm1mIat/ZcYVpLprCRY48y+WMuRtPzEdCcA1qa78T/DmivrwvJbpk0R7eO8khgLqrz42KpH3jyMgdKzNP+H0Xhz4FXngueSXWkisbpA0UHlvMztJIoVCWwwLADnqAeK5jwd8JLy7+CCaDrV5JY65qd1Hqd9PLH5zq4kVlQjcOiIq9eDn6UAdja/FvwxJp/iC7vDqGmjQxG13Df2bwS4k/wBWVQ8nceAODyMgZp2m/Ffw9cvqCX8WqaPJYWP9pXCanZtCyQbtobHOcnoBknp14rC+IvwxXVF8c6r9ou7qXWre0EVpZwqJYXtiCrKzPtckjodvpnvXLeGfAniPxzrniq68crfwWWoaMmlR3FzaxWs7OJBIHEMbuAFIB5bnPpwAD0bSvipo+pSXkCabr8F9BZi/jsp9PdZ7mAsFDwpzvGSBjr+tY2v/ABctpPB/i640O2vLLX9DtRO9nqtqY2AY4DFc8jr0NYdv8DLxNH1OwGtaPYNc2Rs0u9L0Vbad/nRt0jiQkghMMq4BDGrNj8DjDYeJYW1fTrZ9c02OwZNP0kW8MBVs7wgkO4nvkgnrntQB6bL4hg03wOviHVyVghsVvLgxLnA2BmwP6Vz2g/FnwzrF9dW2dRsPI086p5moWb26S2o+9KhYZZR6455xnFbWv+F/7X+Hl34X+2eT9o0/7D9p8rdt+Tbv2ZGfXGfxrmLz4T29/e2b3upu9tD4abw5JEkG1nU4/fBtx2nj7uD9aALek/Frw9qM0kbW+r2X+gyalbte2TRLd26DczxE/e45xwcGk0/4u+Gb63sbmIaolneXNtaQ3M1jJFE0k4bYNzAAj5CCwyBxzzXLeGfgnNo6yQNqGhCEWM9ktxbaGsV1IJImjDSSbzyN2TtA3Y5PNdbf/DiG++EVt4Hn1A7re0hgiv1hwySRYKShN3HKjjd6jNAEl78UvDlrFqDBr24ktNS/shYbe3MklxdgZMUQH3iO54A9a2fBfi7TfF9ndzacl1BLZztbXVreQmGaCQAHayn2IPGR+tcDqXwTtLzwBpGgnUkl1LTrx9QN/cWayJdTOWMnmwlsFW3YxnI2jmur+GPgyXwdZX0c8mklrqVZPL0zThZxJgY6bmLE+pPsKAGSfE7w7HbTStJdCSLWBoRg8k+abs9FC9weoPTANR3PxO0iz8UW2ialp+t2D3V4bC2vLmxZLaebcVCo+eQxBwcYPXpzVCb4U2snxaXxn/aTi23Lctpfk5RrpYzGs27dwQpzjb1Gc1zkfwNmPia31W4160ma316PW1nk0wNeSBXLeQ8/mZ284GBjgHHQAA6e++KuiTxeJLXS5L5L7SFvY5rh9Pkkgt5LeNmYswwpHHC7gWxjjINF58ULLRPDej6jqdhrV/b3OmQahNqFhprfZ0V1zubLfJ0LbckqMZqfTfh19i8K+PNG/tTf/wAJTe395532fH2X7UgTbt3fPtxnOVz6CuR174GzapHYQtr1pLb2+gx6Ji+0wXHklI9nnwAyARsevcjsehAB1uvfFrw5o81vCI9V1CS40tNZiXT7F591qxIEhx90cEktgAdTyBWPe/GO1Xxd4dsNM0vUdR0nV9ON+lxa2cksvJwAEA5A53f3e9XtJ+F39n6rZXv9seZ9n8JJ4X2fZcbtrA+fnfx0+5/49WbZ/CjU9GbwdcaB4jgiv9AspNPeS4sN6XEbnJIUOCrD6nt+IB0uh/EvR9c8QPpelWer3MSXD2h1BLJjaCVAcqZO3QjJGD2PSm/FHxVqGgLoOl+H0t313XL9bO2NwpaOJB80krKCCwVe2R1/CuX0T4OzWXxIt/FU+q2KPbzyzEafp5tZbnfn5ZiJChHPJCAt1Nbfxe0XVJ7zwp4k0Kzkv7zw/qHnSWceN81vINkoTJALAYIB96AOX+JfxX1nwt8Ql8NWk/hm0gXTkvDea080au5cqUHlg88ZAx2PNVvFPxe1rSPEGh6Wt34QtkvdBi1d7+8lnFs7szjbEwwxBCgrlc9a6bxX8N9V1nx//wAJfoHieLSLmTTlsGhuNJW6+Tfvz87jBzjtkY96h1n4X65feLNL8R23iuzh1S10hNKmabRVmjmw7OZAnmgJksPlGcY680Ac1f8Axw1OLwf4K1GbT9P0afxCZ/MvdQ82W0thGcA7Y/nO/ggEjGeSRyNqX4la7YaZ4TnuH8Nap/bfiGHShdaVJI8Bt3C5cZbKyA7gVJIGBU2mfCjVPD3hm00jw94jtHh8yaa+g1TS0uLe7kkKncIww8vbt4AJ61nD4Etb+HLCz0vxEljqdtrv9vm5TTlMImAwqRwBwEQYGBk9MdMYANr44/EfVvh8/h/+xtKh1P7dJOZ4n3bxHEquxTB67dx5B6dKl8J/EZ/G3ifVdN8Oy2i2A0iG/srxkLMJJCRtkXdj5SMFRg5BGalh+H2u3mveGtW8TeLY9VuNEup7hNmlrbiRJIgmz5XOMEE55znGO9V/BXwwsPhx4p8U+JNHlmnstQi3R6VBbfNCQdxVG3fNk5AGBgEDPGaAN74TeLLnxf4Ve41SCK31iwu5tO1CKLOxbiI4bbnnBBU4PTOK7OvP/gn4f1LQ/Ct9c69CLfV9b1O41i6twc+Q8xGEyO4VVz7kivQKACiiigAooooAKKKKACiiigDlfiX/AMi5Z/8AYa0n/wBONvXVVyvxL/5Fyz/7DWk/+nG3rqqAOV+Jf/IuWf8A2GtJ/wDTjb11Vcr8S/8AkXLP/sNaT/6cbeuqoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDlfiX/yLln/2GtJ/9ONvXVVyvxL/AORcs/8AsNaT/wCnG3rqqAOV+Jf/ACLln/2GtJ/9ONvXVVyvxL/5Fyz/AOw1pP8A6cbeuqoAKKKKACiiigBGYKpYngdahvJRCiMTgFwPzpkpJtJwvUb/AOtZXi658vTLV0PD3MYB/X+lRKVk2bUqfPNR7s07a5E19NEDzHGp/Mn/AAq5XL+F5zNr2qgn7sMH85K6K6m8i1lmCl9ilto74FKnLmjceIpezqcnp+KJqKxdN16O6hWSeLyVbuG3gfXjitiN0kQPGysh6MpyDVpp7GLTQ6iiimIKKzZtZtob+S1lEimPaGkK/IpIyMn+vStKkmmNqwUUUUxBmop5NtrJIpxhCc/hQD+/cf7IP86oahLs8P6hJnmOKb8MBqTZcY3a+RKbxWuLRAf9Y5x+Csf6Vfrh9Iumk1PQVY53F8/9+mruKilPnVzfFUfYyUfL9WFFYVv4g8y9uIXtiqwuUJD5Y++3FbFvcw3KboJFcDrg8j6jtVqSexzNNbktFFFMQUVS1HUorB4UkSV2lzgRrnAGM/zqzbzR3MKSwuHjYZBFK6vYdupJRRRTEGeaQMCWA7HBpjnE0fuCP5UyBv39wh6ghvwIx/Q0h20uUpr9VtmJbOZPL/8AHsVqV5wL1ntVJbOdQA/DzhXo9Z0p89zrxWH9il53/QKKxbrXDBrDWX2YkKobfvwT9Bjn860rW9gueIpBvHVDww/CtFJM5GmixRRRTEFFVNSv49PgWWVXYM4QKgySTT7K7ivIvMhJ4O1lYYKn0IpXV7DtpcsUUUUxAeKTcN4U9SM0y4OIi3oQf1pjttu4c9GVlH14P9DSGlcjkuQlzJGT91Q2Pz/wp2nS+fZQyj+MbvzrltZu2TxHfIG+VbaP8/mrd8KPv8NaYx6tbof0rOM7zcTrq4fkoqfe35GrRWXrmrHTDbAQeb5zbcl9oX6nBqe11KCYqjHypT0V+/0PQ1pzK9jks7XLtFFFMQUUyeVYYZJXzsRSxwMnA5qnpuq2+oDEYeN9u4JIMEr6j1pXV7DsX6KKKYgpGYKpJPApaqysfsc+Oo3/ANaTGlcfeTCFY2JwC4X9DUVtcia+njH/ACzRD+Zb/CsvxjceVpto6N9+6jAI9ME/0qDwvOZtb1UE52xQfzkrNz99ROuOHvQdX+t1/mdPRUN3N9ntZZtpfy1LbR3xWVpmvx3UCyzxeSrdw28D68cVo5JOxyJN6m3RTY5ElQPGyup6MpyDTqYgoorOn1e3gvXt5VkXZjdJt+Rc9Mn+vSk2luNK+xo0UDnmimI5X4l/8i5Z/wDYa0n/ANONvXVVyvxL/wCRcs/+w1pP/pxt66qgDlfiX/yLln/2GtJ/9ONvXVVyvxL/AORcs/8AsNaT/wCnG3rqqACiiigAooooAz1k2z30Z6bgR9Co/rmuW8WXYfwppssf/LO7WM/VA6n9RWnrk5stdjZiRHcwhR9VJz/6EtcJ4i1NYbe806RuWuo7qH34KuP/AEE/ia469Syafme1gMM5zhNd1/kzoPh/dtP4k1ZWxhreMjHszf8AxVdVJdGzvjbzn9zMCUY9j6V5Fodnqesa/Jb6Jf8A2G5FsZHl3suV3AY+XryRVW+8Ta5Y6jc6Jrs4k1C0kzFOCCG4yB0GQQc884yDyK5adeXslZWd9H0fl8ztx2W+1rSlCSvZXj1Sta52DrPaA3NocBTh0Hfr/hWjpeqxOxKzNZT9yv3WPuD/AFqDRZ49QsY3QYWdMlf7rcZH86qXunrcRCSAhZs4Y9j25/I13U2q0OeH3fofOyvCXLM6pNU1NB8qWtynZwdpP1qQazqJI/4l0WPTzv8A61cTHb6vHGPIRnT1EuP0xVqEa4cDaVPvMP8ACneYWibGq3N3NeRTrp4iYjZLmXcHXsOnUeta+mpcCELBcypGv3Y2Ctt9skZxXHzRa9KQmAxOes4HT8KuWA8SQINscZUHGGlVv1wKSUr3sDta1ztbKaU3MsE5Viiq6sBjIOeD+X61drA8MG7mlvJ74p5oZYgqHIGBk/8AoX6Vv1tG9tTN7lC5m8nVLde0sb5/4CVx/wChGsfVLgHR/E1v/GltJKP91o2H81P51c8VsYLS3u14EEwLEejAr/MrXGeJNUW1kmnZv3N3aTWz+25PlP8A30APoTWNWpyuzPSwmHdVKS/qzv8AkVfDd87eJPD0Zxt3up/79PivVywHU4r59WSe4uNLhs5TDdy3CRRSBiuxmOAcjnvWlr+seJvBeqQ2WuX/ANusrpCyS7iSvOCcnnI4yDkYOR0NceGxPJF8y0vuexmWWOvViqckpW26uzbduh2WvQs+rXUlu+yVTvDDuNuf6VBYasGmUXu6CdeBKh2kfX2ql4Vv/wC0LcSStudWETfTt+mKu31lHOZEfiVcMrDqM9f616HLzq8T5madKThLob8Wp6gObaa3vI/9sbWH5YqUazqWMf2fDn187+mK4mCy1OIH7MPMI67ZNn8wanhGuDgxsPczD/CovNBaJ0etXt9eWqgad5cyNvjkWbO0+4x0x2qbSPtDjckr2zvy6LhlY+vIOD9K5udddCkE5A7ecB/Sn2UPiOCRgkaeuDMrA/oKVpN3aHpax26TXMFxAkziVJWKEkAFTgkHj6VpVyWkPqlxrFtHqIiRI1aXCtkkgYGe3fP4V1tbRvbUzkUdUlMP2WT+ETAMfYgj+ZFQJchNeER4E8PBPqp6fkx/KpPEMbPot2UBLxr5qgdyhDAfmK4/VtWWFbDU9xK28iu5Xk7ejY/4CTWdSfI9Ttw2HdaOm+q/Vficm1+8VpGvHy3SufXhwa9sOBzXzvqt5GtlfODvjWRyCp6jJwQa3fENz4v8G2tnqN3qg1DT52CPH5hfDEZAywyO+CD16iuDD4jkcrq6/I9/MMu+sKmoySk72T67bf8ABO78WQrc6lCI2UO0eFf0IY//AF6xbfU3jkEOooxKn5ZBwy+4NZPhfWjq0kuXLY/ex564P+f1ror61iuJArqCsg3L7HPB/UV6KSqK6PmKsJUJuEuhqwand4U2V3FdL/cmHI/EYP8AOrA1nUhwbCFj6ibH6YriI9Pvo5iLU7yclQG2nHv2qeJdcVseU4+sw/wqPfWhPus6q/1C7u7KSG40vcrDqk+CCOQR8vY1V0Y3bbXmdre6HyM6YIce4PFYzrroTg8YzjzgP6Ulrb+IUmV0Rfn9ZwR+W2laTeqHokdy0l1bKJHmEiBhuDKOhPOMYrTrioZdakmtob9IUieVVbD5YjcM9K7WtY36mcivqAZrG5CAlzG20D1xxWddXimLT7pSNvmIck8Yb5c/k1bNcBdziTSLuxyymDfDjPI2krx+VTVlynVhKXtXb+tTP8W3b2/inU9uOYkHP+6K7DwJJ5vhDS3PURbfyJH9K8s1nWV1PVPtWR5j2yCUDtIAVYfmMj2IpulW3ilfCMuuaFqpjs7cysLTzCTtVjuwpBXqCcf1rz4V+WtJpXXkfQV8AqmEpxnJQei172asereLhHLp6KxU4lUkZ7ciuPFzcacwhuVE9sR0boOn5dfpXNaD4uk1u+tzOwBmHlyKDwG6gj2Pb6121wqyW6FwCpbY2fcn/EV6EXGtHmR87icPPCVPZz3LljqTGEfYL7ae0M43Ae3PP61eXWNUX79lbye6yFf8a4u502WO4LWjAR8YUnGM9gak8vXI3x5L+n+uH+FS1OOhl7rOzXWNQIIfTUYeizf/AFqxbITi4aN4Ht4UbfAVky8XsDjkf045rPUa7tyvy/8AbYf4VD9n8QO/mKgJU4z9oHX/AL5pPne6GuVHeRC8CBvtRfjPzouP0Aq7ZTG4tIpWXazLlh6HuPzri1n8RQQMZY4NoGcs4/p/hXY6XEYNOto2O5hGNx9Tjk/nWsb9SJWLVZkc2LjUIT/CwK/QoD/PNadc1rsxstchkJIS5h2ceqk//Fj8qJvlVzTDw9pJxMfxbd+Z4U0t1PzRXixN9UV1/XGfxpPh7eNP4h1dWxzBCRj2L/41zXibURDFdWDHh7mO6j+u0qw/9A/WszRLXU9X8RvaaJfmxufspleXey5UMox8vXlhXmyrNVotan01PBJ4OcZvlXd9FdM9ymZfLYMQMjHNeasJ7RftNmSNvDoO/X+g/wD1VyNx4t13T9Su9D12fzL22f5JgfvY5HYZBHIPXrnmu60eRL2yRxysybvzI/pmu6nUjWWx4GLwVTB25ndPZrZroSaXq0TsSJms5++37rH3B7/WthNU1RB8qWtynZwdpP1//VXLX2nrcRCSAhZs4Y9jzjn9agjttXjjHkIXT1EuP0xTcZQ2OZOMjtRrOok/8g6LHp5//wBasvVrm9mvYrhLDymxslBl3K69uMDketY8I1xsDaVPbMw/wpJY9elIThiemZwP6VL52tUC5UdfpqXAhCw3UqRr0jYK232BIzitKznmN1JBOVbCB1YDGeSCD+n51xVgPEkKDbGhUHGGlU/0FdF4ZN3NcXc9+Y/MXbEoQ5A6k/0/KrhcUrFX4l/8i5Z/9hrSf/Tjb11Vcr8S/wDkXLP/ALDWk/8Apxt66qtTM5X4l/8AIuWf/Ya0n/0429dVXK/Ev/kXLP8A7DWk/wDpxt66qgAorxfxT8Sde0b4gXWmak1p4f0mOeGKynvtMnnhvw2NxNyjhYjk4HykA/ePFX9A8T+PLv4p33he+k8L/ZLCGG8nkhtbgO8TsRtQmUgNgdSCPagD1mivHvhr8W7jxX8Q9Q0a6h0+PSbiOabRp4GJknSGVo3EnzHkgbwAB8o713N1488PWt1Nbz3dwssTmNwLKdgGBweQmD+FAC/EK2eTQGu4QfNsmE/H93o34AHP/Aa8f8Q3S3k9rcKQcHmvV5vH/heaF4pbq4aN1KspsLjBB4I/1dfOUniPT7bV7qyNxM0MMzIjNbyZIBwDjbnpXlZjGStKPU+s4cqwalCbScdVfs/6/E9V+E0+fH9zGT97Tnx+Ekdcv8aojH44u5oSQ+EBI7HYGX9QR+NR/Dbxfo9j8QxNNczLC1nJGSLWVjnKnoFz2qt8YPEekX3iozWc8zrMkR+a2lTJBA/iUf3ainCUsJZrW50zrQhmykmrOKX6FzwfHr885t9N15YmCCVY5YAyvzjBPUct2/pXYaRqWpJq6adrFgIbghm82Bi0LgZ5BPI57H2rifBl08Go2LwMA7oYjn+8UOD/AN9BcivTtD1SHV7ISowEyn95H3Uk5/L3rTB04+1k07PR+vr9x5ObSkm1KCa72Safyt+Js2H/AB5nt85/lUq/fH0/xppUQW8gzxkt+lR27NcYWMZ45PYV6p8+SJLGl0pdwqhiMk4FaluFMe5GDBuhByKjtYraHqqyOerGi8iaIrdWSgMv34+zD/PehDJ9E+W4vYvRg/55H/sta1c/pNwrauzJkJcRd/7wPA+v3q6CkBV1S0W/065tHO0TRsm7+6SOD+B5rwzW71rnSpbaYATwko65zgjgivfa+e/ixbto3jqURcQXyC5A7AkkN+oJ/GvPzBNQ50fScONTrOi/VfLf8PyKenXGzX/Dhzx/aNuP/HwK679oKHfHpjKN0iq7KPXaVyPxBIrz+aUW99ok39y9hf8AJwa9W+L100Wl2OoW9vmRWeGKZv8AlmWGSQPXCkA9ufauDC1E6M6e7fQ9XNb0sZQqx8zy7wul9HbxGz8Rm2lnIVYltxKBgkLuJIA/XrXaz3/iDSZidcs0vUIAS5sgeeoAdccZyeRxwPrXmeiP+4KDhoyAPcYBwfxzXrPg/X/7ST7NduPtSLhSeN4H9fau3CR91e87nnZxFqcnyKS9En5O6s/vudPpxJkk4x8lWH6H6/0ptqmxQ395cVEk292RBuYscAV6dj5YlumXfgnHr+daNq0cp3xSK4x2IPNRW1vFGd9xtd/7vYVZuLeOeImBfKnXlGXii4xsX7vWrdv76lP0J/pW3XMG7MlzZySARzwyhXHQc8E/TGa6ekAV4nrUpsZtS0iQBTC5VB/sdV/8dIr2yvGvjvaNY3+matBx54NvL9V5U/XBb8hXFjk/Z8y6HuZBJPE+xl9rb1Wv+Z5/qDbdBmTpxg1658RYDc+AkYwLPBJEkgVnKiNiuN3Hpuz+FePakwbQ5JD3r3meNb74b6crcpNZwK30dAuf/Hs15FCPPTqPqtf8180e9nr9k6E1/M/0PnzQtU1i0AS11EWVurDcRCrlc/e68kA54r0iG78S6dDBPqkcWsaey5FxZKFmQcc7OjDpwK8y0z5Lu5glGG3Hr2IJJ/D5q9H8Ca0LcDTLuQLHn9yWPCk/w59PSuzDUKbWmj7pnLm7lzOaipLdqy6q+61/E7PRZhcPaTKrgPHu+ZcHp3HatVurfT/CobeLEgk/usR+YpjzgXEi9TwAB1r2bHx5POQIgM84x+hq1ZPFIiBJELKOVDDI61Hb2ykiS6xz0Q/1rQaG2uItnlBcjhhxg0dQIbtf9ItWH/PZB/48P8K3K5S7nm+zNbyj/Sofmjfpvx3+tdRDIssSSIco6hgfY0APrzLx0x0jxH5vSC/j3D03qArD8tp/E16bXEfGDT/tfgy4uox+/sWFwh9ujD6YJP4CubFRcqbt0PRyqooYqMZbS0+/b8bHkJbZeXZB+8civQfhuHm+GzeWAymS4hkTONwZifw+9ivLtMnN1bu7nkLXrPwOBuPAN5GO93Mgz7qv+NeFhoOvKUU7Ozs/M+vz6Ps8Im+kl+TPEobrUtP1m4XTXWycyNlQofaM5UDd6ZI/Cu/0O68VS6Wt7b3dprVrkeZbughkVvQEd8+ua4/xPH9k8ZXG5SEkYSbScYDgnH4F66Dwlqv9j6gSzH7LNjzAB1weGx6jvXThaVKau9PO7v3OPMZTqUozjFO6WjSd+m+/Tud3pF//AGhYtJ9nubcrIEaO4TaykAZ+o966eX74+v8AhVCFUuog8Tq6Mm5WU5B9KsXkwSVMkDJNe3GLUUm7nxs2nJtK3kSZAgYscU+zliIdGkRZC2QCwGetMt4jcYaX5Ivfqa1IVtdmwQoV78VRIy6QG1YHkY5rS05/M0+1c9WiU/oKw5S1m7275a0l4Ruuwnt9K0vD0m/TEU/ejYoR6DPA/IihgaVc18QLZpPD0l1HxJZMLgfQcN+hJ/AV0tR3EMdxBJDMoeKRSjqehBGCKiceaLia0KvsqkanZnz74iu1vZbWdSODz+VbHwquAvxGdGI+fTpFH13xn+hriLpJdP8AEF9pUzFhaztECe4BwD+Iwa3vA7NH8RrfyzhxauR+GD/SvmvbOnV52r2P0XF0IvAzjHZxbRU+NEZi8bXcsRw4KqT6ZRWU/nx+Nafhuy1uGZLTT/FEBuEBYW5thJH7gv8Aj2zU/wAZJo4tSl2Wu2a+SKWWVxkhFIAC+nKZJ+lcnoV7LbLa3du22ZACfrjk/wCIrui+es5JtJ66aXPGi51MBBWWmmqT6Lun5npGlX2pRXyWes2Jjumc/vbfLQOBnkHscno2PX2rrLD/AI8znj5z/KsbQdUi1iwEqkCZT+8Tupz/AC9DW5gQW8g7DJ/SvXpq0d7nymI+N3jyvsOT76fT/GmLJGl0pdwqK2CScCmW7NPtSPk45PYVqWsVtB95Vkc9SRVmJJbhTHuRgwPQg5FP0X5bu9j9NrfmW/wqC7iMRW6sl2un34+zj/Pem6VcJJq7SIcLNF0PXcD0+o+ai4FT4l/8i5Z/9hrSf/Tjb11Vcr8S/wDkXLP/ALDWk/8Apxt66qkByvxL/wCRcs/+w1pP/pxt66quV+Jf/IuWf/Ya0n/0429ePfFXW7yD46x6dL4gn0/S/wCzLeXyW16XToi5lYEqEBDtj+EgZx14oA9c1D4deHNR1Z7++gvJvMnW6e1e/nNq8ynIcwb/ACyeB2x7VoS+EtJk1rVdWMUq3+p2gsbmVZWGYgCAAM4U8nkc186at4p1uz+Ml/s8Q3pgtvFFvbjTY9UlaaWBl+aOO0PyNGTjL8Fe3Wtbwxr11B8V7O3vNXbxJLf6rKsNzpmtzCW1jGf3dxYn5FjXHPyjHUEnFAHsVh8M/CenXGhXGnaRDaXOjf8AHrPB8kh+TYfMYcyZHXdnqa7KvmnQ/H5uP2efEMP/AAk80ni22ju5f+P1jdxoJyFbOdwABUD2Ira+FGteKj8XW8MeJL67mfS/Dr7JZJGaK9BniMVyVzgybH2MeuVbnrQB75XzT47jWD4sarGo+VpkY/Vo1Y/qa9s+w+OP+hh8N/8Aghn/APkyvn/x/beII/ilfLc6npUl0XiLSR6dIiH90mMIZyRxj+KvOzNJ0lfufS8LzccTOyv7r7d13sdV8OWI+LVoB3glH/jhNa/7QkGJtMmHWSCWP/vkg/8As1cV4Eg8RH4pWiW2q6THdGOXbJJpsjoPkOflE4P/AI9XU/GvT/FSWmkz6hrOiTqJJIlEOkyxYLAHnNy2fu+1Z4SKeGav1OnM6jjmVKVmvdXbz8zhPD9y8DQ3CqW8mXzBt5OFbPT8K6i4SfS9VnewnaPDHaUODtPI+oxivONLt9aAKxajp6lSBhrN/Qf9NfrXoFmLp9HtJ9Tlt55hmBnhgMQXYAADl25xg5yPpxWcPdlCV91b+vxNMX/GknHR33t/meleCmfW9LM+oXTMyOVZRxnGOtaBuTvMMACIDxiuG8EaiNP1IwyN+4uPlBzwG7V2BGy6+tetTlzRPl8XR9lUaWz2NqxADDnJ9a1dvy1maanzZrVHJAqzlMq/t0tyl1EClyHHlhTw7E4wR75x+NdFWPbp9t1UyNzBaHCjsZCOv4D+ftWxTYBXiH7REYj1Tw/OB87RzKfopQj/ANCNe314r+0av77w43/XwP8A0XXDmH+7y+X5nucOO2Y0/n/6SzgtaOz+yGX/AJ7Rt+or2v4qafPN4Uuo7WJpQHWZVUZKkHnH4E14hr7YTSj2Dp/MV9C/EoTf8IRqkltI0U0KLMjr1Uo4bP6V52Cp88JuOjW39eZ7OfycamHfr+aPmfSWYXUigZGemcH7zDj8q6aCFlKyQyFZByP4WGKwrZJ9Y1u6eCJIp2UytGvRiApJUe53Nj6+lb1lI3khJl3Ae2a2w8rxs90aYt3mpd0vyO88C315qt3LaX16+EXK5xuIz/nmuquWjsZTBaj2LHqa8s0m7On6nDdxH5Ub5gpzx3r0i6kScx3EZBRwGB+tenRnzKzPlMfQVOpzRWjNG0yWBc5JrbiX5Kw7BSzLW6vCgVqcJSvrKCeN2nXAAOXBwQK0NHlkn0y3lmJZ2XO4jG4dj+Iwfxqjfr9qnhsF5WT5pf8AcHUfjwPxraAAGAMAU2AV5n+0BEr+CraQ/ejvo2H4q4/rXplec/HoZ8CZ9LuM/wDoVc2L/gy9D0smdsdS/wASPF7058Kq3djzX0DoR3fCrTmP3ho8bD6iEEfqK+fL0/8AFJR/WvonwZF9q+G2jQj/AJaaXEn5xAV5eWK7mvI+n4n0o03/AHmfOOpjyfFmoLGBt+0SYHqCRj+VbMEPmIDuKsezf55rG15SNahlyQJoYZAfcoAf/HmrY0t3SMq/zp+YqsK/csGI1hCS7L8NDr/COp38uqW9hcXriBuF3HJHsDXoF5HDppXysvKw5duTXkCNsmjlgO2RCDgdR+FemrdpqWnQXUZzlRuHoR1r06M7qzPmMxoKElOK0Zo2zNId0jZz2rctlBQGsCxG/bXQw/LGK3PNIrm1juFIlQMPXoRTvDzk200YcvDFKY4mPdQB/Ikj8KZqMjLAsMJxPOwjQ+me/wCHWtK0t47W2jghGEQYH/1/emwJawvHkYl8E68h/wCfGY/khP8ASt2sfxkN3hDXB62M4/8AIbVnU+Fm2Gdq0H5r8z5p8MtusLrPVVr2L9n858FXXtfyf+gJXjfhk40+9/3a9i/Z8OfBV37ahJ/6BHXg5b/G+TPveJl/sk/8SPNfiqm3xarjGTuTPqUlK/ySqtknmoN/yY79V/OtH4uQOuq3OOWhvplPt5iq6/8Aow1k6Q7owZG3qwyMdfyrbDrllKPZ/q1+hwxfNhacvVfr+p0Ol6nqGmMkcF0y27N8y5+Xnv7V6wbWCCyS7kkM8rAEFunr0rx07JFwAEb06V6D4W1EXuifZXb9/b/KQe47V6dGf2WeFmVFWVSK9Tcime4bczYX0rasQCox0rnrH09K6OxXbHXQeOSzRLIuxlDKexqtpSLbarJbwO3ltFvdCchWyAPzGfyq1PMsFvJNIcKik07RrVoLYyzD/SJz5kmeo9F/AcfnTAv0UUUgPm34hRrD8WdTRR8rvE2PcxoT+tXfAQB+Lenxn7rQyqR7eW1VviaNvxbvT6+Sf/IS1P4BbHxh0weqS/8Aop6+ct/tdv736n6TJ3ytP/p1/wC2mv8AHVMWumOf9Ykc8Lcc/LtI/nXnmiEshXBK7mwV6gbj2r2f416fbS6TBNK+yd38uHPRmI5U/VQfxUV4bom/bw2GUrlTx2AP6g11awq8kt1p8tLP7vxueNl8lUwLt0f+Z1lobiykE1lOyOOMocEf59K9N8Fs+t6Y02oXTMyMQyDjOPX8q8zikDoPNXkD7xH9a6HwTqA0/VDE7fuLj5ODwD2rtpT5XY8/H0VUpuSWqO8a5+cwwAIgPar9iAGHOT61jldl0fetrTl5ya7D581NvyVlanAlsFuocx3SsPL2/wAbHgKR75x+Na4OSBVW3UXmqlyMw2nC+8hH9B/OmBmfEv8A5Fyz/wCw1pP/AKcbeuqrlfiX/wAi5Z/9hrSf/Tjb11VIDlfiX/yLln/2GtJ/9ONvXSTWlvNIHmt4ZHHAZkBNc38S/wDkXLP/ALDWk/8Apxt66qgCJbaBZjMsEQmPVwg3fnTlijWVpVjQSPwzhRk/U0+igCutjaLu22sA3DDYjHI9DUoijEvmCNPM27N2OcemfSn0UAFfN/xOyPi9eDH3vJP/AJCWvpCvnP4qD/i7k3ukP/oArzsz/gr1PpOFnbFy/wAL/NEvw9P/ABd/TvdJf/RTV6H8dIfM8HQPj/V3iMT7FXH9a89+Hy5+LunH0SX/ANFNXq/xatTdfD/VwuN8SLOD/uMGP6Aioy9Xw8l5s3z2XLmFF/3Y/mz5w06Qw3cseRhs9e/Of/Zj+Vdl4df7QtzZchpF86IeroOQPquf++RXBRXCGUSNjAI3Dvxx/WuhtLt7eeOa2lKyxkOhI6Ee3/16wUXKLit09DvxsOa0l1S+9f0jXv5BbRNdfMBEN7FELNgegAyT7Ct3RfiFo95bqsh1M3EY5C6XcsSPXiM1RuzHcwre2qAW83JXP+rf+JD/AE9sVB4buGsvEdmfMCxvIEZcnkNxXZQq3s11PGxVD21O/VHeab4/0UcMusZ9tGvD/KKtKT4gaIkTuE1rIHGdEvf/AIzU8GyC4bdJtIOMZrVuXL6TcFXydjYJPtXoI+eOF8b+JtV03wX4d1Xwrei1W+1KGzmF5p7hm86Tbu2ybWG05xx8wx25rlPiD8T/ABVoPjrXtE0y9tprnTrezaysRpUk76hLIq71yjfJ1JH5V7B4n8GaL4ssrCDX7aeeOzYSRLFdzQBXGMN+7dckYGCc47YyataX4Y0jS9bvNXsrVk1K8higuJ2mkcyJGNqA7mIyB36nvmkBwOl694x8X+JvEdppWoafoMeh+RB9nmtPtLTTvEHbedw2oCdo28nrntWf+0ZkR+HGOPvTg4/7Z13Wu/Drw1rer3Gp3tncLeXUaxXTW15Nbi6RRgLKsbqHAHHIPHHSuJ/aNUCz8P4HAmlH6LXJjv4Ev66ns8Pu2Y0vn+TPNPEhxb6afda+mvFUP2jwxq8OMl7OVQPqhr5m8RLutdOHutfVkiLJG6OMqwII9RXHleqmvT9T1+J3y+wf+L80fHpMkV7BLDK0UgIZXU8qQcZ/8e/Su20q9TWJ/JuUjt9UYfK6cR3R+n8L/oa4e+BtryazdgZLeR4yemcHaa0bWSOW3QhivfHofUGs+S83bR9GdeIh7SlCa32/HQ6y4hbDI6lXQ4ww5Brf8Ja0jbdOuZDv6Ju9fSsLTbw6vAIblw2poMI7cfaV/wDix+orPuDJbXCyo3lOhznJGCK6aNZ313W55VWiq0HCW57Ppk22QK1dDHzg1yVpKk1va3RcKJY1f8SK6DT5Q6HbJuGPWvSWp801Z2J9GXzLi9um6s/lL/ur/wDXJ/KtWs/QlK6f83Uyyn/x9q0KBBXnnx4H/Fvp2x924iP64/rXodcB8dBn4cX3tLCf/IgrDE60ZejPQyp2xtH/ABL8zwy8/wCRSj+tfSHw5OfAXh//AK8Yf/QRXzhcjPhKP619H/DkbfAegD/pyi/9BFeXlXxy9D6jin/d4f4n+R88+K14FxEPnsbyeycD0DF4/wCeP+A0+yuAWVhgg/xLUnjGR9N8c+JNJ2CRb65DRg8BJSwkRvyYj8ayrEtAXhmV4J4mKOjLjBHb+n4UQ/d1ZQfqKH7zDRfb8nZ/mdYNssWMZB9RWl4Y1hbC4+y3MhEUjY56D3rA0+53rtJHHqKW9Q/eUhSOhBNdkZcrujhq0lUi4SPYLGTypAD0NdJCQ6LiuD8L3AvfD1lPJIC65ids9SK6zTJlbaFl3Ae9d0XdXPmakHCTi+hbtl+0a47N922jGP8AebPP5A/nWvWZpKkXl+55BZQPy/8Ar1p02QFZfiobvDGrqO9nMP8Axw1qVQ8QDdoOpD1tpB/46amWzLpO04vzPlvwu27T70/7Nex/s8nPgy+/7CEn/ouOvG/Cn/IPvf8Adr2X9ntdvg6+99Qc/wDkOOvAy3+OvRn6FxL/ALnP/FE5X4tQlvEXiGID94ILe/jHrsGxv0I/KuH0ub9wi8Ns+UdiAOn6Yr0j4yotp460S5kYLDe2r2kmeOMkZP8A38H5V5NpMoEhRztYDAK85A45/L9K6JrkxMl3/r9PxPMwH7zBelv8n+R2ttIJIx19Dmp9Nv20jUBLuKxnggDgisawusMF3Ag98f8A6qvXK+ZGcBfzrpTtqYzgpJxlsz1GwuYpo47mBt0UgyDXUWUgeEEV5f8ADu4aa1vrSWQMYiJF5zgHgiu906VEwiy8/Wu6EuZXPmcRS9jUcDRvx5s9la4BWSQFs9MKNx/lW1WOFLaxaMDkKrk/lj+tbFWzEKKKKQHzn8U+Pi1cD+8kJ/8AHAKXwIf+LxaT/uy/+iXp/wAWRj4sfWGI/pSeBVz8YNJPoJf/AEU9fOvTF/8Ab36n6RF3yr/uE/yPSPjjAJvBQYj/AFV1G+fThl/9mrwHSX8m7mjllGWY4L9GJO4Z9PvH8q+k/irbfafAGsLkAxxCYH/cYN/TH418vrPG8gdgCpwGH0//AF1345WkpLc8HIffozp/10a/E7WwlxmNwVYdjVqcFCsycMpzkDmsGyuhEER3zHxsdgSU9j6r/Kt1GLx4YLn8qmnNv3Zbmk42Z2/hzV49Ut9pcm4hHOepHrXY6TOGGD1rxzw5ctYeIrRt4WN3EbLk8g8V6rDsguCGk2kHAGa9ClPmWp89jqCo1Pd2Z0Ur+XBJJ/dUmn6JD5WmQlvvyDzW+rc/p0/Cs+7Yvo9yVfJ8tsH8K3Yl2RIvoAK2OI5f4l/8i5Z/9hrSf/Tjb11Vcr8S/wDkXLP/ALDWk/8Apxt66qkByvxL/wCRcs/+w1pP/pxt60/+Em0M2eo3Y1axNrpzFLyYTrsgYAEhznAOCOPesz4l/wDIuWf/AGGtJ/8ATjb15nB8NfEt54U8daJLp2iaPFrl2moWgtrtpI4XRoiIWURL8h8o5Yev3aAPYvDviDSfElgb3QtQt762VzGzwvna46qw6g8g4PqK1K8QHwt1rV/EL6r4ih0wQahqNxd3mnR3DyxJGbIwxjcUXe2/DHgD61Tg+EWu2+hSWdu9nHLdaRpdreFbhwJrm3uxJK7HHOYgFB69uBQB73WXba5aXGqyadHDqIuIywLyafcJCcdcSsgjPthjntmvM/C3wvutB8aabqtpDZW9ta6vqE2IpGBFlNCRFEBjGBId23oOvWvTItctJdXbTVi1EXCkgu2n3Cw8DPExTyz+Dc0AFtrlpcarJp0cOoi4jLAvJp9wkJx1xKyCM+2GOe2a8D+Jd1FcfF+ZES4UqsakyW8iAlVwcFlAI9COD2zXvkWuWkurtpqxaiLhSQXbT7hYeBniYp5Z/Bua8J+KN5E/xcESJcBvKjDF7eRFJAI4YqARx1BINcGYq9H5n0HDcuXFvW14v9B3w6uopPi9YxKswdY5gS0LqpxG3RiMH8DXtGoX9nrS6loKw6gJpYZYGeXTrhIeVIOJWQRnrxhjntmvEPBF6i/GLSYQswbMiEtC4X/VP0YjB/Ove4tctJdXbTVh1EXCkgu2n3Cw8DPExTyz+Dc0suX7pq3X/IfEUn9ZhK6furb1fqfHihBfzWt1HcRzxZV/3bAKwJDDOMdasadcs87wRSSb1J4aF9mPZsAfrS+Ib3y/FuroiTM63cwJEbYA3nvjHeqcd+s96Et1nWfqwWFsED14x/8AqrBx5fet3/M9qNT2iUXJapffbbc7Lw7q94LuWJYVSBRtne5DpbEdgzsoXPphs+lalhe2t/qyHQdyTwuW33dvKYyV7xuAEI9CxyfSuKuNa8uW1tb5JlijZpF3RMqMzY5yRg8Dj+fNXNK1ZYdRA0qVy5OfKMbqvrwxG38M81bhZ80dGee481/eX9fM7zw1rDap4luNN1j7QboFmRkikSJwOuCR/Uj0rvtHSzvNZTTbaTVYlUM1wslnOIXAIwolZNmDzyGOccV5DF4id/FWmT/Yb3FpIZbxYbaTfHGBlnX5drD1AJJH3cnAPueh6/pd5rdtDpct3cRz25KzLYzC3dRhlZZinlsME8hscivQpSco6nz2MpRpVLRNq21y0uNVk06OHURcRlgXk0+4jhOOuJWQRn2wxz2zRba5aXGqyadHDqIuIywLyafcJCcdcSsgjPthjntmiLXLSXV201YtRFwpILtp9wsPAzxMU8s/g3NEWuWkurtpqxaiLhSQXbT7hYeBniYp5Z/Bua0OULbXLS41WTTo4dRFxGWBeTT7hITjriVkEZ9sMc9s15F+0BqtveDSrSKK+WW3uJFdpbKaKM8D7sjIEfp/CTXrsWuWkurtpqxaiLhSQXbT7hYeBniYp5Z/Bua8o/aA1S3ubXTrOOO+WaC7YM0llNHEfkP3ZWQI34Ma5car0JHrZE7ZhSfn+jPNtavYpXsYFW4DxsMs9vIqcejFdp/A19QW2uWlxqsmnRw6iJ4ywLyafcRwnHXErIIz7YY57Zr5e8S3sbQ2sKpcCRByzW8iocDs5XafwNfT1nr1pc6iLBItR+0Y5dtPuFh6Z4mKeWfwbmuPLFZzVu36nrcTPmhRd7/Ft8j5d+IMEdr8QdZtHiuFBvHkXdA6AqxLAgkAEZJAI644zWNaTIb5re3kmQgHG+JwMjtkgD9fSux+Od8j/Eq5jjS43pFGvzQOgJA7MQARz1HBxXCSakksixMkyT5wrGMj9cYP/wBanVjaUmlszqwdV1KNKLkveVvx9d/6sdJpV1dXV8unwW0ksxPB2SIoxzncy7eOuc10EerWer3Z09mE+poCGukhc25YHo7AAMcZ+ZTg8deTXFjVp7azngkS6CSgRSv5DqNoILKWIx2HQ89MVPaanaT3SfYJTDcjjmNlRsDu2Nv45qnBSSfU5pRvKzkl/XqdwviG5GvW+nas8n2ZR5AeG2lijDDp87DaQfUHmu/0v7FPeGw09tVtr/fsWRrS4EPXk+Yy7G4zjDc9q8pk1s6n5WnX1vOlwzbFfyX2Oe2HxtPsc17Xpmo2cAstOQ6m17A8SmSTT5licjAP77YIzkE9Dyfeu2hJtWZ4OOoKm1Jdexv6Tqlkt2NIgj1LzoAVaSXT544mI6kSsgjOTzw3PaprbXLS41WTTo4dRFxGWBeTT7hITjriVkEZ9sMc9s0Ra5aS6u2mrFqIuFJBdtPuFh4GeJinln8G5oi1y0l1dtNWLURcKSC7afcLDwM8TFPLP4NzWxwBba5aXGqyadHDqIuIywLyafcJCcdcSsgjPthjntmuD+M+tWt14L1bT44dRE8UkW55NPuI4eJVBxKyCM+2GOe2a7yLXLSXV201YtRFwpILtp9wsPAzxMU8s/g3NcT8YtZtLjwZrOmpFqIuEMWXbTrhYeJUPExTyz/31zWOI/hS9Gd2WO2Mov8AvR/NHiEl7FJ4fS2VLgSKTktbyKn4OV2n8DX0L8NNctLnw1omnxxaiJ47KMF5NPuEh4UZxKyCM+2GOe1fPkl7E/h6O2CXPmKeWNtIE/77K7f1r3z4V6/a3PhfRdOWLURcJb7C7afcLD8uekxTyz0/ve3WvLyxWqPTofUcSvmw0Xe9pvb0PIPjmIX8fSOkF2qTwgM8trLErumVYK7KA4xs5Ukc9a5GLU47zVYYtTuLtSsfl/aFgYucD5SxIAfAwM5zgfn6R+0bqkE+q6LbxR3gltxcq5ktJY0Yny8bXZQrjjqpNeQzaihUwzRyq6dC8bYBH+1jH61tiKXNUlbfoYZdVTw1PmfdfL/PqdbZSkX32azvIZ5D0Mkc1uD7bnTZn6NWnZ3kN7fSaaCJNSR2R4cFI028EtKVCkeykk+3WuT0vVLq08xoVuvMRH2uYHGwlSAwfG36HPbvTbPUtOuvLt4maG5j4DmJgPcFsYI+tKKly3T+/wDpBUi1NwclozuJtdvdN8vT5ifstu580QWc0YA7sJHBVh+P0Nd7oE2l3byRW41VZo42kEv2adIyQM8SMvln8Dz2ry618Rs1s9hewylF+UTiF/KPsHxj9a9Z8BTWS6Cmkk6mtyYn+d9PmESggnAmKeXwOnzH0rtoSfws8PMMOoL2iet/6/4J1vh29toLl9K/4mUt8GZpp5dOuI4nYYBxKyCMjgAYY5x3q9ba5aXGqyadHDqIuIywLyafcJCcdcSsgjPthjntmotO8QW13ex2Pk6it0UyzNp1wsOduTiYp5Z/765qWLXLSXV201YtRFwpILtp9wsPAzxMU8s/g3NdB5gW2uWlxqsmnRw6iLiMsC8mn3CQnHXErIIz7YY57ZqnqGtWt0mpabFDqIuEhlUtJp9xHCcKc4lZBGfbDHPbNXItctJdXbTVi1EXCkgu2n3Cw8DPExTyz+Dc1DPrNpc3dzpSRaiLjY6l2064WH7p6TFPLP4NzSexUXaSZ8v+ErqM297AFn37ephcJx/tY2/rXr/7P2qW50K80/y7z7Qb2R932OXysbE/5a7dmeOm7NeQ+EbqNoLy3CT+YV6+Q+zgZ+/jb+ter/s+6vANO1DTCl2Zzds4YWkpiA8tesu3YD8vQtz2rwcvVq606H33EUubB1PeT95f1uV/j9dW+o6daLBb6j59jclJZJNOuI4grDGRMyBCNwQcMc54ryDUms2js7ixFzGZIVWQvBIsYkQAOA5XaeQDwT1r3r4165ay+CdY05IdRFyjw/O2n3Cw8SoeJigjP/fXNeGeGbyPUIrrQJQ6+efNtGkRhG0oGNuSMfMvHXqBXVjlaop+X9P5bnjZTWcMMpX2l96aGWN9IJtkXmSMM8vDIg/76xtNblvrUSy+Rqaz2823dHG1u+ZsnA2MUCkH1zj61y2nTXKXb2yw3KyKxQo8D4yvUbscHitm1uLa4u55teivLaOd2dZpLdwJCOixvt2jAxjnAA/ChTSjzNHVXSUrKSt/WnqdBZanqVqtzDpkPkmUc7rWfa23nAmYBCfpwa67wPf6brhSPZqX2vJEjPBMsakdR5m0Jn8a4a08XTNeyWqQNLaKuFWK3kKRgdMtjn65613vwgurKe8vUU3we4kyP9Dl8jKjk+bs2ZOcfe5x0rqw05PSSPGzDDrkdW+v5/8ABO38KXNsNYuIC+qy3Cl44zPp86RIitziZkCNnAPDfSty21y0uNVk06OHURcRlgXk0+4SE464lZBGfbDHPbNU9D1u2e9k0oJqDTxSyKJG0+dYSASf9cU8v2+929auRa5aS6u2mrFqIuFJBdtPuFh4GeJinln8G5rrPHC21y0uNVk06OHURcRlgXk0+4SE464lZBGfbDHPbNFtrlpcarJp0cOoi4jLAvJp9wkJx1xKyCM+2GOe2aItctJdXbTVi1EXCkgu2n3Cw8DPExTyz+Dc0Ra5aS6u2mrFqIuFJBdtPuFh4GeJinln8G5oA8F+KV5FcfFzy40uFZI40Jkt5IwSMg4LKAR6EZB7Gj4f3Ucnxk02JRMGUTAloXVTiJ+jEYP4GpvizdxS/Fq3iRLgMtvGrF7eRFJDP0ZlAYe4JHvVTwdexp8YdIjCzBw7IS0LheY3H3iMHr614E1bF3t1R+gUp3ytLmX8Nr8Nt9/6se46rfWmtw6poCQ6gJ5YJYC8unXEcOSpHErIIz14wxz2r5JjMZvJbe5juI5o8q48tgFYHDDOMdRX2JFrlpLq7aasWoi4UkF20+4WHgZ4mKeWfwbmvkTXb3yvFerIiTF1vJ84jbAG898Y9a9TFRvys+cySo4+0je2i/MNPuS87wRSSF1J4aF9hHs2AP1rodBv7maeS1aJktoR88825Iov+2jrtwewzz2rlEvDPdKLeO4WTOCVgbBx15xjp/IVdk19N9taXPmGOGRpP9WwQuQACSRg8A49MnnmuSMFL3Wtj2MQ+a001739NbnXadqSXWrbdGVpZbc7/tEttKY2x3XAC49yTn0FbnhvWjqviOfT9ZNz9ryzRlYZI4nA64JH9SPSuC03VI01ADS5GLk58oxuqevysRt/DPNdf4cvo9a8ZabbtFdW13C/mHFu6gADJ+YrtwenXBzXTRlKMrPY8vGYeNSDba06/oem6OlndazFpts+qx7dzXCyWc4hcKR8okZAhB55DHOOK6+21y0uNVk06OHURcRlgXk0+4SE464lZBGfbDHPbNZdjqtmviaLT4F1DzvLdGL2E6Q8YbIlKbD6cN3rUi1y0l1dtNWLURcKSC7afcLDwM8TFPLP4NzXafPGT8S/+Rcs/wDsNaT/AOnG3rqq5X4l/wDIuWf/AGGtJ/8ATjb11VAHK/Ev/kXLP/sNaT/6cbeuqrlfiX/yLln/ANhrSf8A0429dVQAUUUUAFFFFABXg3xkiKfEzTpOzWkR/wDH5BXvNeNfGe2LeL9HmA6wBc/Ryf8A2auLMFeiz3eHZ8uNXmn+RzWlD7P8S9Cm6ZnRc/72V/rX0VXz7fx/ZvEOk3Z48meKQn/dcH+lfQVZZbpGS8zfiN80qU/7tvuf/BPkr4j2L6N8Q9ahPypJO0yn2f5xj/vrH4V0HgKyiil0q5uUHmXSTkEjknIAH/fIJH1NdD+0R4dmn1TSNWhQeTNtspXHVW3EoT9QW/IetXdNsmn1bTtgXyrN/u9ONjKP51UoWm15o3o4hVMNCXZNP5L/AIJej0SKGGPQ9UgSfTZ9xsZj96EgFvKPuACVPcAg9Oc9fCtpcxst1ZmTbgL8wfH9RXoc9tDcwosyZVGEiHurDoRXPalDLaXfmQpI0cjZBXHB7iuqmuX3eh4mKm6n7xfF1/zMrw/4XtbC6LWdy1m+0hi2HGPoafpttN4Cv77V4me88NuxkvYEiIax38tcxJk5jLAl0HIwWHcHp9K1G5+X/QrmXHBOV/mTW/pEhuZbud4/LO4RFCQegz2/3q2SscMpym7ydy/bzxXNvFPbyJLDKoeORDlWUjIII6gipK8r+LVvc+CvhTqv/CIPd2MBukkla2Ys1lA7r5xhHOwAZOB93cxGMccrr0Hh2b4Z+K7/AMC+N/El3Jpdp9r3wa1OyxyeWxXLZ5zjJXPGBwO4Se/V5d+0JEX8K6a4/gv1H5xv/hXR/CnT2sfAmkyy6hqeoTX1vFeSy6hdvcOHeJMhWckhcjIXoMn1rO+NkHn+DFOP9XdRt+jD+tc+KV6Ml5HpZRPkxtJ+Z474jiMuh2TY7D+VfSPh6b7RoGmzZz5ltE/5oDXgl/a+Z4dtsjpivbfAUvm+DNGOfuWyRn/gI2/0rgy1WlJeSPd4jfNQpvtJr7/+GPHf2jtPa38QaTqqD5JoDCx90bP8n/SuH8O26XKXN1cqGtoJYUZivAUtlj/46ufYmvd/jlosmseArmSBQ0tg4u8d9igh8f8AAST+FeaeGNNd/B0FhGRvuY3Yk8ZLZ/pgV0V4e+/NGGW4hPDRT+y/w3O0a0fT/P1Hyo7jSbgD7dA65KYGDMOxGMbh6Lkehpy+FbNLyW2W13WgbKoHyMEZ6H6/pXd2USGxWJ0UoV2sp5BHcVk6vZCCJJLVGYQqEKg87R0PPpXRTXK/I8rEy9qvNHLWfg7T7a7SWBHtZVYFTngHPoa7jSrOVdTtYptQe5tlJbAiCqXXlVJ79zx/dqlpd9dJ8ptbmU+gwcfrXRWdy95qNukls0BiQy/OwJPBXoD/ALVbpW2POlOU/idzbooooJCuR+LMRm+HmsoBnEaN+Tqf6V11c/8AEBd/gnWhjP8Aorn8hms6qvTkvJnTgpcuJpy7SX5nz5HF5ng/H90/1r3D4PSeZ8O9LB6oZUP4Sv8A0xXkmlWu7w1MhHrXqnwayvhBoz0jupFH4hT/AFryMuXLV+R9fxFJTwrXaf6M5/8AaN055/C1jqESktZ3O1j6K4/+KVB+NeM+HLc6lPcAL5nk2kkwGMjfjC/jk5/CvqPxzpUmt+EdV063VGnngYRBjgFxyvPbkCvAfhvZvbaVeOQVlmuPLKsOVCjp+ZNd2Ih79+6PKyuvfDOHWL/BncaNpspsbLVNBWOR4bcRPbvwtzF1257MOcH1JB60XXh/T5po7mxtdtteoJigbb16jaePw966nwfaNY6Fa2zgeYiAMQep7n86dqWnRrbEWiEMjNIqA92OWAz781pSXLZnJjJ+1co9VszjH8FaWJy4tpLfPQqduf6V11tYTxxQQjVHkhkZEkRIQCqsQD8w6elV9KvbmNgPs9w4PRRj/GuijvJbg2ttLZyQ+ZIBmRl7fMeAfQGulJLVHkynKWknc6IAKAAMAcAUtFFBIUjDcpHqMUtFAHyx4NhKpewkchcV6X+z8dkWvQf3ZInx9Q4/9lrj9CtPJ1zVYsY2yyJ+TEV2HwaH2bxDrEHTzYlf/vliP/Z68DBx5a6+Z+g51UVXB1bdov8AFHcfEixOo+BNbt0Qu5tmdVHUsnzAfmor5Q0yN7ua3skYhpJljyvUAkcivtIgEEEZBr5k0jw9N4e+IurWs6BfsiOYcchkYjYw/wCAn869TEx1jI+byitaFSl80dF4e0m41Wxu44bt4NQivXmR3UNskHQk9SCuB7g1uXenx6tbJc3VmYNUs5DbXEfmkAEgHIPcEEEH0bmtTwVatB9qmcAmZwwPttAx+hrdvbGCUzSbds0yBGYd8cqSPas6FCNO0orUeNre1cqb+Xl/wP67nBTeDNNmCSSWbq+OXBwc/UV0Oh6O2n2QSw1Jo1BO2HyhIzd+o/rTbWa5tLgoYZxsPIUjn9a6OHVJ4bOWSTT5wqqWLMVXgD613pLdHiSnO3JJs29Fi8nSrVSWZigdi3Us3LH8yau1FaoY7aJGxlUAOOnSpaCAooooA8K+NEZX4jaXL2azjH5SSf41j2QMHxI0GXpm5hXP1bb/AFrq/jVbFvE2iTAfehZf++XB/wDZq5vVY/s+t6bd9PJkjkz/ALrA/wBK8DERtiG/NH6Dl9TnwFOPeMl+aPoavlD4ladJpXxI1eBVIW4mMyYH3vM+fj8WI/Cvq+vHvjdoco1vRfEcGAluUikPfcJAU/Ahn/KvXxMbwv2Pksoq8mIUX9pW/wAihplnbw+JtItWUC3hgeODjhpsDcT7lQT+dO17wvHDJFZXMMEkbN/oV1jayqMnyJMdQF3FT6Lj66+gWT3N5Z3LYKQzmUgn/pm6/wA2FddqVpDe2piuU3DIYeqkHIIrOnG3vHZiqqdqb1VrfO71PP08LWl3EVurPzcAAYfeB9O/8qu6B4WtbC63WVy9k5UglsOAOvQ1akFxa3Zj8mTcPuspGGHr1roNK1C5AX/QrmbacE/L/MmutJPU8JynC8bs0PDNvILy4kubl7h40VYyY9g2tySB7lf/AB2uirL0aU3M13O0flncsW0sCflye3+9WpTZByvxL/5Fyz/7DWk/+nG3rqq5X4l/8i5Z/wDYa0n/ANONvXVUAcr8S/8AkXLP/sNaT/6cbeuqrlfiX/yLln/2GtJ/9ONvXVUAFFFFABRRRQAV5j8X4A2qaDL/ALMwP4GP/E16dXA/FWLd/ZEnpI6Z+oB/9lrnxSvSaPSyifJjIP1/JnEeJIC1sjIPm2HH1r3G2kE1vFKvR1DD8RXl2p2ivpkR25IXrXovh1/M8P6Y/wDetoj/AOOCufBrllJHdnE1UpU32bRxHx0na38MabIoBCajHIwPcIkjn/0Gs/QnxdhhzvPWt74tRiXSdKVgCDf4IPoYJQa5LwduFtbJI2ZoFET5/vKME/j1/GtamlQjB2eEt2b/AB/4Y9GgGYhVW8h3q0Z6Gp7J8xYbrUkqhxx19a16HFe0jEtNas7WTybiBfPVtpVQTk11mkTrdQNPGjIjtgKy46AA8fUEfhWPFmCfeowx6+/vWnokqiOW3JfKuzqHxuKsc544PJI/KtVK6OSpTcW2tjTqJLeFITCkMaxHqgUBT+FS0UzIRVCqFUAKBgADAArlPinF5vgm945WSFh/39Uf1rrKwvHEQm8Kaip6bA35MD/Ss6qvCS8jpwcuXEU5dmvzPKvJD6Egx92vSPhk+fCFtGesUkqH/v4xH6EVyOlWyyaKwIzXXfDlDHo1ymMBbpgP++Vrz8HHlnfyPoM3qKeHce0i18QnKeBfEBXgmxmH5oRXlfhGQnTbPcoV4FMLL6FGKn+Veq+PxnwPrw/6cpT/AOOGvK9HjMWq30Tn/WS+eg7YIAOP+BAn8RXVXXvpnDlrTozj53/r7z03TzuhH0Bp1ymOR3qDS3OwBumABV59pGDzWi1Ryy92RgfbrbSrgx3MShSMoeenp+FdFot9FqEyyW8TRpGhzlcZzjHXr0P5VRkjKsG43DocZ/Cr2nXIW/bzC4EyqAWAxuGeAR6g9/StIy0szlq03fmWxtUUUVRgFZPi6PzfCmsx/wB6zmH/AI4a1qrapF5+mXcPXzIXT81IpSV00XSlyzUuzPEtEhB0mZMdq7r4SsV07Ubc/wANwJB/wJQP/Za5nwjEs1k5IzuUGuq+HaCHUNXiAwNsLD83rysLHlqRfqfV5tUU6FSPaz/FHcV88eCJmltbhJRiQXLSn3DgEH+f5V9D18+aHD5N1asThJrYRADuVZiPxwx/I124haxZ5OVPSovJHqmitvt0PTIq9Ony7h2rL0RikUYP3QK2SRjnnNVHYxqaTMK5uIdOnEs8amKQnJ9G/wDr1q6TqltqTxw2kLKdwffsOMKcnn8h+NMmi744ByD6Gpre48q6tppC4VA0btgbApHX1HKr+taRlpZnNWptvmidDRQOaKs5gooooA8QhtxH4t1kY4N3OfzkY1r+AB9m8cHjiWCSP9Vb/wBlpJrcL441RCP+W5b/AL6Ab+tX9JhFv4105gMB3kU/9+3ryIQ5at/M+yr1VPDuPeH6HpVeJeKXb/hausKw+RreONT7hI2I/wDHv0r22vFfHaFPG1/cg4SG5hd8f3TbhT+AyD+Br0MR8PzPAyp/vmu6Z1fhtv3WPQiugkTchHeuZ8P5SPjua6lWBUHNKGxWI0ndGNqBEI+0NGrhPvZ/u/8A1v8AGp9O1+ykPlwW7O5+X5UJ5PAH58VamjDA4AKkYI9ajLOLZ0TeWVhImwD7ykEZz2yBWsHbRnJWg5+9E6S3QxwRxk5KqFJ9cCpKZBKk8SyRtuRuQafVnKFFFFAHmnxgg33uhSY+75w/WP8AwrlPEVt5tshHVoyK7z4pxhrbTGI5EzAfiP8A61YmoWivpkR28heteTioXqyfofX5ZX5MNSXqvxZ6dYzfaLG3m/56Rq/5jNcP8aC3/CJnYCfLcTEeuwgn9M12Hh//AJAOm/8AXtF/6CK5v4lYa1s0YZVi4I7EYFehU96k/M+ewfuYuPk/yMvww4MeFwVwGBHeupZdyYrhPAgeDTIoGYtLAohfPqoxn8Rg/jXeRsCgOaim7xOrFrlqOxj6nFmIybFZovmAP6j/AD6VBY69Yw4SSFfMz91QTmtqVN3KgVBZr9nmygbb2CgEj861g7aM4q0HO0kbWkSi5ikuERkjkICqRjoMHj65H4VfrP0Rg1rIqMzIsrBSwweecH8SRWhWhyNWOV+Jf/IuWf8A2GtJ/wDTjb11Vcr8S/8AkXLP/sNaT/6cbeuqoA5X4l/8i5Z/9hrSf/Tjb11Vcr8S/wDkXLP/ALDWk/8Apxt66qgAooooAKKKKACuS+I8HnaZYEdUuwf/ABxx/hXW1ieMYvM0Rj3SWNh/32Af0JrOqrwZ04OXJXg/M59bfztLUe1dL4UJ/wCEeskP/LNDF/3ySv8ASsvTEDWJX0rU8NfJYSQ/88pnH5nf/wCzVjRVnfyOzGz5oOPZnM/GCTytF0iQkKo1SEMT2BV1/rXMabKttIWIC5bn3Nbnx8jaTwA5XqlzG2fTr/jXHaZqCalptvdxkYlUEgdm/iH50VfiN8Ar0LeZ6XaSh40dehFYmr+PPC+hanJYavrun2d3HgvDNMFZQRkZH0Iqz4emD2W0n5kPNc58QPD99q3iTwZeWFss9vYaiZ7tyyrsj8sjOCQTz2GauLuc1WLi2kdno2uaVrsl1Hpl3HdG1ZUm2Z+QsoYc98qQePWtKRmikiliUM6H7vTcMcj/AD3xXhV74E10+Mb/AFyxtbiO4PiSzuoZI70IpswiiYlN+O2CCNxAwMiqenaZq0/jnxLosF9PPpehC6ksQs5+ae7iBWJiTjEeXxk8FgeKrQw1btY+m4pFliSRDlXUMD7Gq39p2h1g6V53+niAXJi2n/Vltu7OMdRjGc14Xf8Aw71uw0LweP7O1fWrVLNjrOmLqxEhvGt0RHDPIFKoykYVsL1ANR6j4K+JLeGmgjup5dU/4RWKxadb0Avci73vGCWzvMOU8wjBPetTjPdrPVrG81PUNOtrhZL2w8v7TEAcxb13JntyOeKg8WRmTwxqqjr9mkI+oUkfyrg/g54avND1zxVeS6DcaHpt/wDYzaW1xdJcSDZEVfJV3P3j3PevStQh+0WNxD/z0jZPzGKUldNF05cs1LszgvD0GbF0PpXQ+DQYkv4CPuzBx9CoH/sprL8M4eIHH30DVtaIPK1a7Q/8tIkZf+Als/8AoQrjoqzTPYx0+ZTj6MTx8C3gbxCB1/s+c/8AkNq8t0i4WeC2uxg+ZCr7vqASPz/lXrPjBDJ4S1tAMlrGcfnG1eB+Ab5ZdFazLDzrR2UjuVYkg/mSPwrSvuiMs1hI9b0m4We2BU9K09+CGrlfC84DNGT97kV0hG5chunaiLuhVocs7F1SrAZHB9aJY1MDKOBjg+nvVaFx0zUd9epAmGbLHoBV3MORt2R0dhcfabcOwAcHa4HQEf071YrO0JT9jaQn/WOWH5Af0rRrVbHDNJSaQUUUUyTy/wAIW3koYiPurt/Liui8NxfZ/Ec6jpLbkn/gLD/4o1U0uIRarcr2+0Sj8N5rXgQQ69aOOsgeL8CN3/sgrhpRs16nvYurz8y7o6KvAfDcqzWMZOGeCaWM/wCyQ7f0I/Ovfq+avDF0LfxHrunPw5uXmQH2Yqw/lW9foc2Wby+R6roVyssRQHkVtBvlB9K4rw/OI70ZPyscV2I+YEBsEVMHdGmIhyzLcbhlyakVFCnAwDVGJtpwxp9xdLbxbnb6Cruczi72Rr6ROXiMDABoQAMdCvOD+hH4VfrF8OsZjLOPusir+ILH+orarSLujjqrlm0FFFFUZnnWq2+zxvfSf3zG3/kNR/SrlxB5WsadOOq3EY/76O3+tWPEMW3xLv8A70EZ/Hc//wBap9VQLaCcdYiso+qkN/SuFx96T8z3lVvCmu8bfodVXjXi2QH4g67bSAEGK3kCnuNm0/0r2WvCPiRdrpvxcSSY7Ybq0SEk9BnofzUV0VvhODLf4vyOp0K6VZREx5rp4z8pFefWspjulbPKnmu7hcPGpVuGGRWcGduJhZ3LkMgNTKqk7gOaoKSjcmpzKEQsWAUVomcco9i5p03k3bQkDy5Wyp9GxyPoQM/h71r1zGkTi81CMoTiOTcfptYf1FdPWkHdHLXjyysFFFFUYnI/EmDztN08jqt2Py8t/wD61Uo7fzdLUY7Yre8ZR79F3d45oyPxYL/7NVLS0DWJX0NcdWN6nyPZw1Vxwy8ma3hhi2gWQbkpH5Z/4Cdv9Kx/iLFu0qCTukuPzB/wrX8NfLp7w94ppFP4tu/kwrA+K9yLLQLO4f8A1SXqBz6KVdSf1rfen8jjhpitO5z2h3CQzBSAC5BPua66I9fevO43KzIQRxyK7qzlWW2jYH7wFY02ehioa3L8Mgzg1MFUsGxyKoco2SeKsCQKud2BWqZxSj2LVrMbe9xgGOXareobsfxzj8q2a5WyuReX6xxknDqfrhgT/Kuqq4O6OavHlaOV+Jf/ACLln/2GtJ/9ONvXVVyvxL/5Fyz/AOw1pP8A6cbeuqqzA5X4l/8AIuWf/Ya0n/0429dVXK/Ev/kXLP8A7DWk/wDpxt66qgAooooAKKKKACs7xFn+w71gMlIjJj128/0rRqK6hW4tpoX+7IhQ/QjFKSurFQlyyUuxzmhndE4rU0ZytxeQ+jLIP+BDH/stZ3hmCRYEMw+ZlG76961YkEWr/Lx5sJz/AMBIx/6EaxpppJndiZJylFHJ/G3H/CvrzP8Az1i/9CFeUfDiIHTNRsus8cwuEHqrAdPxFeqfHAE+BZAO9xEP1NeHQXj6TfWuoRgkwFd6g43IQMis6z9878ujfD6d/wDI9Y8PzlXKNxnjFdX5iheoxjpXAG4RhBe2jlra4XzEPcZrX/tVHhUh/mHalGVtB1aXO1JGtPdBZDGuRnjIPSrOhaRJcyrOVAh3fM5/i9cev1qlptstywkckRl1TP8AtMQPyGcmvQlAUAAAAdhW0IX1Zw4iuqfuQ3FooorY80KKKKAOK0EeVdPB/wA8neH/AL5Yr/StmP8Ada3bN/z0V4v03f8AstVILNotevCB8hl3L/wIBj+pNal9GEe1lA+ZJlwfqdp/QmuaEWl6Hp1qilJea/Qk1/H9halnp9mk/wDQTXzL8PVjj8SN5xAW6heJSem8EMP5GvpXxTn/AIRjV8HB+xzY/wC+DXyykLNYLtJV9xdWHBB4wR+dKu7NHRlUeanNeh6vpzPa3oV/lKmuzgkXylOcV5tpGpDWdFivkJFxFiG4U/3h3/GugstUX7NsdiGA4zUxdjetTc9TfvLkRtlRkn3qG0sZ9RuG8kFx1JJwF+pqppynUZFAbBAyWPQL613uiRpHpdv5WdjrvGevPPPvzWsI82vQ4q9ZUPdW5YtIRb20cQ/hGCfU96moorc8tu+oUUUUCOOnHk+JLxRwDKrAfVFJ/XNaV9+7ltJRwVnj59AWAP6E1Fq9ozeIEnUcNAo/FWbP/oQrR1C38zTpVUfPsO369q5lF3Z6Uqiag/Kxp18sXTpbfE24u5cCGPUpkc9AFZnXP05r6ljcSRo6nKsAR9K+VNUi8zWNX3jIa7lU/wDfTU672NcqjdzTPRihtL3GPlJ3KfUV2djKrwBs8nmvLvB1/wD2jpDWMjsb6wz97nehPH5dK6fStSEcZjkYj0rKLsdlam5rzR1F9cKg3dT0+tUo4pdQuFWIM7kfd9KpWspvZRGh3MThecCu58NQJDYyKh3HzCrNjkkcflnp7EVrGPP6HFWqLDq3UtaPZmxsliYjeeWx0zV2iit0rHlSk5O7CiiimI5nxXGRfWUwHBR0Y/ipH/s1WHjE+n4YZDJgineKbZp4rNkzlZsH6FT/AFxVuxhxaKrjnGKwcffZ6CqJUYd0WdOZn061ZzlzEpY++BXgH7QdubnxhHGn3/sKEY9Qz173pPFkE/uM6D2AYgfpivDfjGpb4hMeu2zQj/x6iq/cRpl6/wBpfzL8UiXNjZ39vzFPGrEg9GxyD+Ndfoc4eBAx5UYryjwXqMdtfTaRcllivCHhPZXxyPxrsrC8azuWSUkYODisIu2p6VWnzJx7HaXMqiPk5xz9Ky5JmuQFXcDnAHXNUTfLNKVD5UjnFdZ4WsxFdOz/AOuEYYqcHAY8fj8pz9RWsVzvQ4aklQjd7lzw5pclkrSzgK7DAXOSB71t0UV0JWVkeVObnLmYUUUUyDN8SJv0K+PdIjIPqvzD9RWVoR3ROK6SaNZoZInGUdSpHseK5zwvbSRW6Cb720bj796xmvfTO2hNKjKL7/1+Rf0T5Ly/h7ZSX8SCP/ZBXMfG/H/CA3Of+e0ePzrrY0EWrqV4EkTA+5BGP5muO+OYJ8D4He6jH86HpBodJ82Jg+9ji9JxN4f0+5iGdsQjk9ivFdh4fnDQqrH7teY+FdSSwujb3RItrhVQnPCtgYP64rrbed7C8KuThT1HcVzxlbU9mrT5k4ncTSKIzkg1kzXPnIyAlQD1z1qi2oJLIoV8qw5rb0i2jW3aaUf6zEUeccbsDd+v5VrG83ZHBUaoR5pGt4b0qW2k+0TrsyPlU9fr7cGuioorojHlVkeVUqOpLmZyvxL/AORcs/8AsNaT/wCnG3rqq5X4l/8AIuWf/Ya0n/0429dVTIOV+Jf/ACLln/2GtJ/9ONvXVVyvxL/5Fyz/AOw1pP8A6cbeuqoAKKKKACiiigAooooAjjiVB8oxUF0pF3aSD++VY+xU/wBcVbpGUMAD2INJopSs7nF/Fq0kvvC8UMQyftUbEewDGvDtc0+a30y6Z0IAJAz9QB/6DX1DcQR3EeyVQy5zg+tc14i8JWmp2LweWADg8exzWNSlzO56ODxqox5GeW+ELK+Xw/HHIkMkOTtVmKtj27VtwWRhlVntbhxn+Bd/6Cuut9Cks7KOFVwqDGMZBpsEMEEuZgqFTkckVo6cXqcsMXVguVPQvabcF7SOyj0+5i8z92HkjCgDuT+GTXT1jW9xbXnkpbnfKsituGTtAOSc/QEfjWzVnM3fVhRRRQAUUUUAR+UvmFscnFQamhewn2DLhCV+oGRVuik1dWKUmmmZXihTN4W1dI+WezmC/UocV8+HRp4GRGQ7VQZyO/X/ANlFfSrRq0JiYZQrtI9qyb/QbS4jYeUoLDHSsqlPn1O3B4tUE49zwT4cW17tu5IBF9nYksJCQCc12H9nuCXa2kODysZ3fyrqtG8Kf2RbSQ2ykIWzkVIbNIpf36KB3OMU1STSuRLGVIzk4PRsXw5crZW7Y029IxlmMOMY+tddYo0drGJBtc5Zl9CTkj9ax7S8sjE0ORM20gR8tu9q2rVGjtoUc5ZUCk+pArRK2iOWUnJ80tyWiiimSFFFFADHjVnViOQCBSsmUIp1FA7sgsABZwqP4UC8+3FfOt/olyt3O5RsyzSN07lmx/6EK+kFUKMDpkms260a1mBzEufpWVSnzJHZhcX7CUn3PnXwraXh8V3LWexcMVbdnGAPau5bT5Xcs1v83X90+QfpXVWXhFNO1G6uLZP9cSxx2JxUs1h5T5lRcdyRg/nQqa5UmFTGTVSUqb0ZT8LyLaMWGm3rtjH+p4H0JrtdMdpYHnaNohK24I2MgYA5x9KyNOu7KAiIyLz0XJNbOmpstQAu1S7soxjALEjj6GtEklZHLOcqkuaW5aooopkBRRRQAyVBIuGGRkGlCgDAp1FAXKlkpSe7Q8ZkDD6FR/UGvHvinpU914uvLmNSR5EUa4HqCD/Ova9oDFu5AFVLzTre6YtLGGY45I9KznDmjY6sPifY1OfyPl6+sbhdeskgXEwBkX8WOP516U9jcy7RcRRvJ0LxPyT7g11eo+DIH1mG/hjG9FC49gc1Pdaa6cum4f7Qzj8amFJctma18bJ1Oem7aHPaFELa7VmsLyRl5AERYH8eld/pkrXc/nG1kt0jQoBIACScE8D6D86xtPms7Qgu6oT1G41vWBSSaaeAYidVAOMZIzk/qPyrSMVFWRyVasqr5psvUUUVRmFFFFABUccSpnaMck1JRQFypdqRc2kg6LJhvoVYfzxXJ/F2zkvvDNvDEMn7ZGxHsA1dswDDBHcGo7iCO4QLKoZQc8+tTKN00bUqvJOMux8wazp0tvp148iEBPlBP1AH/oNdd4eh1C90S3e9SKRlGxW3FXYAe4wa9N8Q+E7TU7GSDywA3p9c1Wt9DktLKOFVwqDGMZBrKFFK9zuxGYSmouno9TlrG3+ySo72lxIM5+Rd+fy+ldtZ3r3EAtxp1zGZ/kDvGEABHJP4ZNZ9vDDBLmYKhHTBIrbguLe8WJLciSVZEbIydoByTn6Aj8fetYxUdEcFWtOq7zZtUUUVRkcr8S/+Rcs/+w1pP/pxt66quV+Jf/IuWf8A2GtJ/wDTjb11VAHK/Ev/AJFyz/7DWk/+nG3rqq5X4l/8i5Z/9hrSf/Tjb11VABRRRQAUUUUAFFFFABRRRQAUUUUAFMMSE5KKfwp9FAAAAMAACiiigAooooAKKKKACiiigAooooAKa0aN95QadRQAioq/dUD6UtFFABRRRQAUUUUAFFFFABRRRQAUjIrdVBpaKAGrGi8qoB9hTqKKACiiigAooooAKKKKACiiigApCAeopaKAGCKMHIRc/Sn0UUAFFFFABRRRQAUUUUAFFFFABRRRQAwxITyin8KeAAMAAD2oooAKKKKAOV+Jf/IuWf8A2GtJ/wDTjb11Vcr8S/8AkXLP/sNaT/6cbeuqoA5X4l/8i5Z/9hrSf/Tjb11Vcr8S/wDkXLP/ALDWk/8Apxt66qgAooooAyPGFzd2nhXV7jTbq0tL6O1kaC4vGCwxybTtZyeAoOMk8V438N9T17XdWvvDOsa74m0rxCNOS8lfz7O8hP7xQZYXRCEycjYcjaePu5Pu9zBDdW8kFzFHNBIpV45FDKwPUEHgisaGx8N+C9Jvr61sNL0SwjQz3UltbpAuFGcttAzQB4VoPjbxFZ/AS28UX/ia9u9e8QTfYLNZYI2S1kE8iGRFRNxxGjMQc8qPWvTPgR4tufFfgphq1ybnWNMupLK7laPyzKVOUk2YGAyFe3UGqGneNvAcOk2txbeHb20sdN/0ixx4elRY0k3EzQAR8KecsuPvc9a6b4feIPDXihdQ1bwvZNF9pZHuLttPa2N0cEK25lHmYAIzzigDm4PiPqcni6PSTBofkNfC1LCW+83b5m3ODa7N2P8Ab25/ixzUnxrv/Elo+gxeGrnEEjzPfWltew2t7cRqq4MLygjClssAMnKjjNejrfWjSCNbqAyE4CiQZz6Yrk/iZqXhCxt9Oi8Y6Zb6tLcytHY2Taf9tmlfALeXHtY8DGT9PagDhfCXxaiXTdFje5lntLrSb6/W91h0inaSGYqsRKYRuONw6hc9c1RuPjZrQ0S61OHTdHjistKsdUmiuLh1eYT5zFH/ALXoTn6HPHptkfB3ibSNLmuNM00wxK32S21KySOS3w/lsBFIoKfMu3gDPHXisHSdA8Brex+L7yzsbH7QkdrawaklukVr9nZ1XyRjCN9G6Y4FAGTD8V9ZvPiBLpVloUR0q21WPS7jzWKXCbwv745O0DLDC4JIBwe1VLL4h6/rejeDdZvbC0s9P1XxDFYQizvpRI2HuEcyLtA2/uh8uWz1OOBXpd1Y+ErvxNBPd2ugzeIY1E0UkkcLXSqBkMpPzgAdxXOL4t+HyaLoT2EOnT6W2sCzsxBaIsdpdkynzNrBfL5WU7wO5IznNAHPaJ8XdSvtQs2n07TxY6mupfZYY5WNzbGzDHNwDwA+3tjGR1zXa/DvX9f8T+DIdbvrLS7SS+tknsY4biSQHcmR5uUG3nsu7jua0LC18JyXU+pafBoTXGoxuZbqBIi91GD8+5xy6+uSR61oabc6PbW1tZaZNp8NuiIkEFuyKqqR8oVV4AwDjHpQB4B4V8beO9ds/hdcJqOnXGpapJqIZXkaKGdUhYr9oWNcAqQSAo7DkZJG3N8b9RsvCeg6zfaJCRrFpdx26QOzZ1CGYxrF7I+Mjv1HNeiqvg3SrS81bR9M0aeXTJJJ5DpsMBljlcbXORja7LwSSCQMGsHx3H4J01/CMeostomn6nFc2WkWAhQGeViqSPFjO0O5bK45JJzQBBcfETxDaar4wjm0bTZLHwtaRXF80dzIJpGez87bGuwgjfwWJGF5wTXN6n8UtWl0i8t9QhszcxDS7xLjSLuRUEdzMF8tm6hh9cMD0Fez3C6NpM93e3I06ymvcG4nk2RtPsXA3scbtqjHOcD2rJsdP8EpZXFlY2nhxbTCX00EMUATsyTMoGPQhj9QaAPMfEPxA13VfFulQWU1rp2lWvjOPRXhjmb7VcBEfeXHTymOCBj+7XV/GD4gX/g6Wzt9Fjsbm9e1uLyS3uEcsY49vIIKqo5bJJz0wDzjqrrSPCR1V9Wu9O0E6lEEu3vJYIfOQDhZC5GRjs2ah1t/Bet2Ftf643h3ULKNykFzeGGWNWPUKzZAJwMgUAcJpvxJ8TeJY9Y/sHTNKtobLRrPUnmubl/MQ3Nq0yqqhCGwwxyRwOhzxg2Xxa8VW/hXwhCbXTdS13V7GS88/wCbY4RUwhVQoEpLZbHCjnBzXqPhzVvCiXviGPS7Wx00aV5FpfXHkxwRMgiBiG8cFFRsDPAzgcVctvC/g/UdDit7XQ9AutGdzPHFHaQvblzwXUAbcnHUelAHH6D4+8T+I9el07StF0uEwaZa38/2q7fcjzI58tdikPhlxnK8c+1WfhL8R7r4gXdz5empa2ljaQreMxbet8xbfEoP8KhevXkV3tho+madM02n6dZ2srRJCXggVGMafcQkD7q5OB0Has3wX4UsPCOn3drpz3ExvLyW+uJ7gqZJZpDlmJUAegHHQCgDoK8U1PVGj/aIutMTxLerZL4fe+FiL/8AdC88wps2Z6+X82zr/FXtdUzpWnm9N4bC0N2eTMYV39MfexnpxQB83/DDVviJN4Ql8S2U2s3lqugXUrtqU6Tpc3qu3lGBMlwAByDgHBGOme/+CN9o18mn3Nt461LXtcu9L8+9sLnUPPWJ90e9vK/5ZFWO0Djhu/WvWLa3htYEhtoo4YU4WONQqr9AKZbWNpayyyWtrBDJKcyPHGFLn3I60AeceM/GXifSvEt5ZaXZebZxbNj/ANgahc5yik/vIhsbknp06HkGtL40X0ll8Kdav49Tn0y8gtTNBNBMYGMwUlVHfk/w9TXe1jeK9T0DS9MEviq7022sGcKDfuiozdgN3BPWgDxZfHview0OC08Najpl7FZeEF8R3F5qQku5ppRJJ5sW9ZAOqlRkHbgj6U77xf4hXxV4h8XMVu4dH8O2eo2mlpJOscbXEbZJVZAr4yxYspyAMbSM17Imu+CYLmxsI9R8Pxz6jAFtYFliBuIXJICgfeViTgdCScZqa18S+EV10aVaavof9ruTbfZYbiLziY8gxlQc5XBG09MH0NAHkmnfFbxfNBaQRp4eubi81mysLe4LxsDFcRTMS8dvcy7CrRDBLfMCeMg4uan461vw/rHjCOSPTUv4L/RrCa+YztawGeBfMnaN5SFjUk4C7Oo3FjknsdW8e/DrQbDUZ/7S0OQ6a4nmt7NonlV9wTcEHJYFsZHIzW1c+J/CIjlddV0GeW9iWTyxdwbrtSCE5LYYHaQCeOD6UAeb6X8TPFeq3uh6Tpg0Ga6vdV1LTRqLwy/ZrlLaISJPGqyZAPII3MCVOCO3ZfFHxZqPhZfDMVpc6XaNqmoCyuLu+jZooFMbsXADp0Kjq3+NXl8W+ErHSdCvtWvdG0j7TEJLKOe6g+QMMHYysVI5wWUlfese+8QeAPGrzT6hqtkU8Lagzyie4REV1XZvYE/NGd5UHoTkdRQB51aeM/F3iXXfCd3pt7YW961pqy+aY5Ws7tYXRVmEYcZ3AcEk4yTz0qv4g+O+uWugaVqlj/Za3I0u3v7yxmgAWRpJGVgkjTq3IAIVI5Mc7jXt6+JPB62Gn6h/bGgpZyxulncNcxKjIo+dUYnoAPmA6Y5qfW38LaVYW9zrbaLZ2WPJhku/Kjj5BbYpbjkAnA9CaAOEl8Y+Nr5vHsmh2+gtF4enmgt4ZoJmluGSJJADiQDkFhxjkjpjnHt/ix4i1vRdO1fQbXS4LDWPENvo2nG9glZhG0LmWR9si7sSLgYxwpHOQR6Ra+J/CGqR3dtpuv6SZLm2e6la1uow/lYw0pIPGP7x6YqPw+ng7w74d0vSbC+0pNOsbMX9sJbmNsQZ/wCPkEn7pL58zpluvNAHl8XxY8SCW10vULrw/pl3HqWp2V1qtzC/2Z/se3CohkXDPu7vwBx1wKF58afFc1joBsrTRra6vNGXVHa5aOKCeQyshjVpriPYoC5JBkbn7uOa9B8UXXw88T+H0vrnxRZWukxXLB57HU1t0eZgCQ5U8vjn+91I61Z8Pa74L8jUdCtobGLQvDFrZypd3Dxva+VMjNGySMTnheWPXPU0AcXqnxf1WL4iadp1hJp0unT6nZabPayRKJYzOiFmR/P3SYLH5hFsxj5j1rtPgReXN94CM17cTXE39o3q75nLttFw4AyewAAFdRo8/h3xHCmraQ+l6nHuAF3Bslwy9BuGcEcfSte3t4baPy7aKOKPJbbGoUZJyTge9AElFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHK/Ev/kXLP8A7DWk/wDpxt66quV+Jf8AyLln/wBhrSf/AE429dVQByvxL/5Fyz/7DWk/+nG3rqq5/wAdaXfav4fFvpS2zXsV7Z3kaXMrRRv5F1FMVLKrFciMjO08kcVV+3eOP+he8N/+D6f/AOQ6AOqorlft3jj/AKF7w3/4Pp//AJDo+3eOP+he8N/+D6f/AOQ6AOqrnfiH4ZTxj4K1fw+9w1t9ugMazAZ2MCGUkdxkDI7jNV/t3jj/AKF7w3/4Pp//AJDo+3eOP+he8N/+D6f/AOQ6AM/QdN8azaDfaZ4obw8qmwNrbtp7TEvIVK733qNoxjgA9+e1aXwx8P3XhXwBoeh6hJBJd2NuIpHgYlCcn7pIBxz3Apv27xx/0L3hv/wfT/8AyHR9u8cf9C94b/8AB9P/APIdAHP6b8K7ey8TQ6wtxpReO5+0bU0CzjfO7OBKqbwf9oHPernxC8J6zqXibw34m8LXGnrq2jGeMW+obxBNHMoVgWQFlYY4IB961Pt3jj/oXvDf/g+n/wDkOj7d44/6F7w3/wCD6f8A+Q6AOes/Aup6r8QdL8TeNLfQL1rbSXtTDCjSLFc/aRJG8YkX+FBjfkNuzgAGuX0T4T6/olp4emVPDmr3en2l7Zy2WotIbYCe6aYSxt5ZO/aQrAryMjPevSft3jj/AKF7w3/4Pp//AJDo+3eOP+he8N/+D6f/AOQ6AOAh+E2rL4ohnkl0UaeNbh1t7tFcXa7IlQ2iKVx5ORgZbhSRg1W0/wCD+oQ6RpmkXNt4dexsvEyas7qG3XVqDN8kiGPG4CVQFyVwDyO/pH27xx/0L3hv/wAH0/8A8h0fbvHH/QveG/8AwfT/APyHQB4z42+F2taZoUNtoCiPUrzxLeraNp0LvHaadeqUcSYUCNVUAnsCBg5wa7+1+FNpH4q1i8aGwWxfSLbTdLkEe+4smjjdC65XCnDLgqcnHaun+3eOP+he8N/+D6f/AOQ6Pt3jj/oXvDf/AIPp/wD5DoA8sh+DWvnw7qlm8uhWlw3h6PQbdbQyCO5KyB/tE52Ah/lxgBvvNzVvWPhPr8/iC6ntm0Ka2udVsdTa8uHkF1GsAQNCuIyCvynb8w64I716R9u8cf8AQveG/wDwfT//ACHR9u8cf9C94b/8H0//AMh0AU/iB4MbxXr/AISuJorC407S7yWe7t7td4lVoiqhV2kEhiDzjpXmmifA3U7HQbaxM+j29w3h290m7ntwxMs8su6Nz8gLqAACTyOwNer/AG7xx/0L3hv/AMH0/wD8h0fbvHH/AEL3hv8A8H0//wAh0AeY3fwr8V6xBqba/wD8I7LJc6VZadHDb3VxGu6CXfuL7Mg9wcMM8FSOS/SPhT4n0x9K1C4l8O61e2bXa/YNQUrAqTbAreYkQ3yDZguYxuBxxgV6X9u8cf8AQveG/wDwfT//ACHR9u8cf9C94b/8H0//AMh0Aecav8Idb1Cw1lUu9Jtpp9UsdSt7eHesDCC3ETRMNpKLnJXG7G1a9A+Ffhefwl4bmsLqK2hklu5bny7a4edF34JwzKncE4CgDNT/AG7xx/0L3hv/AMH0/wD8h0fbvHH/AEL3hv8A8H0//wAh0AdVRXK/bvHH/QveG/8AwfT/APyHR9u8cf8AQveG/wDwfT//ACHQB1VFcr9u8cf9C94b/wDB9P8A/IdH27xx/wBC94b/APB9P/8AIdAHVUVyv27xx/0L3hv/AMH0/wD8h0fbvHH/AEL3hv8A8H0//wAh0AdVXG+OvCl/rOueHNc0W8tINT0R52iivYWlglEqBGyFYEMAMhh7+tWPt3jj/oXvDf8A4Pp//kOj7d44/wChe8N/+D6f/wCQ6AOH1T4TapqN3qHmavpsdprX9nyamIrJkeOS1IIFt8+EVsd845POTVqP4VTJcQ3H2uz8+PxhJ4kMnlHcYW3/ALnPXPzD24rrvt3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q6APL4/gdq76Drmky+ILa20+7szbW1lbRzPbxSGZZPMCSyN5eSuCqEDnvjFdlH8Prq68SajrervpT3V3oqaaqQW5CQShnO9N2SB84754re+3eOP+he8N/wDg+n/+Q6Pt3jj/AKF7w3/4Pp//AJDoA4vTPhhrehjSrjRtU0iS8i0KLQrpdQs2miKIxbzIwGB5J5Q8HjNF38KdRd9dW21LTkhudej8RWRe1Yss6lD5UoDANF8nQYOTn2rtPt3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q6AOO0j4TTQ69o2qareWN40Wq6hq19b/AGciF5LmIIEjVicKpVTluScnrXXeP/CbeKf+EaWOWGKLStYg1KRJE3CRI1dSgHqd4/Kn/bvHH/QveG//AAfT/wDyHR9u8cf9C94b/wDB9P8A/IdAHB6d8GZbdNIje/tUW1XWI53ihIZ1vRhMf7g9fwqra/CDXpbYQ63qmh30UPhxfD8EX2OVUMaTRurSYk3E4jwSpUgkEdOfRvt3jj/oXvDf/g+n/wDkOj7d44/6F7w3/wCD6f8A+Q6AOD0n4VeJNNuNK1b/AISWC91jTLuee2hv45bi3SOWJYym9n80kBQQxJxkjHWn6p8Ir/V4fErXur2kF1qq6ZJG1pA8Ucc1oGz8oYEIxbjDAjrnIruft3jj/oXvDf8A4Pp//kOj7d44/wChe8N/+D6f/wCQ6AIPhp4Un8KWGopdmzNxfXZupTbSXEm5iqqWZ55HZmO3rkDp9T2Ncr9u8cf9C94b/wDB9P8A/IdH27xx/wBC94b/APB9P/8AIdAHVUVyv27xx/0L3hv/AMH0/wD8h0fbvHH/AEL3hv8A8H0//wAh0AdVRXK/bvHH/QveG/8AwfT/APyHR9u8cf8AQveG/wDwfT//ACHQB1VFcr9u8cf9C94b/wDB9P8A/IdH27xx/wBC94b/APB9P/8AIdAHVUVyv27xx/0L3hv/AMH0/wD8h0fbvHH/AEL3hv8A8H0//wAh0AdVRXK/bvHH/QveG/8AwfT/APyHR9u8cf8AQveG/wDwfT//ACHQB1VFcr9u8cf9C94b/wDB9P8A/IdH27xx/wBC94b/APB9P/8AIdAHVUVyv27xx/0L3hv/AMH0/wD8h0fbvHH/AEL3hv8A8H0//wAh0AdVRXK/bvHH/QveG/8AwfT/APyHR9u8cf8AQveG/wDwfT//ACHQB1VFcr9u8cf9C94b/wDB9P8A/IdH27xx/wBC94b/APB9P/8AIdAHVUVyv27xx/0L3hv/AMH0/wD8h0fbvHH/AEL3hv8A8H0//wAh0AHxL/5Fyz/7DWk/+nG3rqq4XWrTxjr0FnZ3mk+H7O2TULK7lmi1iaZ1SC5imIVDaqCSIyBlh1ruqAMrxPrUfh/SGv5bW5u/30FukFts8ySSaVIkA3sqj5pF5LAAZrK/4SjV/wDoRPEn/f8A07/5Ko+Jf/IuWf8A2GtJ/wDTjb11VAHK/wDCUav/ANCJ4k/7/wCnf/JVH/CUav8A9CJ4k/7/AOnf/JVdVRQByv8AwlGr/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXVUUAcr/AMJRq/8A0IniT/v/AKd/8lUf8JRq/wD0IniT/v8A6d/8lV1VFAHK/wDCUav/ANCJ4k/7/wCnf/JVH/CUav8A9CJ4k/7/AOnf/JVdVRQByv8AwlGr/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXVUUAcr/AMJRq/8A0IniT/v/AKd/8lUf8JRq/wD0IniT/v8A6d/8lV1VFAHK/wDCUav/ANCJ4k/7/wCnf/JVH/CUav8A9CJ4k/7/AOnf/JVdVRQByv8AwlGr/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXVUUAcr/AMJRq/8A0IniT/v/AKd/8lUf8JRq/wD0IniT/v8A6d/8lV1VFAHK/wDCUav/ANCJ4k/7/wCnf/JVH/CUav8A9CJ4k/7/AOnf/JVdVRQByv8AwlGr/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXVUUAcr/AMJRq/8A0IniT/v/AKd/8lUf8JRq/wD0IniT/v8A6d/8lV1VFAHK/wDCUav/ANCJ4k/7/wCnf/JVH/CUav8A9CJ4k/7/AOnf/JVdVRQByv8AwlGr/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXVUUAcr/AMJRq/8A0IniT/v/AKd/8lUf8JRq/wD0IniT/v8A6d/8lV1VFAHK/wDCUav/ANCJ4k/7/wCnf/JVH/CUav8A9CJ4k/7/AOnf/JVdVRQByv8AwlGr/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXVUUAcr/AMJRq/8A0IniT/v/AKd/8lUf8JRq/wD0IniT/v8A6d/8lV1VFAHK/wDCUav/ANCJ4k/7/wCnf/JVH/CUav8A9CJ4k/7/AOnf/JVdVRQByv8AwlGr/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXVUUAcr/AMJRq/8A0IniT/v/AKd/8lUf8JRq/wD0IniT/v8A6d/8lV1VFAHK/wDCUav/ANCJ4k/7/wCnf/JVH/CUav8A9CJ4k/7/AOnf/JVdVRQByv8AwlGr/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXVUUAcr/AMJRq/8A0IniT/v/AKd/8lUf8JRq/wD0IniT/v8A6d/8lV1VFAHK/wDCUav/ANCJ4k/7/wCnf/JVH/CUav8A9CJ4k/7/AOnf/JVdVRQBxieNr6TUZ7BPBPiQ3kEUc8kfm2Hyo5dUbP2rByY3GAc/LzjIzZ/4SjV/+hE8Sf8Af/Tv/kqtK102eLxhqepsU+zXFhaWyAH5t0clwzZHpiZMfjWxQByv/CUav/0IniT/AL/6d/8AJVH/AAlGr/8AQieJP+/+nf8AyVXVUUAcr/wlGr/9CJ4k/wC/+nf/ACVR/wAJRq//AEIniT/v/p3/AMlV1VFAHK/8JRq//QieJP8Av/p3/wAlVWuvG19aT2cNx4J8SJLeSmCBfNsD5jhHkK8XXHyxucnA4x1IB7OsfXdNnvtU8O3EJTy7C/e5l3HBKm1ni49TulX8M0AZv/CUav8A9CJ4k/7/AOnf/JVH/CUav/0IniT/AL/6d/8AJVdVRQByv/CUav8A9CJ4k/7/AOnf/JVH/CUav/0IniT/AL/6d/8AJVdVRQByv/CUav8A9CJ4k/7/AOnf/JVH/CUav/0IniT/AL/6d/8AJVdVRQBx9x4zurNrZtT8IeILG2muoLT7RLJZMkbzSrEhYJcM2NzrnCmuwrlfiX/yLln/ANhrSf8A0429dVQByvxL/wCRcs/+w1pP/pxt66quV+Jf/IuWf/Ya0n/0429dVQAUV85/GOG71H482WnRWbalCfDYmFo+sSadGH8+UeZvTqR0x3/Cuw/Z68U2k3wz0S11fXDNqv2iayBv50Ek8qNkpEdxMiqGUAgnj06UAeuUUV8Uaje3gtvEFxt1WyvpvF01ha+J21WWO208B0by3iVjwAWOSuMN1+XFAH2vRXgnjH4j+NP+Ez8Q6P4Rt1l/sGGBtn2ET/bC6By0jeanlJg8FQ2fatfT/GfivxZ4p1q00i/0fw/aaLbWc8sV9B573BmiEjbmDgJGM43DPr3oA9korwvXvizrFhoHje4jfTRfaP4hTTLSJ0OWgLoMsu7JOC3Ix09q39N8VeLdW+IPi/TrOXR4tF0CeEOJYJDPIjwl8KQ23Oe5FAHqtFfPifFHxta/CGz8ZX6aLL/abx2tpHBbyAwO0rKZZcvgjC4ABHJGTTtQ+JXjrQvCfiObU7WE3dlNZfYLu8shbmeOaTY++FZWxg9CG5oA+gaK+bviN4t8ZxeGviZoWp6nYi80aKyuYr3T4Xgby5mBZB85II4w2emc5zx7V4fGqDwOf7dvrS+vGtmbzrWExIVKZUYLNzjvnmgDp6K+YvBni3WNI+FPgfSvDF+U1OTTrq8azi01bp3RZnAYs8saxp1yck+1dTY/Ezxbrtl8L00ZNHt9Q8UQX5uTdRSPEj26AhlCsCAcMcZPYZ70Ae6UV4TrXxL8WaN4lvfBdwmnS+KLm8sY9KnSBvJkglBMsjLuzhNjjr3HpUHjn4jeNdOu/H9zo9xo8eneFJ7UeTPau8lwsqrlSwcAck84z9KAPfaK8I8W/EnxN/avjSTR7/SNKs/DFlDcC0vLczS3zyReZ13rtUdARnnHHOKz9U+KfjbU9WmsPDNogubDSbO+eNLAXAu5ZoVlIJMqeXEN23IDEHPtQB9D0V89eO/it4ms7e5v/D88Rl0/TbO+v9NGnLNHbNNGH2y3BmXrnjYrdvw6XwNdnUPjx4hvCgQ3Hh+wmKg527ucZ/GgD2CivHfiF4x8XW/jfXtF8NXWlWlvpmgf2wXurVpXcqzAoCGAGQByQcVz2o/Fbxbq9x4b07w9aLbX19oEesStDY/amlkYkbERpE2xgg5bLEZxg4yQD6DorxGy8eeO9c1/w7ounQ6JpmoX+hvfXYvInlWKZJzG23Y/TjgE8Z5Jxii4+JfiSPxnN4KWKyPiM6+kELGFtn9mNGZfOxnlwqnPbNAHt1FfPdj8UvG2qa/dXum6cH0Wz1g6fPZGzAEcCvtZ3uDKCsvfbsx0616b8W/EupeD/D1nrmnpDJY2t9ANTV0LMLRm2uyYPDAlfbGaAO3orwyb4la5qHhltUtL6CxXVNeksNDWDTjdzXVtHuXIQyIpZnXqWAAB7kVn6f8AFbxfP4O09/I05NdPjNfDEpuYCqMpXO5lRztbJAO1mHBxmgD6Dorw/VPEV/4e+JV+fEL6JFqlp4JlvJdWhtJCFYXZCIF3EmMfKdvUnvzWZoPxR8WQ3fiiz1TZci18LT+IbC5udPW0dinC5jSVwUJOeSrcdBxQB9B0V4BZeOfG1y1laaneaQyeIPCsurWr21q8bWkgiDDPznd155HPTGOaHhzxR4+0v4OeGLzT7iPWZb8oN8Fmbq8t4Bv3ny2lBnfIHQjGDkc5AB9HUVx3wm8SSeKvBVtqU99HfT+bJFJKto1qcqxGGjJbawGMgEj0rybQGe++CfxI8ZTyN/b2rG+LzhsSQRxZSOJT1AULkD3oA+iqK+VvhFcXA+JHgO1iXUfD7yaKL28+3anJcJrgeIbWjQsyLzl8ZBHPAK13f7PuvQyfC29iv9VjfUDeXiok1wDKeTtABOfpQB7dRXwzca/4p8LfBRob69vrzSPFUKT2F4JWL2d1FcL5kZbOQrJGSPXt/FX0d4+QaD8Z/Ams6biK41h5tK1CNePtMQTcjMO5Ruc9cYHSgD1iiiigAooooAKKKKACiiigAooooAKKKKAMO0vrmTxvq1g8mbSDTrOeOPaPleSW6VznqciNOOnHHU53Kz44bCPXL26SSMai9rClwPM5WFWlMZK54GWl574PpxLpOpWWr6fDfaXcxXdnMCY54m3I4zjIPcZFAHi/g/4w6zrnxEi0A2WlzxPqd5ZSQ24lFxbww9J3JJTaemODnpW7o3xatn8P6LL9j1LWtRv47y5KWlrFbskFvK6PIyvMVUDaAPnJbrgZxW3bfCzw1a6haX9rFdQX9rqM2pxXMcxDiSXHmKT3Q4Hynj8zXPeKvhEJdI0ew8IXMWnfYY7uE3E8s/neXcPvZQ0brldzMSre2COcgFK4+NTW+sTXkejaje+G/wCwrbVwLeKPz4FkdgzSZkAwFA4XJz7cjq/BXj+bxL448R6Kuj3MVjpogeG9O3a6yRBxvG7ILbsrgH5fvbTxSaT8K9Ds9BbTrl7i5ebRYtDuZg+zzYUB5C87SSxPU1taJ4L0rRfENzrOnG8iubm3it54/tDGKURIERmTpuCqBmgDpaw/EN9cWmr+GILeTZFeai8E42g70FpcSAc9PmjQ5GDx6E1o3WpWVrFdyXF1CiWieZcEuP3K4J3MOwwCcn0qrM2lam2iXrXEEo877Rp8iyjErtBIMpz8+YmkOOeAT2oA1a474v8AiO98I/DjW9d0oQm9s40eMTKWTJkVTkAjsT3roNO1rT9Sv9RsrC5E9xp8ixXQRTtjcqG27sYLYIyASRnnFJ4k0LTvEuiXWka3b/adOulCzRb2TcAQw5UgjkDoaAOT8d/EWLwjbaDG1g9/qerq7QwrIIkxGis5ZiDj7ygDByT261xOpfE7xNq/ibS18OabPaad/YMutzW9wkYlkKPsKPvOVUMNvy4Y5z06d+nwu8Ipp0ViNOuDDDObiJ2v7kyxOVCkpKZN6ZAAIVgD6Vp6f4L0CwvIrq2sD9ojsX00PLPJKTbu/mMjbmO7Lcljk+9AFb4XeItR8V+BtK1rWLCOyuruFZdsTgo4Kg71GSVByeCcjHNdXWR4W8OaZ4W0lNM0OCS3sUYskTzyS7c44BdiQOBwDgelXri/s7a8tbS4u7eK7uywt4ZJFV5io3NsUnLYHJx0HNAHPfEv/kXLP/sNaT/6cbeuqrhPGmtafrHh8rp1wJXsvEOl21whVlaKQahbEqQwB6EEHoQciu7oA5X4l/8AIuWf/Ya0n/0429dVXK/Ev/kXLP8A7DWk/wDpxt66qgDnvEPgrwz4kvUvNf0LTtRukjESy3MCuwQEkKCe2WJ/E1YTwvoMa6WsWj2Ea6WxaxVIFUWxPUoAPlJ9q2aKACsQ+E/D50u/006NYHT7+Y3N1bmFSk0pIJdh0LZVefYVt0UAcpq/w58HaybQ6p4c025NrGsMJeEZRF+6me6jsDwKfq3w/wDCWr3dpdal4d0y4ntESOB2gXKIv3V46qOwPArqKKAOX1D4feEdS1afVL/w5pdzqE+PNnlt1ZmIxgnPfgc9eK2bbR9Otbu/ubeyt4rjUCpu5EQBpyBtG898Dir9FAGSvhvRV8Pf2ENKsv7F27PsJhUw7c7sbMY68/WsnTfhx4O02wubKy8N6ZFa3LI00fkgiQocpnPXB5HpXWUUAZF34a0S8l1KS70qzmfUolhvGeIE3CKMKr+oHb0p2geHdI8PaT/Zei2EFnp+WbyIh8uW6/nWrRQBy138PfCF5b6dBdeG9Klh08EWsbWylYgTkgDHTJJx0zWhZ+F9CsjpRtNJsoTpQkFiUiA+zCQYfZ/d3DrjrWzRQByF14Ht7z4oWfjO7ufMlsrBrK1tfKAEZZiWkL5yThmXGMAGta68L6FdpqiXOk2UqaoUN8HiBFyV+7v/AL2MDGa2aKAPK/iN8IIPG2rtczapBaWrwrbtGulW8kyoBg7J2G9cj647Y5rqNU+HPhHV7fT4dW0CxvfsECW0DzxhnWNRhVLdSB6HjrXWUUAcpffDnwbf3MdxeeGNImljgW1QvaqdsSgKqgYxgKAB6AYHFbdnommWWoPfWlhbQ3jwpbtMkYDtGn3UJ9B2FaFFAGbcaFpVxfXN7Pp9tJd3VsbOeZowWkhPPlse68nisvWPAPhTWdOsrHU/D+nXFpZII7aNoR+5X+6pHIHTgcV01FAGPpnhjQ9KntZtN0mytZbS3NrA8MIUxxFtxRcdAW5I9eambQdJbXl1s6baHWFi8kXnlDzQn93d1xzWlRQBy1/8PfCGoa6NZvfDmmTapvEhuGgG5nHRm7E+5zXQ6jY2up2E9lqNvFc2k6GOWGVQyup6gg9asUUAc/qPgvw1qWhWui32h6fNpVqQ0Fq0I2REd1HbqenqfWltfBnhq0tYba10LTobeG9GoxxR26qqXIGBKABgOAMZrfooAy7/AMPaPqF7PeX+mWdzdT2hsZZJYlcvbltxiOeqZ5x0zWXpPw/8I6RHPHpvh3TLZbi2ezm8uBQZYXOWjY9WU9wa6iigDKh8O6NDPYzRaZaLLY232O2YRDMMOAPLX0XAAxXPn4VeBTZTWn/CLaWLeWUTNGIcDeAQCPTgngYrtaKAKWjaVYaJpsOn6RZwWVlCMRwQIERecnge/Ncz4d8A2ejTeJbbzxd6Brk7XL6XPCGSGRxiXa2eUbrtI47d89nRQBjXHhbQrhNKWfSbJxpIUWGYhm12gAeWf4cBV6egrMtfhv4LtL5L228L6RFdxv5izJaqGVuuQcda6yigDCuPCHh248Pw6FPounyaNCd0dk8CmJDknIXoDkn8zVG88HrqHxCsPFGo3rzrpls8On2Qj2pA8nEkpbJLMR8vYAe/NdXRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5f8ULLVLix+If9kxTfaJvDdtHCyA/OQ94XRT3ba3Qc/MPUVyfj3U4rvVfBFp4b/tu60C90O6eCx0S7aAybViERO10Hy57njnIxkV7Vb6p53iW+0nycfZbS3uvN3Z3ea8y7cY4x5Oc553dsc2INPsrcxG3s7eIxBhGUiVdgY5bGBxk9fWgD538QeHfia6aMmpX2uEx6RAiXGl5nkhu1JMm8C5hUuRtBdxIp56cmujfw746uPDnj+8ttR12PX5NRni0q3e+KRfZSYSTEpJVWIEoU5wp6Y5Ne30UAfP3ibRvElzpumL4Y0/xdZaEl5KdQtL67kuLlyYkEboBdJIYw+7KiUDd820gYqpdeFvHV/pWoi51HxdJNaeHYzYP9qa2ea9WWTBdElZS+3ZnLHPBPPT6MooA8c8FaHqGjfFTxDrev2+rJbahptnN9se5P2UMkLCcTLvxkE/KCpCjdjAPL/hja3B8H/D+SOCYWI1q8uLZShzFZtDe+SW9F2umPZlHtXrs8MVxC8VxGksTjDI6hlYehB61nanqS6XeaHZx24ZNQujaLhtoiC28suQMc/wCp244+9ntggHgmt3T6f8H/ABBpO+aPxBY+JgL9IpTFNKZr4Oj5BBAeN0AbIHHtU+oeAPGc+g3QsbGez0uXXPtg8PG+SSQW3lbSN5fyzl/n8svt9819EUUAeHeBPh9raeJtDPiGLWBolhpMqIJ9TAdbgXgkiRxDJ84CZwCWXAAJOAKzIPAfjAeE9Y0+PTLmHxfNBMsniQ6sNl9mdX2Kgbcu6MFRuVQnY8mvoSigD530b4c+JH/sy0uNO1a10dtZiuby0k1CJFjh8iRZNnkyk7C2zI3ZJ/hAzTrL4a69a3fhCe80W6v7XRtY1EfZxqSiRLOTP2dgxkHyqSGIzuxwQelfQ1FAHiOqOmoeMfF2p6bhtM/tfw7YyTIcpNdRX8XmYPqqvGh9xjtXt1cr8S/+Rcs/+w1pP/pxt66qgDlfiX/yLln/ANhrSf8A0429dVXI/FOFbjwpDBIXCS6tpcbGN2RgDqFuDtZSCp54III6gg1o6f4W0+wvI7mC41lpIzkCfWLuZDxjlHlKn8QaAN2isjV/D1lq1ys91NqkbqgQC11O5tlxknlYpFUnnqRnp6CrGj6Vb6TA8VrJeyK7bibu8muWzjHDSsxA46A4oAv0VzX/AAhel/8AP14g/wDB/f8A/wAerW1XSrfVLSO2uZL1I0YODbXk1u+QCOXjZWI56E46HsKAL9FY+k+HLLSro3FrPqryFSuLrVLq5TB/2JJGXPHXGaj1LwxYajeyXVxcawksmMrb6vdwIMADhI5Qo6dgMnnqaANyiqFtpVvbaU+nRyXrW7qyF5LyaSbDZziVmMgPPBDZHbGKzYPCGmwTxypc66XjYMA+uXrqSDnlTKQR7EEGgDoaKzdZ0W11jyftcuoR+Vnb9kv57XOcZ3eU67unGc45x1NN0bQ7TSGla0l1GQyABvteoXF0Bj0Ertt69sZoA1KK5+68I6bc3Ms8lzrivK5dhHrd7GoJOThVlCqPQAADtWjNpVvNpA015L0W4VU3pezLNgEEfvgwkzxyd2TznOTQBforC0/wtp9heR3MFxrLSRnIE+sXcyHjHKPKVP4g1Nq/h6y1a5We6m1SN1QIBa6nc2y4yTysUiqTz1Iz09BQBr0VQ0fSrfSYHitZL2RXbcTd3k1y2cY4aVmIHHQHFZP/AAhel/8AP14g/wDB/f8A/wAeoA6WiqGq6Vb6paR21zJepGjBwba8mt3yARy8bKxHPQnHQ9hVbSfDllpV0bi1n1V5CpXF1ql1cpg/7EkjLnjrjNAGxRWHqXhiw1G9kuri41hJZMZW31e7gQYAHCRyhR07AZPPU1dttKt7bSn06OS9a3dWQvJeTSTYbOcSsxkB54IbI7YxQBfornoPCGmwTxypc66XjYMA+uXrqSDnlTKQR7EEGr+s6La6x5P2uXUI/Kzt+yX89rnOM7vKdd3TjOcc46mgDSorL0bQ7TSGla0l1GQyABvteoXF0Bj0Ertt69sZqndeEdNubmWeS51xXlcuwj1u9jUEnJwqyhVHoAAB2oA6CiqE2lW82kDTXkvRbhVTel7Ms2AQR++DCTPHJ3ZPOc5NUdP8LafYXkdzBcay0kZyBPrF3Mh4xyjylT+INAG7RWRq/h6y1a5We6m1SN1QIBa6nc2y4yTysUiqTz1Iz09BVjR9Kt9JgeK1kvZFdtxN3eTXLZxjhpWYgcdAcUAX6K5r/hC9L/5+vEH/AIP7/wD+PVrarpVvqlpHbXMl6kaMHBtrya3fIBHLxsrEc9CcdD2FAF+isfSfDllpV0bi1n1V5CpXF1ql1cpg/wCxJIy5464zUepeGLDUb2S6uLjWElkxlbfV7uBBgAcJHKFHTsBk89TQBuUVQttKt7bSn06OS9a3dWQvJeTSTYbOcSsxkB54IbI7YxWbB4Q02CeOVLnXS8bBgH1y9dSQc8qZSCPYgg0AdDRWbrOi2useT9rl1CPys7fsl/Pa5zjO7ynXd04znHOOppujaHaaQ0rWkuoyGQAN9r1C4ugMegldtvXtjNAGpRXP3XhHTbm5lnkudcV5XLsI9bvY1BJycKsoVR6AAAdq0ZtKt5tIGmvJei3Cqm9L2ZZsAgj98GEmeOTuyec5yaAL9FYWn+FtPsLyO5guNZaSM5An1i7mQ8Y5R5Sp/EGptX8PWWrXKz3U2qRuqBALXU7m2XGSeVikVSeepGenoKANeiqGj6Vb6TA8VrJeyK7bibu8muWzjHDSsxA46A4rJ/4QvS/+frxB/wCD+/8A/j1AHS0VQ1XSrfVLSO2uZL1I0YODbXk1u+QCOXjZWI56E46HsKraT4cstKujcWs+qvIVK4utUurlMH/YkkZc8dcZoA2KKw9S8MWGo3sl1cXGsJLJjK2+r3cCDAA4SOUKOnYDJ56mrttpVvbaU+nRyXrW7qyF5LyaSbDZziVmMgPPBDZHbGKAL9Fc9B4Q02CeOVLnXS8bBgH1y9dSQc8qZSCPYgg1f1nRbXWPJ+1y6hH5Wdv2S/ntc5xnd5Tru6cZzjnHU0AaVFZejaHaaQ0rWkuoyGQAN9r1C4ugMegldtvXtjNU7rwjptzcyzyXOuK8rl2Eet3sagk5OFWUKo9AAAO1AFy30tovE9/q3mgrdWdtaiPbypiedt2ffzgP+A+9alchBYrceKdZ0WW61H+z4tJ08oq386yK3nXeWEgffuOxAW3ZYKASRWlp/hbT7C8juYLjWWkjOQJ9Yu5kPGOUeUqfxBoA3aKyNX8PWWrXKz3U2qRuqBALXU7m2XGSeVikVSeepGenoKsaPpVvpMDxWsl7IrtuJu7ya5bOMcNKzEDjoDigC/RXNf8ACF6X/wA/XiD/AMH9/wD/AB6tbVdKt9UtI7a5kvUjRg4NteTW75AI5eNlYjnoTjoewoAv1l6vpZ1DUNEuRKEGnXjXRUrneDbzRbfb/W5/Co9J8OWWlXRuLWfVXkKlcXWqXVymD/sSSMueOuM1z/jPRoZvEfh2T7ZrEP8AaGotBcJb6tdQoyLZ3DgBEkCr80SHKgEkc9TkA7iiqFtpVvbaU+nRyXrW7qyF5LyaSbDZziVmMgPPBDZHbGKzYPCGmwTxypc66XjYMA+uXrqSDnlTKQR7EEGgDoaKzdZ0W11jyftcuoR+Vnb9kv57XOcZ3eU67unGc45x1NN0bQ7TSGla0l1GQyABvteoXF0Bj0Ertt69sZoA1KK5+68I6bc3Ms8lzrivK5dhHrd7GoJOThVlCqPQAADtWjNpVvNpA015L0W4VU3pezLNgEEfvgwkzxyd2TznOTQBifEv/kXLP/sNaT/6cbeuqrgPGWg2mkaDbvaTalI0msaQpF3qNxdAD+0bfoJXYA+4xXf0Acr8S/8AkXLP/sNaT/6cbeuqrlfiX/yLln/2GtJ/9ONvXVUAFFFFADJpUgheWZgkcalmZjgADkk15n4I+Mmi+ItF8QapqNvPo9to4jmlMwaQvbyLmOYBVzhhngA4rtvGOiN4k8LanoovJbIX0DW7TxKCyo3DYB9RkfjXn198DNBzepo17qGm217pf9lXEJme4DIGUowMjEqV2gADAx2FAF/W/jP4XsNA1bUrNr29fTZbeOa2+ySwyYmYBHw6D5SMkN0OAOrLnXvPib4Ws7uG3uL25RnEJkc2M4S2844iE7bMRFj0D4Pris7xH8LLHXf+Eh8/UbqI6vaWdqxjVcxG2fejjPXLAZBqlq/wdsdU8QvrlzqQl1K5jhS9luNMtLjzmjUKHTzI28piAAdvHA4yM0AaWp/FPw+La7Ok6hBNcWl0ltP9pguY4kbzliZd6xNltzYAA54OQOa1Y/iB4ck8SnQlvpDe/aDZ7/s8nkG4C7jAJtuwyBedu7PbrxWTJ8MbN/CN5oB1C4ENzqx1Yy7F3K5nE2zHpkYz6UkXwvsY/Ew1H+071tOXVm11dMKp5YvWUqZN+3fjknbnGT+FAHQeDvGmg+MreWfw3eveQxKrNIbeWJcMWAwXUZOUbIHTHOMiua0D4weHNV0a71CVdQtVgv8A+z44WspmkuJCzBFjUJl2bYx2DLLj5gK6fwB4Yh8G+D9N8P21xJcw2KMiyyABmyxbkD/erlB8KIo4p0ttev4SmrnWtPYRRE2U7Fy45X94rbyMN0wMd6AOrt/FWm6j4PuvEOkXMU1nFBNLvlV4wpjB3K67S64KkEbSR6GuduPi34W03TbCXWNQKXM+n2+oyLaWlzNGkUo4k3eWMJnPLBT0yATitbRvBFnpXge/8OQ3VxKt+tx9ou5AvmSST7i8mAAByxwAMcCsEfCaxGm3ln/adztufD0Hh4tsXKxxKQJP9456dKAIYvi5p7+MvEOnyxxW+haHBHJcajKJt0rSBdojURFSCXUAFtzZyoYc1sn4p+Eo7EXN1qFxa/6WbFoZ7GdJkn2b/LaMpuB28jIwe3PFZt58I9Iv7DxLZ315dSQa2tkH2qoMLWsaojLkEHOwEggjqKbo/wAJ7PTpNKl+3x+Zp+orqKi1022tEdljZApWJFB+8Tk5P0FAF+P4l6NE2qSXt1H5EF1BaW0dtDcSXM0k0QkRDEYgd5BztTdwOSCCBPcfFHwhb2GmXcuqsItSE/2ZVtJndzCQJVKKhZWUkZUgH2qhqnwvtL3VdS1SHVbu11K41OHVreeNEP2aWOLygNrAhlK5yD61LoPwysNG1Pw5fw391LcaQ99M7Shc3Ut3t8x2wABgrwAKANDxt490/wAI61oGn6hb3kravK8SPBA8vl7VzkhVJPYYHPfoCaw/Dvxc0a+1y+0fVVlsb+PWLrSrYLDLJHMYmIX94E2h2wcJnPHuM9H408JDxJd6Jew6lcadfaRcm5t5oo0kzuQoylWBByD+FYyfDGzXyv8AiYXH7vxO/icfIvMrbv3X+783XrxQBcHxS8HHT0vV1gNavYvqQdbaZsW6yeWzkBMj5/lwcHIPFNvPin4StLWG4a/uZI5VklAhsLiRlijxvlZQmVjGR85GPQmuP8N/B5fsHxCt9TY2S+IrqSK1ELiU21pvZ1C54XLu5Kjgcda63xd8O4dfuoLu21e90y7GmyaRPLbpG/n2jkFkIdTtORkMORnvQA+7+I2i6ffau1/qFiumWNpa3SywmWSVxPnZ8oTa27A27GYnuBU/w88aDxjL4g2WM1nFpl/9jQTo8cjjy1bLxuoZD82MEdqwtQ+D+k3IuxbX13aBrawt7UxhSbU2ZzE4yDu9CCK6TwJ4RPhZtZll1OfUrrVbw3s800aRneUVcAIAMfL6UAVE+Jvhj7df2lxdXlpNZWst64urCeEPBEMySR7kG8Ac/LkkdM1mD4weGp/EOg6Zp/268j1YyKl1HZThEKqjDgplgfMHzLkL1YgVh6d8CdOsnuyNbu5RNY31hue2hEhW5BDPJIFDSuM/ecnoOnfrbvwCklx4MubTVbm1uvDMTW8Mixo4niaNEdWDA4JEY5HTJoAP+Fo+EvtVzC2oyqsEVxN57Wk3kzLbgmfypNu2QoAchCTxxmn2nxO8I3awPFqxEc8c80TyWs0ayJDGsshVmQAhUdW498Zwccrb/A3R7N9SSyvRDaXkN3EqnTrVp4vtEbxsBceX5pVfMYgbs9ASRwZ/il8NJfE3g7wp4dsGJXTrmCKa8MnlulqIjHLjHUsvG3oc+1AHpej6la6xpVpqWnyNJZ3cSzwu0bIWRhlTtYAjIOeRVumQRRwQxwwoqRRqERFGAoAwAKfQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFCGWwOvXkUQT+1FtoGnIQhvJLSiLLYwRuWbAzxz6jN+sKzsrhPHOr3zxkWs2nWUMcmRhnSW6LD14Eif8AfVbtABRRRQAUUUUAFUNSlsI7zSlvghuJLllstyFiJvJkJwcfKfLEvJxxkd8VfrC8RWVxdax4Xmt4y8dpqLzTsCPkQ2lygP8A306Dj1oA3aKKKACiiigAooooA5X4l/8AIuWf/Ya0n/0429dVXK/Ev/kXLP8A7DWk/wDpxt66qgDlfiX/AMi5Z/8AYa0n/wBONvXVVyvxL/5Fyz/7DWk/+nG3rqqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKyDrQF+bVoGDCYQk7umeh/HI/OteuehiqWI5vZO/K2n5NdC505QtzLcKKKK6CAooooAKKKKACiiigAooqO5mFvbyzMrMI1LkL1OBnA96G7agtSSiqOn6lDfSSJCHBRQ2WxyDnp+X61erHD4iniaaq0neL6lSi4O0twooorYkKKKKACiiigAooooAKKKrX92llb+dIrsu4L8vbJwP1qKlSNKDnN2S1Y0nJ2RZoqppt8l/C8kasuxyjBuuRg/yIq3SpVYVoKpTd01degSi4uzCiiitBGRbanNL4u1LS2WP7PbWNrcowB3FpZLhWBOcYxCuOO568Y16oQ6ZFFr15qqu5mubaC1ZDjaFiaVgR7kzNn6Cr9ABRRRQAUUUUAFZGt6nNYan4ft4VjZNQvmtpSwOVUW08uV567olHOeCfqNeqGpaZFf3mlXMjuradctcxhcYZjDJFg+2JSfqBQBfooooAKKKKACiiigDlfiX/wAi5Z/9hrSf/Tjb11Vcr8S/+Rcs/wDsNaT/AOnG3rqqAOV+Jf8AyLln/wBhrSf/AE429dVXK/Ev/kXLP/sNaT/6cbeuqoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoopk8qQQyTTMEijUuzHsAMk0AlfRD6K5s+OPDo66kP+/Un/wATUsXjHw/L93Vbcf75KfzArL6xSf2l96Op4HErV05fczfoqlZ6rp96cWd/aXBPaKZX/kau1omnqjnlGUXaSscd4hJtdWuZl7LFc/ivH/sgrsa5Txbj7VMcZ/0UZ/N66e3BFvGCcnaOfwr5/Kfdx+Mprbmi/vjqdOI1pU2SUUUV9CcgUUUUAFFct8S9RfS/CF3cRvKmWRGeIkMoLAHBHT0/GvILPxtPDIDFr+oR/wDXaQyj8myK4cRjo0J8kkezgMlq46i60HbW39WPoiivI9N+Id1tH/E0sLr2mhKsfxUgfpWzbfElFfbfac23+/azCTP4Hb/OnHH0Zbu39eRNTI8ZDaN/687HodIwDKQwyDwQa47/AIWLomzdtvQfTyf/AK+Ko3fxP02Nd0NrKR/02kRP5E1o8ZQW8kYxynGSdlTf5Gn4cVrXULRGJIaF4D7suD/7K1dbXnF14lh0/RtN16aLMLXbvsVxwJNwHJ443VPF8VNFb71vdD/daIj9XFeNklajh8O6LlopO3z1/Ns2q5ficRLnpwbto/VHoFFefz/FPSFH7qCdj/tyRqP0Y0mk/EZdU1a3tLXTjIkkgRmhkMhUE43HC4AHU817H12heykZ/wBj41RcnTsl6f5noNFFFdR5g12VFLOwVVGSScACsP8A4TDw9/0F7T/vurHiwyr4a1JoF3usDNt9QBkj8s18/wD/AAktiTzFb/8AfIrz8ZjHh5KK6nvZRlEcfCU5N6O2lv1PfYPFGhTtti1ewLehnUH9TWrBNFPGHgkSRD0ZGBH5ivne28QaU6bXs7aTPfHNSR32nLMJdPeewm/vQSFT+YrmjmvdL8jvqcM/yuS9Un+TX5H0RWd4hBOi3bD+BPM/75O7+leTWHivW7FA1vq32uIfwXSCT9eG/Wrk3xNknt5rO6isd8qGI7XZOox0OfWtamOoVqcoT0umvvOB5BiqclKFpJf11seg+GlMU99ET3STH1GP/ZRW7Xmeu+Lm8L6paj7Os32u2XgkggrjoADn71UpfFHjLWxt0nS7mONujJB5QI/35OPyxXFk2MhTwVOnq2rqy10TaX4GbyqtXftrqMX1bsj07UdRs9NiEt/cxQITgbzgsfQDqfwqSyu7e+tUuLOVZYX+66ng4ODXmdj8O9W1SZbnxLqrxMeDHA5kl2+hkbp9ADXo+kabaaRp8Vlp8QitohhVyT7kknkknvXsUalWo25xsvxOXF0MNQio0qnPPrZaf1+BjWH/ACUnXf8AsE6f/wCjr2ulqhDqNvLr15pqxuLq3toLiRyBtKSNKqgHOcgxPnjuOuTi/XSeeFFU9Yvv7M0y4vPst1eGFdwgtI/Mlk9lXIyfxFctofxJ0TU9B1zVLiO+0pdEkaK/t9QhCTQsBkDClg27IwATknFAHa0VheB/FFh4z8LWWv6Os62N3v8ALE6BX+R2Q5AJ7qe9VfCvjfR/FOua7pekNcvcaM0SXLSwtGuZAxAXdgn7h5wB0xkc0AdPXNeLP+Q94L/7C0n/AKQXddLVDUtRt7K80q3njdpL+5a3hKgEK4hklJOTwNsbDjPJHbJABfoorI8Wa9B4Z8P3ur3dveXEFqhkeO0gaWQgf7I7epPAHJIFAGvRXnWpfFOzg0Twrd2Gk319e+JIHuLKxRo0fy44/MkLMzbRhSOMnJOBXS6B4otvEPgm38SaLbXF1BcWrXENsAqyuwB/d8naG3Ar1xnvjmgDoKK4fwL8QU8WeIda0ZtD1LTL3SVjNyLoxsqs/KrujZhuwM4ruKAOV+Jf/IuWf/Ya0n/0429dVXK/Ev8A5Fyz/wCw1pP/AKcbeuqoA5X4l/8AIuWf/Ya0n/0429dVXK/Ev/kXLP8A7DWk/wDpxt66qgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACsXxlbXl54X1GDTF33jxYjTIG45BIyeORkVtUVM4qcXF9TSlUdKcai3Tv8AcfPJ07xlbph/Dtw4/wBkK38jUDXPiO0wZ/DF8oHXdakj+VfRtFeY8rj0mz6JcSyfx0Y/ij5pm8Rwq23UtD8snruhKmrtl4tjikQ6Vql5ZkdEMhKf98ng/lX0O6LIpWRVZT1DDIrD1Pwf4d1JSLzRrJif4liCN/30uDUPLakdYT19Lfkbw4hw09KtFpeTv+D0OQ0HWLnWdK1ee/ninkitwiuibcjk8gcZ57Uab8TJns4Wn0Q8oDmK5DZ/AqKut4d07wxb6ta6UsqQ3Ft5mx3LYb5hxnnHFcyvwj1S2gjSw8QRyIqgAywlePwJrzcM8TDEVo09ZK19vO25FP8As2tOTre7F/De66a/CdTH8SrP/lrpOpqf9gRt/wCzCr2nePdOvr6C2FnqEDSuEDyxoFBPTOHJ/SuCk+Gfi5P9XqmmMPd5Af8A0GrWhfDzxPFrFnLqd9Y/Yo5VeURO5dgDnA4xzivShXxt0nH8C6uCyjkbjUW3dnsVFFFewfJDZI0lQpIiuh4KsMg1mT+HNEuF2z6Rpzj/AGrZD/StWiplCMt0XCrOHwNr0ORvfhx4Uu8ltJiiY/xQuyY/I4rnNQ+D9kQx0nVr21bsswEqj+RxXqNFYTwdCe8F+R3Uc3xtH4ar+bv+dzwHWPh54rsVOxItRgXJ3W8mGx/utg59hmr/AIC17RtKf7Bq+jwidG+ad4Mzxn0ZW5IH+z+Xevb6ytb8P6VrkRTU7KGc4wJMYdfow5H51yf2aqUvaUHr56o9T/WB4mn7DGRvHvHR/wCT/AxdNe3u5tLeIK9tJdzugK4BUq5HB/CukfTbGT79lbN9YlP9K881vRbu50iy0nQ7gQ3FveOsLzOwyE3cFl5yQvWqUM3xA0VQJ7S6uEHeKRLkH8D89eflOI5Kc+aLfvPVa9Ec7wSr606qi+ibs2rvU9MTR9MRtyadZKfUQKP6VdRFjUKiqqjoAMCvKpfiNrVmFF7pJjI+95lpLGf5mtPwt8SY9a1y202S1SN5yQCjMSCAT0Kjjj1r14Y2g5KK0b8jKtk+OUHUkrpa73PRKKKK7TxxCARg9KwpfB/hyVmL6JpxLHJ/cKP6VvUVMoRl8SuaU61Sl8EmvR2OI1T4X+Fb9Dt082kh6SWzlSPwOR+lea+M/hzf+GYGvbGd9Q01eZCVxJCPUgdR7jp+tfQNIyhlKsAVIwQehrkr5fRrRatZ90ergs9xmFmm5uUez1/HdHzz4P8ADsevRMlpqxtNS5aJJVDRTD0BGCCO459R3xoPF4k8LCa31Kyb7JOSrOqCaBiRjdkfcPucHjnOK6fxd8P5rWeTU/CQ2OTvksg20Z9Yj/Cfb8sdKpaR8QpJrC60zWInabynhLldsqNgjDqev1HPseteWqEaD5Kl4y6NbM+injKmMg6tC1SD3i/ij6f0/Ly37zxRZeHNbhS+hmk+02yhGi2/LtxnOSP7w6VrQeO9AlXJuZYz/da3cn9AaitNI0zWLuZdUsLa7CQRFPOjDlMg5wT0zgdPSiX4deFZGydJVT/sTSJ+gapyRYj6lB02re9vf+Znz0pYB+7iFJS7xt+pLceOtDiAImmde5ELLj/vrFdLDIk0SSxMGjdQysO4PQ1zVt4B8L27Bk0iFyP+ezNKPyYmumVVRQqAKqjAAGABXuUVW19rb5HDinhdFhubz5rfoZNrps8XjDU9TYp9muLC0tkAPzbo5LhmyPTEyY/GtisO0vrmTxvq1g8mbSDTrOeOPaPleSW6VznqciNOOnHHU53K3OMzPEsOq3Og3sPh+6t7PVZI9sFxcRmRI2P8RXuQM47ZxnI4rzjw18K70eF30fxRqcJcaimqi80nfFPcXA3EyTtKXDncVIwAAVGBwK9aooA83+F3gXXPAnhPw/ocOtQXMFrczy3weMkPG5YqkPdACQxznJLevEvg3wj4h0f4jeKPEWo3uky2uveR5sMEcgePyIyke0k45B+bPfpivQ6KACsfXdNnvtU8O3EJTy7C/e5l3HBKm1ni49TulX8M1sVh+Ib64tNX8MQW8myK81F4JxtB3oLS4kA56fNGhyMHj0JoA3KxfGWk3mu+GdR0rT76KwmvIWgM8tuZwqMMN8m5ecE4OeOvPStqigDye6+E95eeAdF8M3us6XcNpX7uG8l0be6R7Qo2KZvlcYPzZIOeV4rq/D/hK58NWOh6Z4f1Y22jabZyW7WktsshuJDjbKz5BBB3EqMA7u1dbRQByPw08GJ4K0W5tpb5tT1O+upL2+v3i8triZzknbk4AGBjJ7nvXXUUUAcr8S/+Rcs/+w1pP/pxt66quV+Jf/IuWf8A2GtJ/wDTjb11VAHK/Ev/AJFyz/7DWk/+nG3rqq5X4l/8i5Z/9hrSf/Tjb11VABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcv4qXddkf3rfH6t/jXQac/mafbP/AHolb8wKp6rpj3txHIkiqFQqQR15q5p0DWun2tu7BmiiWMsO5AAzXh4HDVqWY4qrKNoT5LPvZWZ01JxlSjFPVFiiiivcOYKKKKACiiigAooooAKKKKAOMsSf7dib0vp/1Mg/rXZ1z0GkXMeoefmPaLlpRzztLE+nXBroa8HIaFWhCtGrFq9STV+qdrM6sVOM2nF9ApNoJBwM+tLRXvHKFFFFABRRRQAUUUUAFcx4v8JaTrkL3N1b7L2FSyXEJ2vxzgnuOOh/SunpkyeZDIn95SPzqKkI1IuMlc1o1p0ZqdN2fkeVa9put6jf6bP4ebE0NuS4E5hYjjGCOv4+tRjW/HemKEutO1CbH92BJ+PqgyfzrvtE0m5sruGWZoyq25ibaSfmJQ+nsa3q+fyXAVY4OKqOUJK+nzdj13mkaf7uVOM4rutfvPKbDxz4le/ghk0e5fe4XY1i6ZGeec8fXpXq1FFe5QpSp35pcx5+MxNPENOnTULdupQht7FdevLiJ0OpSW0Ec6iTLCJWlMZK9gWaXB74PpV+uesYZV+IWtTNG4hfS7BFkKnazCW8JAPcgMuR7j1roa3OMKKKKACiiigAqhqVvYzXmlSXrotxBctJZhpNpaXyZFIA/iPltIcc8AntV+ud8UQyy634QeON3WLVJHkZVJCL9iulyfQZYDPqRQB0VFFFABRRRQAUUUUAcr8S/wDkXLP/ALDWk/8Apxt66quV+Jf/ACLln/2GtJ/9ONvXVUAcr8S/+Rcs/wDsNaT/AOnG3rqq5H4pmVfCkLWyJJONW0sxpI5RWf8AtC32hmAJUE4yQDjrg9K0dPuvE0l5Guo6Ro0FqT+8kg1SWV1GOyG3UHnH8QoA3aKyNXuNeiuVXR9N0u6t9gLPdahJbsGycgKsDgjGOc9zxxk2NHl1SWBzrNnZWkwbCLaXbXClcdSWjjwc54wfrQBformvtnjH/oBeH/8AwdTf/Ila2qy6pFaRtpNnZXN0WAeO5u2gQLg5IZY3JOccbR1PIxggF+isfSbjxBLdFdX0zSrW22kh7XUZJ33dhtaBBjrzn8Kj1K58SR3si6ZpOj3FoMbJLjVJYXbgZygt3A5yPvHjnjoADcoqhay6o2lPJdWdlHqQVisEd2zwludoMhjBAPGTsOPQ1mwXfixp4xcaLoSQlgHZNYlZlXPJANqMnHbI+ooA6Gis3WZtYh8n+xbHT7vO7zftd69vt6Y27YpN2ec5xjA654TRp9alaX+2rDTrRQB5ZtL57gse+d0MeO3r+FAGnRXP3V34qW5lW10XQ5LcORG8mryozLnglRbEA46gE49T1rRml1QaQJIbOyfVNqk273bLDuyNw80RlsAZwdnPHAzkAF+isLT7rxNJeRrqOkaNBak/vJINUlldRjsht1B5x/EKm1e416K5VdH03S7q32As91qEluwbJyAqwOCMY5z3PHGSAa9FUNHl1SWBzrNnZWkwbCLaXbXClcdSWjjwc54wfrWT9s8Y/wDQC8P/APg6m/8AkSgDpaKoarLqkVpG2k2dlc3RYB47m7aBAuDkhljck5xxtHU8jGDW0m48QS3RXV9M0q1ttpIe11GSd93YbWgQY685/CgDYorD1K58SR3si6ZpOj3FoMbJLjVJYXbgZygt3A5yPvHjnjoLtrLqjaU8l1Z2UepBWKwR3bPCW52gyGMEA8ZOw49DQBfornoLvxY08YuNF0JISwDsmsSsyrnkgG1GTjtkfUVf1mbWIfJ/sWx0+7zu837Xevb7emNu2KTdnnOcYwOueADSorM0afWpWl/tqw060UAeWbS+e4LHvndDHjt6/hVK6u/FS3Mq2ui6HJbhyI3k1eVGZc8EqLYgHHUAnHqetAHQUVQml1QaQJIbOyfVNqk273bLDuyNw80RlsAZwdnPHAzkUdPuvE0l5Guo6Ro0FqT+8kg1SWV1GOyG3UHnH8QoA3aKyNXuNeiuVXR9N0u6t9gLPdahJbsGycgKsDgjGOc9zxxk2NHl1SWBzrNnZWkwbCLaXbXClcdSWjjwc54wfrQBformvtnjH/oBeH//AAdTf/Ila2qy6pFaRtpNnZXN0WAeO5u2gQLg5IZY3JOccbR1PIxggF+isfSbjxBLdFdX0zSrW22kh7XUZJ33dhtaBBjrzn8Kj1K58SR3si6ZpOj3FoMbJLjVJYXbgZygt3A5yPvHjnjoADcoqhay6o2lPJdWdlHqQVisEd2zwludoMhjBAPGTsOPQ1mwXfixp4xcaLoSQlgHZNYlZlXPJANqMnHbI+ooA6Gis3WZtYh8n+xbHT7vO7zftd69vt6Y27YpN2ec5xjA654TRp9alaX+2rDTrRQB5ZtL57gse+d0MeO3r+FAGnRXP3V34qW5lW10XQ5LcORG8mryozLnglRbEA46gE49T1rRml1QaQJIbOyfVNqk273bLDuyNw80RlsAZwdnPHAzkAF+isLT7rxNJeRrqOkaNBak/vJINUlldRjsht1B5x/EKm1e416K5VdH03S7q32As91qEluwbJyAqwOCMY5z3PHGSAa9FUNHl1SWBzrNnZWkwbCLaXbXClcdSWjjwc54wfrWT9s8Y/8AQC8P/wDg6m/+RKAOloqhqsuqRWkbaTZ2VzdFgHjubtoEC4OSGWNyTnHG0dTyMYNbSbjxBLdFdX0zSrW22kh7XUZJ33dhtaBBjrzn8KANiisPUrnxJHeyLpmk6PcWgxskuNUlhduBnKC3cDnI+8eOeOgu2suqNpTyXVnZR6kFYrBHds8JbnaDIYwQDxk7Dj0NAF+iuegu/FjTxi40XQkhLAOyaxKzKueSAbUZOO2R9RV/WZtYh8n+xbHT7vO7zftd69vt6Y27YpN2ec5xjA654ANKiszRp9alaX+2rDTrRQB5ZtL57gse+d0MeO3r+FUrq78VLcyra6LocluHIjeTV5UZlzwSotiAcdQCcep60AXrfVPO8S32k+Tj7LaW915u7O7zXmXbjHGPJznPO7tjnSrnFsNVg1C+1qGCxk1K6sbW2+xvcusStFJMzHzvLJIxNx+7/h7Z4m0+68TSXka6jpGjQWpP7ySDVJZXUY7IbdQecfxCgDdorI1e416K5VdH03S7q32As91qEluwbJyAqwOCMY5z3PHGTY0eXVJYHOs2dlaTBsItpdtcKVx1JaOPBznjB+tAF+iua+2eMf8AoBeH/wDwdTf/ACJWtqsuqRWkbaTZ2VzdFgHjubtoEC4OSGWNyTnHG0dTyMYIBfrN1bVP7Pv9FtvJ8z+0rtrXdux5eIJZd2Mc/wCqxjj72e2DDpNx4gluiur6ZpVrbbSQ9rqMk77uw2tAgx15z+FZPii08SXmuaTPpmn6PJaabdm6RrjUZInmzbyxFSogYLgzE53NkL2zwAddRVC1l1RtKeS6s7KPUgrFYI7tnhLc7QZDGCAeMnYcehrNgu/FjTxi40XQkhLAOyaxKzKueSAbUZOO2R9RQB0NFZuszaxD5P8AYtjp93nd5v2u9e329MbdsUm7POc4xgdc8Jo0+tStL/bVhp1ooA8s2l89wWPfO6GPHb1/CgDTorn7q78VLcyra6LocluHIjeTV5UZlzwSotiAcdQCcep61ozS6oNIEkNnZPqm1Sbd7tlh3ZG4eaIy2AM4OznjgZyADE+Jf/IuWf8A2GtJ/wDTjb11Vee+NLjXpdFtl1jTdLtbf+19KKva6hJcMW/tG2wCrQIAMZ5z2HHOR6FQByvxL/5Fyz/7DWk/+nG3rqq5X4l/8i5Z/wDYa0n/ANONvXVUAFFFFABUUFzBcbvImil29djBsflUtfL/AMIfhx4t0vwdZ+I7KzttH1yy0nUILa1Ns0V3dzvI/l/aQ4A+XClAc8bckCgD6gor57tbjxyfDHiEafc+LIbc2dl5U+o2LyXa3Zb/AEgRpt8wx4wCyg7c5TOKzrHTvE99qXgHWdds/FsEdlqd9FK8ZkuJUjaELHIFaMSojtlT5i5C5zgEUAfStQS3ltDdQW0txDHc3AYwxM4DybRlto6nAIzjpmvnO2u/iYl7rkl5P4gTUha6oGto7GWS3dhDIbZoHC+WpDCMLtJZicEc5rq0sfGNnf8AgSWC51fU7y507ULm8k1CBdttctaw+VExVFEa+YGwG5JLZJoA9oor5rF78R4/Cetyab/wlsl0uhwNP9ttm80ap56CQWy7ctHs3/cBXGO+a9d8a+Hb6X4T+JdGt9R1PVL+fT7oRyzNH50zsrFY/lVVwThcADg496AO3qC7vLayjR7y4ht0d1jVpXCBmY4CjPcnoK+dZ28X2nhjQ4NO/wCE1jtIvD7LZrDaOsw1VWwI7hdgIhAAC7wFIB5PBPp3xD/4SFvBnhzyLeWXV/7R083qWsPmhRvXzjgA4Uc89h3oA9DqrZ6lY301xFZXltcS2zbJ0hlV2ibnhgD8p4PB9K8REHjl9bi1FtQ8Tqr+MrjTTaCP9wmltvxNt2Z2jC4kJIHGK5bRdB8Y+HPhv4ZTTYtftYry+vn1kQW7/a4iJHFudqJ5uw4LHAPLDscUAfUNQWV5bX9rHdWNxDc20gyksLh0bnHBHBrx/wAFw+M9T8XaFDrereIIdNttDhuZ5VtBbJd3KXbjZKJEJUtGE3KCrEc8ZrjbeX4gw+DNBW5h8U2sg0O4a2j060Kyf2p577FuUC5WPZs+8AuC3egD6Zpk0scEMks0iRxRqWd3OFUDkkk9BXmnhC28WX/xE1iTxDf6taWFjbae8VtEiraXMzwOJwGKEsFfBwjDkjPaua8baDqQ+K/ii8SDX5bfUvDMkNsbaFpLaSURTAwuVU7ezKpIJdhjOQKAPb7eeK5t4p7aVJoJVDxyRsGV1IyCCOCCO9SV85aRo/jbR9BjsdP1XxBbQN4JivVa8XbFZX8RjxApKAR/IGUoecZJyRmr2ial438WeH/Dmtpe6xYReIddZ3SxQP8AYdPETqv3kYKCy7tzDHzLQB7/AFXtr21uopJbW5gmijZkd45Ayqy8MCR0I7jtXit8fHNr4+W2t5vEc8kWqWkVq/l7tPl00IomeZwoTzCd5OcNuxtGKyZ28YCG1g1CDxNBo0mq6t9o/su0cTv83+i7gq7vKOW+YDB4ycc0AfQVndW97bR3NnPFcW8g3JLE4dGHqCODU1eS+Fota0L9m6zittL1M63baWVWyhzBdB8nhQVJDAHOME8cDOK4nRLn4iSW09itz4oS3fxBpiRXcllKsqWsin7QR5yElFOMlwQMcgZxQB9IUV4AdA8UeHfHHxBk0OfxFeandaVbnS7u5jDw3UiROG8xwgj8xSRsU45J4IrN0eb4gyWdtBDf+K1S51fTY5Wn0+UTWkbF1uCHlTDLjax4ZFwOcHFAH0jRXh2vzeLdL+Kuj+D9O1vULrTdXS2u3u5pFM1tFb7hcD5VAHm4j5xjLHAr3GgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOfsbiZviBrVu0sht49MsZEiLHarNLdhmA6AkKoJ77R6CugqhDLYHXryKIJ/ai20DTkIQ3klpRFlsYI3LNgZ459Rm/QAUUUUAFFFFABXP8Aia4mh1rwkkMskaT6o8cqqxAkX7FdNtYdxuVTg91B7V0FUNSlsI7zSlvghuJLllstyFiJvJkJwcfKfLEvJxxkd8UAX6KKKACiiigAooooA5X4l/8AIuWf/Ya0n/0429dVXK/Ev/kXLP8A7DWk/wDpxt66qgDlfiX/AMi5Z/8AYa0n/wBONvXVVyvxL/5Fyz/7DWk/+nG3rqqACiiigAooooAKKKKACiiigAooooAKKKKACiisnXbi5t5rP7PJsSVmjYYBy2Mj9Fb8658XiVhaMq0k2o62W/6Fwg5y5Ua1FUtGuGutMt5ZDmTbtc+rA4P6g1drWnNVIqcdnqTJOLaYUUUVYiK6t4by1mtruGOe2mQxyxSqGR1IwVYHggg4INFpbQWdrDbWkMUFtCgjjiiUKiKBgKoHAAHYVLRQAUUUUAFFFFABRXNvqN1Dq8kUspMUdykeNoAKvjH5bh+VdJXHhMbDFOaimuSTi7+XX0NKlJ07X6lX+zrL+1P7S+x239o+T9n+1eUvm+Vnds34ztzzjOM81aoorsMwooooAKKKKACiiigAoormNOu7j+14I3mldPNmtyGY4O3OGx/wD9a4sXjY4WdOEl8b5b9n0NadJzTa6HT0UUV2mQUUUUAFFFFABRRRQAUUUUAFFc1pN5cjUraG4neVW823YHu69/8Ax1vzrpa48FjI4ym6kU1ZtWfkaVaTpuzCiiiuwzMKzsrhPHOr3zxkWs2nWUMcmRhnSW6LD14Eif8AfVbtZFtqc0vi7UtLZY/s9tY2tyjAHcWlkuFYE5xjEK447nrxjXoAKKKKACiiigArC8RWVxdax4Xmt4y8dpqLzTsCPkQ2lygP/fToOPWt2sjW9TmsNT8P28KxsmoXzW0pYHKqLaeXK89d0SjnPBP1ABr0UUUAFFFFABRRRQByvxL/AORcs/8AsNaT/wCnG3rqq5X4l/8AIuWf/Ya0n/0429dVQByvxL/5Fyz/AOw1pP8A6cbeuqrlfiX/AMi5Z/8AYa0n/wBONvXVUAFFFFABRRRQAUUUUAFFFFABRUN7P9ms558Z8qNnx64Ga+fZPGKyM7tr2rBmJOEupFAz6AHiuTE4uOHsmr3PUy3KqmPUnB2tbpfc+iKK+ebbxa38PiTVE93nZv5mtm18aahGo+zeKEm/2J4EOfxxn9a545pTe6/L/M76nDVeO0l90v8AJnttZfiIYsY5e8UyMPxO3/2avP7P4h6zGV+0WNjep3a3cxkj8d1at/460vUNLeGWO6tJ98ZKyxZHDqTyuewPXFZ47F0q2Eqxi9XF/kcn9kYujUi3G6v01/4P4HU+HG/cXkQ+7FcuB+ID/wDs1a1cd4X8S6KVvBJqlnE0lxuVZZlQkbEHQ47g10sWqafN/qr61f8A3ZlP9a2yuqp4Sk29eVfkcWJw9SFR80WvkXKKjE8R6Sxn6MKkr0Tlaa3CuIvfiFaWmq3Vo9hdSxwSGPzYWU7iODwSO+e9dvXkeufCe/udTu7vTtfEazytKIpYj8uTnGQeevpXJi3XSXsF6np5XDBTlJYx2VtN/wBDtLbx1ocqZlmmtj/dmgb+YBH61s6frOm6jj7Df2tw392OQFh9R1FeOt8PfG1hn7Le2NyvZVlYE/8AfQArMv8ARPFdqDJqXht5wn8dvtkP1wpJrk+uYmHx0/wf/BPVeT4Ct/Brr71+Tt+Z9CUV852vjee3LQNqOqWkq/KYpJW+X2w2cVfsL3VPEOoxWdvrMv74/fvLtxHn0Cjgk9hVLNItqKjqZy4aqwTlOaUV1sz1HxMvlXl46feNskg/3lLY/kK6tGDqGXoRkV49eeCbvTWlEup28siQ+cStkPcYyWJPTrWwnw5v8B4fEskWRnC2uAPycVwYCpOOLxHJG7bTa2tp363/AAOethcI4RTr/PllrselUyWVIULyuqIOrMcCvOZPAGun5R4slK+jQv8Ay8yoB8KpJW3XmvNI/wDeS0VT+ZJr13Xr9KX4owWDwS1liV8oyPTo3SWNXjdXRhlWU5BHsadWb4e0mPRNJgsIZ550iz88zAsckk9AB3rSrqi20ubc8yooqTUHddDgtW8fy2mp3FtaaR9piicoJWufL3EcHjaeM571CnxCviMnw65Hql1u/wDZK4bxj4Y8U2viS/8A7LsJ7uzklaWKSPkbW5wfcZx+FYUreMtLXfc6VqUUS9W8pio/EcV4U8XiYyfNdL0X+R9tRynL6tOLhyttL7Tv+f6HsFr8RbPdt1LTr6zP94L5ij8uf0rf03xRompOEtNTt2kPAR22MforYNfPlr4vvJ32ud79Nrjmrl3qCpFFJqumvDHMMxyvGQj/AEbofzop5pUW+vy/yJr8NUXt7rfZ3/B6/ifSNcjOfI1qXb1W+jA/4GEz/wChGvLdFe/upkg0PUIrYuPkV7uSEMf7oK8Z+uKuPp/i9LySOWMtMJo42dtQc/Odu053e689q58yxH1qFJ2tacXfzXT1ZwRyWOHm4yqrbZ6P8z3J3VFLOwVRySTgCub1jxvomnRyFbpbqVf4IDuGfdvuj88+1caPAXijVCv9taxaxoPRpLlh/wB94FdDo/w30azZZNQabVJhyPtJ/dj6IOPzzXs+1xNTSEOXzf8AkcKw2X0Na1VzfaK/VlzwL4rfxQt4/wBjMMMJAWVSWRyc5UEgZI46etdXUcEMVvEkUEaRRIMKiKFCj0AFSV1UoyjFKbuzy8ROnUqOVKPLHor3Cqc+p2EE5gnvrWOYYzG8qhhn2JzVyvnnUPE1u+s3rX9sskpmcPuPIOSMfh0rnxeLWGS8zvyrLHmEpJP4e3mfQUM8Uy5hlSQeqMD/ACqSvnpp9NvAHtLaJJByADg5q1pN94kuZpINJj1J2gGTHHe4AHqFZuR+Fc0czTduW/pr+h6NThxxi5e0tb+ZJfqe91m6rrmmaTgahewwueQhOXI9do5/SvHr+68eSIUa215V9EHP5pg/rWHp+k6quoedq/h7WLqEkloxBKnmH/aYDJpVMyltCD+Y6HD1Npyq1k12i1d/fodre+ONNsdQaSAecUuWnjDME3Bs545I+8e1Xf8AhO/EV8mdK8NXDZ6MYJGX/vo7RWDZak2n3hbT/DE1u3nI2xLJ8gjGFzjPJH610h8ZeKH/ANT4Wuwf9u3cfzIrzcvnyuqlJxTk3pre/Xy9Nzpq4SnG3LRT85TX5LQfpN54+vNUtWu7GO0sRKpm3tGMpn5gAMtnHvXolcPoHiLxPe6tbwah4fe3tXJDzFCuwYPPLGu4r3sLZxbTb9Twcy5lUSlGMdPs7fPV6lCHTIotevNVV3M1zbQWrIcbQsTSsCPcmZs/QVfrmrD/AJKTrv8A2CdP/wDR17XS11HmhRVDX759M0LUr+KIzyWttJOsQ6uVUsF/HGK8F8BfFbVrax1K+8TNqepanJoiazbWsHktbOryiJFRY03xkOyqd7McAscYoA+iaK8g+Avj698QaF4lfxfrVtcXmn6zJarOYRbRCIhRGq5VerB8BsvyM9q1rHX/ABCvx/uvDd9fW0mhnQDqVvbw24Qo32lYwXckszYDdCF5Hy5GaAPSaoalpkV/eaVcyO6tp1y1zGFxhmMMkWD7YlJ+oFX65rxZ/wAh7wX/ANhaT/0gu6AOloork/ijNbWfgrUNQvta1LRraxX7S9xp0iRytgECMF1YfMSBjHJxQB1lFfPOral4z0D9mw65qHiee28QTYvAZ1R5jFIyhIVJxhgpDEgZ6jHevWNa8Q2g8Iypb61ZW+p3OlT3FrK9wqjKR/NLu6bVJBJ6CgDrqK8W+AWu6hd6xrmj63rF5rGo2UFu8t0moxXtkxbP+rZI0KMf7rFuB14r2mgDlfiX/wAi5Z/9hrSf/Tjb11Vcr8S/+Rcs/wDsNaT/AOnG3rqqAOV+Jf8AyLln/wBhrSf/AE429dVXK/Ev/kXLP/sNaT/6cbeuqoAKKKKACiiigAooooAKKKKAA8jmsGbwf4cmJMmh6cSepECj+QreoqZQjL4lc0p1qlLWEmvR2OTm+HfhSb7+jQD/AHHdf5Gsy6+EnhWfPl21xB7xTH/2bNd/RWTwtF7wX3HVDM8ZD4asvvZ5Rd/ByCIFtG1q8tpOwlAcH8sViah4U8a6EhkjkstQgBAzuHOTgZDY9RXuVZniU40iT/rpF/6MWuDG4SnSoTq01ZxTf3I78PnuLclCo1NPul+lmeDzza4VcXnhVnCthpIIiyg9cZHHes2TUIlbF3oFzH/wAivoTw193UB2F0R/5DStmuXB4J4nDwrSlrJJ7He+I/ZScXS+6TX+Z8wx6rp7SqkGjXLTZwoVec9q+mbXzBawif8A12wb/wDexzUtFephMJ9Wvre/lY8rNM0WP5Uoctr9b7/cFFFFdh5AUUUUAUtR0rT9SXbqNjbXQxj99Er4H4iuE1v4VafIzz6BcSabMefJP7yFj7g8j8D+FekUVjVw9OqvfVzrw2PxGFd6U2vLp92x4xdya9oAmt9aSUp5WzzlzcR7OcEYO5RnPX8q6jSfiVps0aJcwspAxvgcSL9SDhh+RrW8Vpvlu+M/6H/Vqtaj4U0HWY1e+0q1kdgD5irsf/vpcH9a8HBQqRxmIhRsmnHfrppf0PVqYzC1oRliqer6x0/D/giW/jLw/OcDU4Yv+u4aIf8Aj4FaUWsaZKuYtRs3Hqs6n+tcdJ8K9E3lra71W2H9yO4BX/x5TVSX4U25/wBTrd8vpvjRv6CvW9pilvBP0Zi6GWS+GrKPqr/kekggjI6UtUtGsf7M0q1svOefyIwnmP1bHfirtdqba1PHkkpNRd0FFFFMk5zxR4N0bxFbuLu1jiujyl1EoWVG9cjr9DmvM7S91TwHqLaVr1ul3ptwSFDjMVwoP3lzwG55B69+xr2+qOs6VZa1p8llqVuk9vIOVbqD6g9QfcVyV8Kpvnp6SX9anrYLM3Rj7Guuem+nVea7HnU3gjQfEcL6j4RvPsFx/HABmIMezRnlfw49AawTaeLdIvHt1txO0M0YL204Kl/lKYV/qvapNb8Ka94MvRf6JLdX2mx8iSLHnwD0Zf41/DHqBVnRfHNvfO098ys73MMrSQr0CFQcp1zhc8Z/CvBxytyJwtLmV+1u6813PoYSrOnzUJKtT6J6yXk+v9bF/wD4TXxXYjbe6HcnH8b2Mh/VTigfEDxDN8tvokzv/s6fMx/9Cr0LT9f0nUFBs9QtpCf4fMAb8VPI/KtMHI46V7UaE5L3ara+R4c8bRg7VMKk/mvwMXwlfalqGkifWLNrS53kBGXaSvGCRk47/lW1RRXbCPLFJu55FWanNyStfougVxPiD4ZeHdbvp7yeGaC5nO53gk25bucEEZNdtRU1KUKqtNXLw+JrYaXNRk4vyPHtR+DIiQvoesyxyDolymQT/vL0/I1ys7at4V1GG28QwSWz5/cXkDdfdWH6g/jX0XVDW9Jstb06Wx1KBZreQYII5U+oPY+9cNXLab96lo/wPbwvEVdPkxXvx/Fen/BON8M+P4Xj8nW5BkAbLyNCVkH+0oHyn9PpXUjxRoRUEaxYc9vPXP5ZzXj/AIj+HOt6BJJLohk1HTxyFU/vkHoV/i/D8hWP4XGmX1zNF4h1HUbXbwFtwAwPfdkEj8BXLHG4ijJUqkde7/zPRnk2AxUHicPN27R1f3bo9QfxBpf9ozOLpWQ3iSBlVmG0bcnge1dAPGOgnA+3jn1icf8AstefWnhzw1cXZjju7meIzxohkunVih25447k9q6qb4eeFFTLRSxD+99tk/q1YZXKpet7G3xu9++m1unY87E0cBFxjUc7+i/U6ey1rTL6RY7PULWaRukaygsfw61oVwOj+DfDNrrdtNp+qzyXUD+alv8AbFcEj1GM4/Gu+r3aMpyXvpfI8jGUqNOSVFtrzVihDqNvLr15pqxuLq3toLiRyBtKSNKqgHOcgxPnjuOuTi/WPa6bPF4w1PU2KfZriwtLZAD826OS4Zsj0xMmPxrYrY5AIyMHpWRoPhnQvD8lzJoWj6fpz3JDTNa26xGQjpnaPc/nWvRQBjHwvoRtLu2Ok2Rt7u7+33EflDbLcZDeaw7tlVOfYVX/AOEK8M/2/wD25/YWnf2x5nm/bPIXzd/Tdu65roaKACqGpajb2V5pVvPG7SX9y1vCVAIVxDJKScngbY2HGeSO2SL9Y+u6bPfap4duISnl2F+9zLuOCVNrPFx6ndKv4ZoA2KrahYWepWxttRtLe7tyQTFPGJFJHIOCMVZooApappOnatCkOq2Fpewo25UuYVkVTjGQGBwaZFomlQpCkWmWKJDG8USrboBGjfeVeOAe4HWtCigCnpel6fpMLQ6XY2llCx3FLaFY1J9cKBzVyiigDlfiX/yLln/2GtJ/9ONvXVVyvxL/AORcs/8AsNaT/wCnG3rqqAOV+Jf/ACLln/2GtJ/9ONvXVVyvxL/5Fyz/AOw1pP8A6cbeuqoAKKKKACiiigAooooAKKKKACiiigAooooAKyvFH/IGk/66w/8Ao1a1ahu7eO6gMM6loyQSM46EEfqKwxVJ1qE6S3kmvvRdOXLNSfRmZ4aYFb0dzMH/ADVR/Stmq1pZQ2hcwKQXxnJz0/8A11ZrDLMPUw2Ep0a1uaKs7bDrSU5uUdgoooruMwooooAKKKKACiiigDm/ERzqBT+/bY/U1uaac6fanOcxKf0FMutPtrqYSzIWcLtB3EcZzViCJYYUijGERQqjPYcV5WEwdWjja9eTXLPlt30Vnc3qVIypxit0Pooor1TAKKKKACiiigAooooAK808ZeF9I1LU9QnubUJcK0bCaE7HAKjPI69D1zXpdV5rK2mZ2mgjdnGGLLnI968/MsJUxdJQpuzTTOrCYmWGnzxbXoeb3nwlQZ/s3XruJey3USzY/Ebay2+FuvRN+41bTHH+3bsv8s17JRVyy/Dt35Tvhn2Ogrc9/VL/ACMzw1YXGmaHaWd7cC5uIlw8gGAeScAegzj8K06KK7IxUUoroeTUm6knOW71CiiimQFFFFABWVrPh3SNZH/Ez0+3uG6ByuHH0YYI/OtWiplFSVpK5dOpOnLmg2n5Hk2peDLK2v7qKzvL+2ijmjRVWXcArBSfvA+prRHwqtd2TrOoY9lQf0rvJ9MtJ5HklhDO5BY5IzgADv7CrleRhMscKlV17OLleO+i7dP1PVlnWKUUoTd+uxyXhzwJp+halHfQ3d/cXCKVHnyKVGRg8BRXW0UV61OlCkuWCsjza+Iq4iXPVldmHaX1zJ431aweTNpBp1nPHHtHyvJLdK5z1ORGnHTjjqc7lUIbexXXry4idDqUltBHOokywiVpTGSvYFmlwe+D6VfqzEKKKKACiiigArD8Q31xaav4Ygt5NkV5qLwTjaDvQWlxIBz0+aNDkYPHoTW5VDUrexmvNKkvXRbiC5aSzDSbS0vkyKQB/EfLaQ454BPagC/RRRQAUUUUAFFFFAHK/Ev/AJFyz/7DWk/+nG3rqq5X4l/8i5Z/9hrSf/Tjb11VAHK/Ev8A5Fyz/wCw1pP/AKcbeuqrkfimJW8KQrbOkc51bSxG8iF1V/7Qt9pZQQWAOMgEZ6ZHWtHT7XxNHeRtqOr6NPag/vI4NLlidhjs5uGA5x/CaAN2isjV7fXpblW0fUtLtbfYAyXWnyXDFsnJDLOgAxjjHY884FjR4tUigcazeWV3MWyjWlo1uoXHQhpJMnOecj6UAX6K5r7H4x/6Dvh//wAEs3/yXWtqsWqS2ka6TeWVtdBgXkubRp0K4OQFWRCDnHO49Dwc5ABforH0m38QRXRbV9T0q6ttpAS106SB93Y7mncY68Y/Go9StvEkl7I2mato9vaHGyO40uWZ14GcuLhAecn7o4456kA3KKoWsWqLpTx3V5ZSakVYLPHaMkIbnaTGZCSBxkbxn1FZsFp4sWeM3GtaE8IYF1TR5VZlzyATdHBx3wfoaAOhorN1mHWJvJ/sW+0+0xu837XZPcbumNu2WPbjnOc5yOmOU0aDWoml/tq/067UgeWLSxe3KnvndNJnt6fjQBp0Vz91aeKmuZWtda0OO3LkxpJpErsq54BYXIBOOpAGfQdK0ZotUOkCOG8sk1TaoNw9ozQ7sjcfKEgbBGcDfxxycYIBforC0+18TR3kbajq+jT2oP7yODS5YnYY7ObhgOcfwmptXt9eluVbR9S0u1t9gDJdafJcMWyckMs6ADGOMdjzzgAGvRVDR4tUigcazeWV3MWyjWlo1uoXHQhpJMnOecj6Vk/Y/GP/AEHfD/8A4JZv/kugDpaKoarFqktpGuk3llbXQYF5Lm0adCuDkBVkQg5xzuPQ8HORW0m38QRXRbV9T0q6ttpAS106SB93Y7mncY68Y/GgDYorD1K28SSXsjaZq2j29ocbI7jS5ZnXgZy4uEB5yfujjjnqbtrFqi6U8d1eWUmpFWCzx2jJCG52kxmQkgcZG8Z9RQBfornoLTxYs8ZuNa0J4QwLqmjyqzLnkAm6ODjvg/Q1f1mHWJvJ/sW+0+0xu837XZPcbumNu2WPbjnOc5yOmOQDSorM0aDWoml/tq/067UgeWLSxe3KnvndNJnt6fjVK6tPFTXMrWutaHHblyY0k0iV2Vc8AsLkAnHUgDPoOlAHQUVQmi1Q6QI4byyTVNqg3D2jNDuyNx8oSBsEZwN/HHJxg0dPtfE0d5G2o6vo09qD+8jg0uWJ2GOzm4YDnH8JoA3aKyNXt9eluVbR9S0u1t9gDJdafJcMWyckMs6ADGOMdjzzgWNHi1SKBxrN5ZXcxbKNaWjW6hcdCGkkyc55yPpQBformvsfjH/oO+H/APwSzf8AyXWtqsWqS2ka6TeWVtdBgXkubRp0K4OQFWRCDnHO49Dwc5ABforH0m38QRXRbV9T0q6ttpAS106SB93Y7mncY68Y/Go9StvEkl7I2mato9vaHGyO40uWZ14GcuLhAecn7o4456kA3KKoWsWqLpTx3V5ZSakVYLPHaMkIbnaTGZCSBxkbxn1FZsFp4sWeM3GtaE8IYF1TR5VZlzyATdHBx3wfoaAOhorN1mHWJvJ/sW+0+0xu837XZPcbumNu2WPbjnOc5yOmOU0aDWoml/tq/wBOu1IHli0sXtyp753TSZ7en40AadFc/dWniprmVrXWtDjty5MaSaRK7KueAWFyATjqQBn0HStGaLVDpAjhvLJNU2qDcPaM0O7I3HyhIGwRnA38ccnGCAX6KwtPtfE0d5G2o6vo09qD+8jg0uWJ2GOzm4YDnH8JqbV7fXpblW0fUtLtbfYAyXWnyXDFsnJDLOgAxjjHY884ABr0VQ0eLVIoHGs3lldzFso1paNbqFx0IaSTJznnI+lZP2Pxj/0HfD//AIJZv/kugDpaKoarFqktpGuk3llbXQYF5Lm0adCuDkBVkQg5xzuPQ8HORW0m38QRXRbV9T0q6ttpAS106SB93Y7mncY68Y/GgDYorD1K28SSXsjaZq2j29ocbI7jS5ZnXgZy4uEB5yfujjjnqbtrFqi6U8d1eWUmpFWCzx2jJCG52kxmQkgcZG8Z9RQBfornoLTxYs8ZuNa0J4QwLqmjyqzLnkAm6ODjvg/Q1f1mHWJvJ/sW+0+0xu837XZPcbumNu2WPbjnOc5yOmOQDSorM0aDWoml/tq/067UgeWLSxe3KnvndNJnt6fjVK6tPFTXMrWutaHHblyY0k0iV2Vc8AsLkAnHUgDPoOlACWMMq/ELWpmjcQvpdgiyFTtZhLeEgHuQGXI9x610Nc6L/VJ72+0WGayj1S1srW6N69uzwu0skysPJEgYACA4/eH7w9OZdPtfE0d5G2o6vo09qD+8jg0uWJ2GOzm4YDnH8JoA3aKyNXt9eluVbR9S0u1t9gDJdafJcMWyckMs6ADGOMdjzzgWNHi1SKBxrN5ZXcxbKNaWjW6hcdCGkkyc55yPpQBformvsfjH/oO+H/8AwSzf/Jda2qxapLaRrpN5ZW10GBeS5tGnQrg5AVZEIOcc7j0PBzkAF+ud8UQyy634QeON3WLVJHkZVJCL9iulyfQZYDPqRVrSbfxBFdFtX1PSrq22kBLXTpIH3djuadxjrxj8ayfFF34ks9c0mDTNQ0eO01K7Nqi3GnSSvDi3llLFhOobJhIxtXAbvjkA66iqFrFqi6U8d1eWUmpFWCzx2jJCG52kxmQkgcZG8Z9RWbBaeLFnjNxrWhPCGBdU0eVWZc8gE3Rwcd8H6GgDoaKzdZh1ibyf7FvtPtMbvN+12T3G7pjbtlj245znOcjpjlNGg1qJpf7av9Ou1IHli0sXtyp753TSZ7en40AadFc/dWniprmVrXWtDjty5MaSaRK7KueAWFyATjqQBn0HStGaLVDpAjhvLJNU2qDcPaM0O7I3HyhIGwRnA38ccnGCAYnxL/5Fyz/7DWk/+nG3rqq4DxnBrcWg251nUNNu4zrGkbFtLB7cqf7Rt+SWmkyPbArv6AOV+Jf/ACLln/2GtJ/9ONvXVVyvxL/5Fyz/AOw1pP8A6cbeuqoAKKKKAKOt6tYaHpVxqWr3UdpY24DSzSH5UBIAz+JFVPDXijRPE8E02ganbX6QPsl8psmNiMgMOoz71h/GjQNQ8UfDHXtG0aJZtQu4kWJGcICRIrHk8DgGvJ4/hj41m8P+J4oVNpHf3ljcCyu75J7i7WJcTJJMFI2t8u1W3AbcEAE5APoK81Oysruztru6hhuLxzHbRuwDSsBuIUdyACat1872/wAK9UisfDcr6BJdJpus3Fy+n3V/DuW3liUYQoFRFEgLbBn9cBmufDfx9b3msS6BKvladc3J0KI3QVZIrzeJg2Tx5e5due68UAfRdFfO3i74R+IDrFqLFbjUdPttPtLaxlgvIoJrKWEfMwaVGK72+YsnJ5BB4rTtfh14jg+LcuvXkc90h1dryDUYLyFNlq3HkOGQyFVXK7Adp46cmgD3aqkOo282p3NgnnfabdEkk3QOqYbOMORtY8HIBJHfFeK/DH4Zav4Y1XwDqU1mIL63tL6DXphdbzJux5Cn5iGA56dKufEbwL4j13X/ABRNYRFrO/XS1hxciMkQzFpu4K/KfbPagD1TxL4h0vwzpov9bufs9s0qQqRG8jPIxwqKiAszE9gCa0LWdLq1huId/lyoJF3oUbBGRlSAQfYgEV4JqXwgu3vLmxtNKi/sEeKrLUbe3Nz8qWgQC5IBbIyQeOp7U5vhp4li+JV3q8sU9yrak9za6hBewx7LVl2i3cMhkKqp27Adp4PHJoA9zvtRt7Ga0iuPO33UvkxeXA8g3YJ+YqCEGAeWwPerdeI+GPhtq2j6H8Ptls6apZ38dxrTNeGTKpHKoxliCBvHC/0rD074YeLre11CMW0MOo/2Tqtpeail7ubXJ5wfIZgeV2k5y2MdBxQB9Eu6xozuwVVGST0ArEh8W6FPeaLbW+oxTS61HLLp5iDOk6xAFyGAKjAYdSM9s1leEvB9tpXw9GhyW5Wa8swt+sk7y+ZM0KxyEsSTj5ccHHHFeU+E/hFeSW/gTTvEfh2CLT9LGox6oovA63DSxQrHL8pBwxTGO23J60AfQ9FfL+reDPE2n6R8OdBa5lt9a1a0m0LVUWUyFbNZhMXVgSAUQFc+jgV3l18M9Subv4gXNsWsr69URaHcC7fbEhtljb5VbC5IK5IyByO1AHrOp6jb6bDFLdedsklSFfKgeU7mOBkICQM9WPA7kVBq+u6do91ptvqNx5M2pXAtbVdjN5ku0ttyAccKeTgV4hY/DjxNFbXB0/SodGs5NS0qZNKivQ6r5Df6RPnO0F+OBy23J5qW2+HPiFPiHZ6ndaPBcSxeJJdSl1s3amSW0ZWEcWw/MoTIG0cDHGaAPfKiuriG0tZrm6kSK3hQySSOcKigZJJ9AK8X+PngbxH4w1SI6PpttdWsenOkM6yQpPDdbyRlpQdqYxgx4bOcsBipYfhjfarqPjW78Q25luL6xt4dMkku2KCX7D5MrFVbH388ke4oA9hsbu3v7K3vLKZJ7W4jWWKWM5V0YZVge4IINT181ah8KfEd14c8LWj6MVs7HTXsrvTYb2EuLnC5u0MgZMtg9CGXjHcV2vhf4aXF14h1y58XQ3EsE2l2FpayNftI3mLavFcFtpAZst94qM5JAGTQB7BWboeu6drq3zaVceeLK7lsbj5GXZNGcOnzAZwe4yD2NeVfs2abqkukX+v69ctczSeXpVjIdwDWlsCiuAefnbcSe+AaytD+HPiCH4gC/OkQ2OzxRd6u2si7UvJZSF8WwjXJ+fcCc4A+tAHvlFfPtt8Ltbs/hJoumLpMF1rctzGdYSe5Wd2iRpdpi80tDuAkHBBHJ4JAqPw58J9auLDwxp3iqx+0abY2upwzwPeBgDJIGgHyEbhj0AA9BxQB9DVm6Druna/az3Gk3H2iGC4ktZG2Mm2WNtrrhgOh79PSvDtG+HXiW2TRH8S6BB4lEOkQWMUE+oiM6dOjsWcHvkFfnQlhtwOMVLpvwp1my1LTtWs7VbPWl8Q31xNeJcAsllKJNvG7BGWU7QM9fegD36ivmvw78KfFGn6ZrEF3Z3wvrrTHs7i4tdVhiS8cyq3mAiPeXIDHdJzjKk4OR6Z8DvDGseFtA1C21uzsbPzbrzII7aNEfZtUZkEf7sNkfw/U80AekUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBl2+ltF4nv8AVvNBW6s7a1Ee3lTE87bs+/nAf8B961K5+xuJm+IGtW7SyG3j0yxkSIsdqs0t2GYDoCQqgnvtHoK6CgAooooAKKKKACsvV9LOoaholyJQg068a6Klc7wbeaLb7f63P4VqVz/ia4mh1rwkkMskaT6o8cqqxAkX7FdNtYdxuVTg91B7UAdBRRRQAUUUUAFFFFAHK/Ev/kXLP/sNaT/6cbeuqrlfiX/yLln/ANhrSf8A0429dVQByvxL/wCRcs/+w1pP/pxt66quV+Jf/IuWf/Ya0n/0429dVQAUUUUAFFFFABUEN3bzMqwzxSMy7wFYHK8c8duR+dT1x2kn7JrUUQ4UTywfRfmKj9FrzcfjpYSpRileM5cr8rrQ3pUlUjJ9jsaKKK9IwCiiigAooooAKKKKACiiigCGS6t432STRq24LtLDOTjA/UVNXJ+IoGOp3RQnJtlmX/eUn/Ba6tGDorKcqwyDXn4TGTrV61GcbcjVvNNXNqlNQjGSe4tFFFegYhRRRQAUUUUAFFFFABUUs8ULKJZY0LAkBmAJA6/zH51LWH4ojBWyk/iEpjH0Kk/zUVxZjiZ4XC1K9NXcVe3oaUoKc1Fm1G6yxrJGwZHAZWByCD0NOrL8NOW0eFD1iLRY9ArED9AK1K6KFVVqUai+0k/vJnHkk49gooorUkKKKKACiiigCKW4hhYLLLGjEEgMwBIp6MrorIQysMgjoRWH4oiJexlUZIdovwZc/wA0FXPDspl0a2z1QGI/8BJX+lebSx0pY6phJLRRUk+99H9xtKklSVRM0qKKK9IxCiiigAooooAKKKKACkyM4zzS1x2hnyNat0UYAaa2x6AZP/tMV52Nx/1SrRpuN1Uly3vs7aet/kbUqXtIyd9jsaKKK9ExKEMtgdevIogn9qLbQNOQhDeSWlEWWxgjcs2Bnjn1Gb9YVnZXCeOdXvnjItZtOsoY5MjDOkt0WHrwJE/76rdoAKKKKACiiigAqhqUthHeaUt8ENxJcstluQsRN5MhODj5T5Yl5OOMjvir9YXiKyuLrWPC81vGXjtNReadgR8iG0uUB/76dBx60AbtFFFABRRRQAUUUUAcr8S/+Rcs/wDsNaT/AOnG3rqq5X4l/wDIuWf/AGGtJ/8ATjb11VAHK/Ev/kXLP/sNaT/6cbeovGfi4+H7+3too7eR3j8xxLIVOCSBj8jUvxL/AORcs/8AsNaT/wCnG3qv438Aad4tvYby6uLm3uYovKDREYK5JGQR6k/nWGJVV0/3O53Ze8Mq6+tfAVbD4hLOoabTWI7/AGa4WQ/k22teHxtorAfaJprVj/DPAw/UAj9a4Wf4LIvNlr9zGR0Dxbv1DCs+5+Gvi+xQ/wBnata3SD/lm7spP4EY/WuBVcbT+KN/u/Q9x4XJ67/d1eX71+dz2Wx1Gy1BN9jd29yvrFIG/lVliFUliAB1JNfOGoWHifRju1fw2xVes0SCRR7lkziqEOureyiNYYFcnH7wFtvvgmpeaOGk4Wf9eRUeGY1ffpVU4+Vn+TPoybX9HgfZNqthG/8Ada4QH+dcveajYtrTyW97bOhu4WDJKpBGUyc5+tZui+AdM1O0W4j8Q31xGeM2uyEA+hBUkH2PNVbvwXDBfPBHqur+ULiKHLTKTh9uf4f9o1wZzKdSnRdVWXPFq2uvT5eZx0cPgqc5RVR3trdWPT1vbRhlbmAj2kFVp9b0q3z5+p2UeOzTqD/OuNk+F1owwutap/wPy2/9koj+FljkedrGrOB2R40/kle26mJ6QX3nKsPl61dZ/wDgJ2ml6vYaoZRp9yk/lkBtueM9OvUe9X6wvDXhbTPDplfT0mM0oCvLNM0jMB25OB+Ardrpp8/L+838jz8QqSqP2Dbj57mfresWei2YutQkZIiwQbULEk+w+hrNt/Gvh24YBdUhQn/nqrRj82ArO+J+garr2lWiaJJEs8Mu9kkbaGUgjg+ucV5uvhjx3Zn/AJBMc6r/AHZ4iD+BauHEYivTqWhC8fRs9nAZfgsRQU6tVRnro5Jfmj3S0vLa8j32lxDOn96Jww/Sp6+fbldas/nv/C11E4/5bwW5yv8AwJOKdpXjmexkKxavewsDzDcjzV+mG5H4EVCzNJ2qRt/XmbS4cnNOVCal/XdX/I+gKK8Xn+JeoyRFY7y3VuxitTuP/fTEfpU9pF4912CK5gknjt5VDpNLdrCGB6HbGMj8q0WYQm7U4uT8jnlkNakuavOMF5v/AIB6JrgH9rWmRw9vOp/8c/xNX9CYvomns3JNvGT/AN8iuF0LTdf03VB/wkd1HPut5PJ2XEk23GN2d4GOorP06x+IiWcT2d3aNasu6BTKuRGeVBBj7DHevPwuIaxtd8j+zp8kZywUZJU1VjZdW7J77HrFFeVSaZ8SLniS5t4/cXe0f+OLWz4Q8M+JbDVo7zWdajliUNvgjaSXzMjABZyMYOD07V6scTOUklTfzMqmX0qcHJ14t9ld3O8rN8Ramuj6Pc3z7T5YGA3QkkAZ/E1pVl+JtJXXdBvdNd/L+0R7VfGdjA5U49iAa6KnNyPk36HBQ5Pax9r8N1f06nmcnj/VnPGoWMef7lvnH5k1LF4y1ZxldbsyfRrYf0rBT4NeISD5ms2CnttDn+gqpefCTxbbfNbXdhdY/hWRlJ/76AH614X+2rVp/ez7hRyeXuxnH7l+qOtj+IWs2rEXUWnXKDoyBoyfxyR+laVl8ULZh/pumyxnv5Eyyfz215TfeH/FmixltS0i68kcs8WJlA99pOK0vBmqaQN8V/pdpqFrK251eNfOjOOSjHBx0+XI/wAYhi8RGfLN29V/TLrZTgalJ1aUFO38r/4Nj1m2+IugSsA8lzCf9uAn/wBBzTdW8UaPqUMEFldmW4MyFF8pxnnnkrjpmsix8EeCdfRpNJaeMj76RXMisv1VySPyqa48B6NoKw3tl9ra4SVArSzlgMnB46Vtj54l4Oq5crjyvVX7Hz8qWWwnaPPGfZpb+Zak8ZaboF5fWVzHcPKsvmYiCYwwGOWYehrOuPixYRt8toNuf+WlwAcfQAj9a3LLw1omsXV5f6jpsFzcNLt3yjd8oVcDHTvW1beHtFtSrW2kadEynIKWyKQfqBV5fHEVMLTlTmlFpW06WMfbZfT0qU5Sl11srmjBKs0McqZ2OoYZGDgjNNupDDazSqNxRCwHrgVLQeRzXs9Dxrq9zwU+JZ5pmeXWtRQuxJCXTqBn0AOB9KmTVzL93xHrCt/18uR/6FXQ6j8GtLur+eeDUry2jkcuIVAKpnsPasfUvgtdRRM2ka7uk7R3EW0H/gQJ/lXgSwuKWtr/AD/4J91DMcrnZKfL/wBu/wDAJ7bxJrVgA1priXqD/lldxhs/j1/Wtm1+JVzEyjUdI3L3e2mGfwVv/iq8m1fR9a8P3C22uQyWhfiKcENG59mGR+HX2rftfDmoalaeb4evotSZFDS2M+IZ0/3STtce4I+meKzp18Sm4xvddP8AhzfEYDL5RVSpZxf2lovvjZfeenP4y0vWDbW0C3UVyZlZUlix9eRkdM96m0/xPpOkPe2d/dNFLHOWCiF3+VgD1VSOua8y8HPbW2vw2N5pzwaqspfM7yJJHxyAp+Vl4PbvnNdVJovhHUvEN/Jrt88d95gBhe6aFCu0YPbJ6965qWJq1MyUtObk66fa/M8bE4DDUJ+yalyWvpZv1Xl6mxqvxN0i0Qm1imuG7M+Ik/M8/wDjtc1P4q8U+LE8vw/Yzrbngvb5jU/WZsf+O4Nd5pXhDwvbqJLHSrCX0kdRMfwZs10LvHBHl2SOMcZJAAr3/YV6n8Sdl5f5nAsZg8O/9no3l3l/kjB8C6PqOi6MYNXvRdXLyGTCZKRAgfKpPJ6Zzx16V0VIDkAg5B6GlrrhBQiox2R5VarKtUdSe7Kd/qdjpxjF/eW9sZM7fNkC5x1602DWNMn4g1GzkP8AsTqf5GvJPibr8Vn4ymt7xQVjjj8vcONpGePxJrEGtaZdpt+zwBj0IFebVzLkqONlofRYfh/2tCFVt+8r6W6n0GpDAFSCD0Ipa+d4XvTcxw6OkiSTHC+Xc+SGPpkkDP1raa1+IUAKtaasy+gv1f8AUPmnDMXJXVNv01/Qirw/Gm7OvFetk/zPYNU1aw0qMPqN3Dbg/dDt8zfQdT+Febal4007T9UlmiYMPP8ANjMjeWGB68H5hnJ/hrlJdE8RSziS80XUiCwMm1dzOO4LA5/HNa1hdTafdZsfDM1vIkyEL9nJYMCuFyTuOSB19a8rM60sR7Lnha04tdHfvrv6bs66OV4bDr4vaNrW0kl+dzoF8c+ItQUHSfD0zKejmCRlP0Y7RUaz/EbUH2izFnGerPJCg/Tc1WW8UeNJDiDw2QPV4SP5yCkTW/HxIzoCH8EH85a9Lm5vilN+isZez5P4dOkvWV3+Z1ek6jeP4iu9JvPJb7Lp1ncNIgOWlke4V/bb+5XHA6n2xu1n2+mRxa5d6rvfz7m2gtnTjaBE0rAj3JmbP0FaFestD5Zu7uFcp458dad4LiE2rWOsS2vlmWS5s7F5ooVBx87gYX8a6uuH+KXhC/8AG9vpGkC6gg0D7YlxqsbFvMuI0IZYlwMYJ6kkdBimI6A+JNMTwkniW5nNtpLWa3xlmUqUiZAwyvXOD0654qHwh4mg8UWUl3aWGpWkCkBGvYPKMoIyGUZJx9cH2rG8feFNT8XaPr2gSXdla6He2CRW2yNjNFcK+7c3YpwnA561R+EfgK78GT69d30mnRvqskDCx0yNo7WDyo9m5Qf4nPzNx1xQB6LWRrepzWGp+H7eFY2TUL5raUsDlVFtPLleeu6JRzngn6jXqhqWmRX95pVzI7q2nXLXMYXGGYwyRYPtiUn6gUAX6KKKAOIsfiRpuoeM7zw1ZaZrM93Z3H2a4uI7YGCJsZyz7uB74rW8d+L9J8EeHpdZ16V0tUYIqRrukkY/wqvc4BPsAT2rirv4Y3t/8SrHxFcT6HaW1lfPepJYaeYb65yMCOeXdhlHQ8cj68TeOPhpfeN/Dnla7rTrrcEd3Fay2o8u3CzcDehBJITCkgg8t60Aei6Rfw6rpNlqFqHEF3AlxHvGG2uoYZHrg1brH8G6O/h/wrpOkS3Ul3JZWyQtNIcliBj06dh7AVsUAcr8S/8AkXLP/sNaT/6cbeuqrlfiX/yLln/2GtJ/9ONvXVUAcr8S/wDkXLP/ALDWk/8Apxt66quV+Jf/ACLln/2GtJ/9ONvXVUAFFFFABWD4h8I6J4gjYajYRNKek8Y2SKf94c/nxW9RUyhGatJXRpSqzoy56cmn5Hkl58P/ABBoMwuPCupNdIMfupn8qUewccMPY4q3Lq+oaf4TudV1u2YajbXUck0MhCE7SuMlRgZAHIFeoVyWsFTqM8cihkN5bsVIyCMJmvnc4oU8PGlKLsueOnTqevDMamKtGvFSa1vaza7XRR074naNcqPPjnhbuV2yL+hz+lasXjrw9KB/p5Q+jwyL/wCy1Jf+CvDd+SbnRrPcepjTyz+a4rHm+Fvhp/8AVRXkHtHcv/XNetbGR6xf3hfKam6nH0s1/mddpep2WqwNNp9wk8attJXsferlYPhTwtY+GIriPT5bqQTsGY3Eu8jAOAOPc1vV103JxXPueVXVJVGqLbj0vuFFFFWYhVDUtH03VFK6jY21yCMZljDH8+tX6KTSkrMqM5QfNF2Z53rHwn0S5Jk0qW40yftsbzI8+6tz+RFYEMHjHwOWZLf7ZYA5ZrYGSM+5j+8p9SMfjXsdFck8DTb5qfuvyPVpZ1iFH2df95HtLX8d/wAzyyPxxba5JbTPGInijdW8tt+SSvbhh0Pb8TXZ+Hdc0uXTLK3S/txPHCiNE7hHBCgH5Tg1keOvD+l6jfWbXVlEZGSTMiDY5IKY+YYPGT+dYlt8M4b3SrWa01rUIHkjV2WULKgJHOBgHH4142GcqeY11Bc07Rv0VrO1v1Oqay+vRi23TX3pfqeoggjI6UteSP8ADPXoOLTW7OQD7peBoz/46TXQeB/DniPRtWkl1e/tJrNoimyGSRiWyMHDcDv0r2oYiq5KMqbXzOOtgcNCm508QpNdLNXO7ooorrPKCiiigArjfGXgDTPEO65gH2DUxytzCoG4/wC2v8X16+9dlRUVKcaseWaujfD4mrhpqpSlZnzfqI1bwxqKWeuW+yU8xToxw49Ucfy6iukstY8S3WlrIq3V5YLKoDGWKQq2eA2TvH4mvX9Y0qx1mxez1O2juLd+qOOh9QeoPuK8u174e3mhRtd+H9SEkAZB5F5kOpLADEi47kdvxNeFi8DOjTm4u8LP8uvdH1VDN8PjYqFeKjU81dP07P8AAks/FHieyhkFrolxKpfLH7C8mDgf3X9AKmTx94m6P4euifbTZx/7NUWl3/jfT4JPs2l/aUV8OA8cgDbR2yrdMVI/jzxTbZF74cnUf3hYzY/PJFTgp8uHp2k0rLZe7t08uwpUIzk+WlTl6S1PQvDd7dajolrd39q9pcygl4XQoVwxAyDyMgA8+tadZHhTVJtZ0K3vbm2e2lk3Bo2Ur0YjODzjitevfpu8E730PlcRFxqyi1azei6eQUUUVZiVdSsLXU7KW01C3juLaQYeNxkH/wCv714z4o8H6n4NnOpaJLcXGlRnfuQ/vrT/AOKX39M5GOa9wo61zYjDQrrXR9GehgMyq4KXu6xe6ezPK9N8Z2uuWNsdTghF7HIoiuwg2t68/wADe3Q/jirR8B2niG5udSfUb+1uHk2MsRQoQAMHBU88+tP8a+CbeES6poLrZXcrqskBXNvMWOMsvY89R+VclZa/4j8JRS/6FKtqr4kAjM9sGwDkMMMvBHGRXz04Rp5ipYmXM+S1vK/xfoz3qUI14+0y6fJLs/xS/r7joJfhZeI26016If8AXSxGf++gw/lSp8Lr6RwbvX4z/uWQz+Zfj8qbp3xgtZQBc2SE92huBz/wFgMfnWvD8UtHkI3Wt8g7n90QP/H69NLAS6/iyJzzyGjX4R/yOv0LTV0jSbawSeWdYFKiSXG48k9vrV+oraeO5top4G3RSoHRvUEZBqWvVikklHY+XqSlKblPd7+pgeJPCOieJHjfV7JZpY12pIGZGA9MgjI+tcbqHwY0OXc1he31o56ZZXUfhgH9a9RorKphaVR3lFHXh8zxeGSjSqNJdOn3PQ+efEXhLXvCELST7dR0jOGmjByg/wBpeo+vI966PwV49ksIY4bqR73T8YBJzLD9M/eX9R+lewuqujI6hlYYKkZBHpXkvjH4VOZ5L7wpIsTuSz2Uh2pn/YPb6Hj3HSvOq4Oph5e0w33Hv4bNsPmEPq+YpJ/zdP8AgPz27ncweNfD80YddRRf9l0ZSPwIrHm1TT1S41cz5slvUbzVRjwCvYDPX2rx2CKaw1hLLxMNRsU5DpGQkjD1QtlTz/8Arr0vT7fRJ/C81tulbRDdxq7XUm1thK7izAjHOeQRXlY/FTxCpKokmpx+8WLyrD4K0qblJS66NW8n37HVHx3oAH/HzPj/AK9Zf/iasW/jLQJ8bdTiTP8Az2Vov/QgKxB4P8B+VkQ2Ww/xfbn/AJ76z5fCngAzKkF+kUjEKFh1JmOT7FjXvOpiVu4/ieesPl89Iqr9yZ02nnPxI10j/oE6f/6Ova6Ws2zvbUaxc6RDG6z2lpBMzEDaY5GlVADnJIML5z6jrk40q7zw35BRRRQAUUUUAFc14s/5D3gv/sLSf+kF3XS1Q1LUbeyvNKt543aS/uWt4SoBCuIZJSTk8DbGw4zyR2yQAX6KKKACiiigAooooA5X4l/8i5Z/9hrSf/Tjb11Vcr8S/wDkXLP/ALDWk/8Apxt66qgDlfiX/wAi5Z/9hrSf/Tjb11Vcr8S/+Rcs/wDsNaT/AOnG3rqqACiiigAooooAK5LXoJje3bxxSNyrjapOcKvT8q62ivOzLL1j6SpuVrNP7jajV9lLmsFFFFeiYhRRRQAUUUUAFFFFABRRRQBg+JYZJJrNo0Ztu8HaM4zj/Crvh5XTSLdJFZGTcuGGDwxArRorz6eAVPGTxilrJJW9DaVVumqdtgooor0DEKKKKACiiigAooooAKzPEcbS6RIsaszb4zhRk8SKf6Vp0VlXpKtSlSf2k195UJcklLsY3h4SLJfCSN0DSK43KRnKgH+VbNFFZ4PDfVaEaN78q3HUnzy5gooorpICiiigAooooAyvEsbSaSwjVmYSxHCjJ/1i5/So/DKNHDdh0Zd024ZGM/Io/pWzRXnTy9Sx0cbzaqLjb53NlVtTdOxm32haRqH/AB/aXY3PvLbox/UVlt4D8LMwY6HZA9eEwPyFdNRXc6UJbpDhia1NWhNr0bGxosaKkaqiKAFVRgADsKdRRVmAUUUUAFFFFAFe9srW+gMN7bQ3MJ6pKgdT+BrhNW0awhtNV0i3i+z2MkyDZEcbVZV3bfTqa9DowPQZrzsxwH12EYp2aad7X26dDpoYmVH07X69zz5vhZpZbP8Aaus49PNi/wDjdWLT4ZaLBPHLJcalcbGDbJbgbSR6hQK7miuhYSivso3ebYxqzqMx7XTZ4vGGp6mxT7NcWFpbIAfm3RyXDNkemJkx+NbFYdpfXMnjfVrB5M2kGnWc8ce0fK8kt0rnPU5EacdOOOpzuV0nnhRRRQAUUUUAFY+u6bPfap4duISnl2F+9zLuOCVNrPFx6ndKv4ZrYrD8Q31xaav4Ygt5NkV5qLwTjaDvQWlxIBz0+aNDkYPHoTQBuUUUUAFFFFABRRRQByvxL/5Fyz/7DWk/+nG3rqq5X4l/8i5Z/wDYa0n/ANONvXVUAcr8S/8AkXLP/sNaT/6cbeuqrlfiX/yLln/2GtJ/9ONvXVUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFCG3sV168uInQ6lJbQRzqJMsIlaUxkr2BZpcHvg+lX656xhlX4ha1M0biF9LsEWQqdrMJbwkA9yAy5HuPWuhoAKKKKACiiigAqhqVvYzXmlSXrotxBctJZhpNpaXyZFIA/iPltIcc8AntV+ud8UQyy634QeON3WLVJHkZVJCL9iulyfQZYDPqRQB0VFFFABRRRQAUUUUAcr8S/+Rcs/+w1pP/pxt66quV+Jf/IuWf8A2GtJ/wDTjb11VAGL4x0afXtD+x2d3FZ3KXVtdxTSwmZFeCeOYBkDKSCYwDhh1rP+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkyuqooA4rUfDvirV1tLfVfEGiNZRXtreSJbaNLFI/kTpMFDNdMFyYwM7TwTxXa0UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) The external branch of the superior laryngeal nerve innervates the inferior constrictor and cricothyroid muscles. The external branch travels with the superior thyroid artery until approximately 1 cm before the artery enters the superior thyroid pole and then divides into branches that enter the lateral inferior pharyngeal constrictor muscle and the cricothyroid muscle. A few smaller branches may be seen entering the superior thyroid.",
"    <br>",
"     <br>",
"      (B) The recurrent laryngeal nerve (RLN) is associated with the inferior thyroid artery at approximately the junction of the lower and middle thirds of the thyroid gland. On the left, the RLN ascends in the tracheoesophageal groove and crosses deep to the inferior thyroid artery; on the right, the RLN crosses more obliquely and is oriented more laterally than caudally.",
"      <br>",
"       <br>",
"        While the nerve most often crosses deep to the inferior thyroid artery, documented variations include passing anterior to the artery as well as passing between branches of the inferior thyroid artery. Another variation of the nerve is the nonrecurrent laryngeal nerve, in which the laryngeal nerve branches directly from the vagus nerve. This variation occurs more commonly&nbsp;on the right side.",
"        <div class=\"footnotes\">",
"        </div>",
"        <div class=\"reference\">",
"         (A) Adapted from: Morton RP, Whitfield Al-Ali S. Anatomical and surgical considerations of the external branch of the superior laryngeal nerve: a systematic review. Clin Otolaryngol 2006; 31:368-374.",
"         <br>",
"          (B) Adapted from: Makay O, Icoz G, Yilmaz M, Akyildiz M, Yetkin E. The recurrent laryngeal nerve and the inferior thyroid artery-anatomical variations during surgery. Langenbecks Arch Surg 2008; 393:681.",
"         </br>",
"        </div>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23177=[""].join("\n");
var outline_f22_40_23177=null;
var title_f22_40_23178="Approach to neuroimaging in children";
var content_f22_40_23178=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to neuroimaging in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/40/23178/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23178/contributors\">",
"     Jill V Hunter, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/40/23178/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23178/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23178/contributors\">",
"     Eric D Schwartz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/40/23178/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/40/23178/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/40/23178/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging modalities can be classified as structural or functional [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Structural imaging modalities provide spatial resolution based primarily upon anatomic or morphologic data. Functional imaging modalities provide spatial resolution based upon physiologic or metabolic data. Some techniques provide both structural and functional information.",
"   </p>",
"   <p>",
"    The major imaging modalities for structural and functional evaluation of the developing central nervous system (CNS) are ultrasonography (US), computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Ultrasonography and CT provide rapid screening for gross macrostructural abnormalities. Nuclear medicine techniques may offer additional functional data. MRI in current clinical use and advanced MR techniques often provide the most definitive macrostructural, microstructural, and functional imaging information.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ULTRASONOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The resolving power of ultrasonography (US) is based upon variations in acoustic reflectance of tissues. This technique has many advantages. It is readily accessible, portable, and fast; images are viewed in real time and are multiplanar [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. It is less expensive than other cross sectional modalities and is considered relatively noninvasive because it does not involve ionizing radiation. Furthermore, US requires no contrast agent, and patient sedation rarely is needed.",
"   </p>",
"   <p>",
"    However, US also has certain limitations. The diagnostic effectiveness of US depends primarily upon the skill and experience of the operator and interpreter. In addition, US requires a window or path for cranial and spinal imaging that is unimpeded by bone or air. Thus, US can be used for neuroimaging in the fetus during a prenatal examination and in the infant who has an open fontanelle and sutures. US also can be used to examine the immature or dysplastic cranium or spine (eg, dysraphism), the orbit, and the neck [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1,4,5\">",
"     1,4,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Safety issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical US is generally considered safe. However, concerns have been raised regarding the use of ultrasonography for nonmedical imaging of the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. These concerns include the deposition of radio-frequency from the current generation of machines with 3D and 4D capabilities. As with radiation, the principle of \"as low as reasonably achievable\" (ALARA) should be followed during ultrasonography to maintain the lowest possible exposure to mechanical and thermal indices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Ultrasound applications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important applications of US in the neuroimaging of children are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fetal and neonatal screening (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53684 \" href=\"UTD.htm?4/45/4818\">",
"       image 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/2-4\">",
"       2-4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Bedside examination of a critically ill infant who is too unstable to be examined in the radiology department (eg, infant requiring extracorporeal membrane oxygenation)",
"     </li>",
"     <li>",
"      Rapid provision of important adjunctive information using Doppler (eg, determination whether a mass is cystic, solid, or vascular), differentiation of subarachnoid collections (eg, benign external hydrocephalus) from subdural collections (eg, chronic subdural hematoma) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/8\">",
"       8",
"      </a>",
"      ], assessment of vascularity, vascular flow, increased intracranial pressure, or edema (eg, measuring resistive index) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/4,9\">",
"       4,9",
"      </a>",
"      ] (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef81194 \" href=\"UTD.htm?6/16/6404\">",
"       image 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Real-time guidance and monitoring during diagnostic or therapeutic interventional neuroradiologic procedures (eg, transcatheter endovascular ablation of vein of Galen vascular malformation) and surgical procedures (eg, craniotomy and laminectomy) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/10\">",
"       10",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Ultrasound techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in US technology include the development of high-resolution transducers, improvements in color Doppler signal processing, and new scanning techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. These techniques have significantly improved the ability to visualize structural and vascular abnormalities in the neonatal brain. Other improvements include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The use of the mastoid view to better visualize posterior fossa lesions",
"     </li>",
"     <li>",
"      The graded fontanelle compression Doppler technique to evaluate ventriculomegaly versus hydrocephalus",
"     </li>",
"     <li>",
"      Power color Doppler, which displays the integrated power of the Doppler signal, has increased sensitivity to low flow that makes it useful in the evaluation of intracranial venous flow [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Transcranial Doppler (TCD), which uses advanced transducer technology to evaluate flow velocity in major intracranial arteries [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]; specific windows are used in older children, such as the transtemporal window, to screen for risk of stroke in sickle cell disease or beta thalassemia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/11/31930?source=see_link&amp;anchor=H3#H3\">",
"       \"Cerebrovascular complications of sickle cell disease\", section on 'Cerebral infarction'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another important advance is the use of vascular US contrast agents that amplify reflected sound waves. A variety of microbubble-based preparations are being tested [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/11\">",
"     11",
"    </a>",
"    ]. Potential applications include the detection of slow blood flow and the assessment of organ perfusion. In addition, if TCD is performed at the same time as bubble echocardiography, the visualization of bubbles in the intracranial circulation indicates significant right-to-left shunting with potential for cerebral thromboembolus [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Improvements in computerized analysis of textural features of the CNS will provide increased sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PLAIN RADIOGRAPHS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain film radiography has little utility in imaging the pediatric central nervous system. However, skull radiographs are useful in the diagnosis of nonaccidental injury in infants, usually as part of a skeletal survey. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=see_link\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other indications for plain radiographs may include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clearance of the cervical spine in trauma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=see_link\">",
"       \"Evaluation of cervical spine injuries in children and adolescents\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Special views of the lumbosacral spine to make the diagnosis of spondylolysis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=see_link\">",
"       \"Evaluation of the child with back pain\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19162?source=see_link&amp;anchor=H7#H7\">",
"       \"Back pain in children and adolescents: Overview of causes\", section on 'Spondylolysis and spondylolisthesis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Whole spine imaging for angle measurement and follow-up of scoliosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33770?source=see_link&amp;anchor=H15#H15\">",
"       \"Clinical features; evaluation; and diagnosis of adolescent idiopathic scoliosis\", section on 'Radiographic evaluation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37065?source=see_link&amp;anchor=H2#H2\">",
"       \"Treatment and prognosis of adolescent idiopathic scoliosis\", section on 'Overview'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     COMPUTED TOMOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT utilizes an x-ray tube, which rotates axially around the patient, and a diametrically opposed array of detectors, which detect the residual radiation traversing the body. The data are digitized and converted to cross-sectional images with the help of powerful array processors. These devices record, digitize, store, and tomographically reconstruct hundreds of projection images acquired at many angles about the patient, using special mathematical algorithms. High-resolution bone and soft tissue algorithms are needed to demonstrate fine anatomy (eg, the base of the skull). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17032?source=see_link\">",
"     \"Principles of computed tomography of the chest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although CT uses ionizing radiation, current-generation scanners effectively collimate and restrict the exposure to the immediate volume of interest [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Direct imaging usually is restricted to the axial or coronal plane. Reformatting from thin axial sections to other planes (eg, coronal or sagittal) also limits the radiation exposure.",
"   </p>",
"   <p>",
"    Projection scout images may provide information similar to plain radiographs but with less spatial resolution. CT scanning of the pediatric central nervous system is performed using either the conventional noncontinuous or the continuous",
"    <span class=\"nowrap\">",
"     helical/spiral",
"    </span>",
"    technique; the latter includes the more advanced",
"    <span class=\"nowrap\">",
"     multidetector/multislice",
"    </span>",
"    technology. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17032?source=see_link\">",
"     \"Principles of computed tomography of the chest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Safety considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;When clinically indicated, CT is considered a relatively safe procedure in children with proper application of radiation protection, appropriate use of nonionic contrast agents, proper administration of sedation or anesthesia when needed, and monitoring of vital signs.",
"   </p>",
"   <p>",
"    Relative contraindications to CT in children are unusual but include certain syndromes in which radiation could induce chromosome breaks and increase the genetic predisposition to tumors (eg, ataxia telangiectasia, Nijmegen breakage syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1-3,15-18\">",
"     1-3,15-18",
"    </a>",
"    ]. However, such studies should not be withheld if they are required to provide optimal management. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/60/23497?source=see_link\">",
"     \"Ataxia-telangiectasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/27/439?source=see_link\">",
"     \"Nijmegen breakage syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation dose is particularly important in children because radiation exposure from CT scanning appears to be associated with a small increased lifetime cancer risk [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. In addition, there is a suggestion in the literature that early radiation to the brain may impair long-term cognitive function [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Although pediatric CT accounts for approximately 15 percent of radiographic examinations, it contributes to an estimated 70 percent of the total radiation dose to the population [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most studies of CT have been performed in adults; the same doses of radiation that have been studied in adults are typically used in children. Many CT units have software that automatically chooses tube current based upon optimal image quality calculated for adults.",
"   </p>",
"   <p>",
"    Every effort must be made to minimize the radiation dose to children from CT examinations. The policy of \"as low as reasonably achievable\" (ALARA), or \"least radiation dose necessary\" to produce a diagnostic scan should always be followed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/25\">",
"     25",
"    </a>",
"    ]. This concept employs the following methods:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Use weight-based protocols and improved shielding",
"     </li>",
"     <li>",
"      Consider alternative nonradiating imaging modalities, such as MRI",
"     </li>",
"     <li>",
"      When clinically appropriate, use focused",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      limited-view studies",
"     </li>",
"     <li>",
"      Dissuade repeat CT studies (eg, scanning with and without contrast is rarely needed in children)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Two technical factors can be adjusted to reduce radiation exposure in children during CT scanning: tube current and pitch [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tube current refers to the number of electrons used to generate the x-ray source. Decreasing tube current decreases radiation exposure, but results in increased noise. However, the small size of young patients compensates for this disadvantage [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pitch refers to the ratio between the rate at which the table moves through the scanner and the rate at which the scanner spins. Increasing pitch reduces radiation exposure. The pitch can be increased by about one-half to decrease the radiation dose by about one-third without sacrificing image quality [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a two-year study that evaluated the use of lower doses of radiation for pediatric CT scans by adjusting tube current and pitch, diagnostic capabilities were not compromised [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, there was no increase in the number of repeat studies related to poor technical quality.",
"   </p>",
"   <p>",
"    The Image Gently campaign (",
"    <a class=\"external\" href=\"file://www.imagegently.org/\">",
"     www.imagegently.org",
"    </a>",
"    ) offers information for practitioners, radiology technicians, and parents regarding opportunities to use lower radiation doses in the imaging of children [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Sedation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sedation is rarely required for CT examinations in children because most CT examinations take only seconds or minutes to perform, particularly when ultrafast",
"    <span class=\"nowrap\">",
"     helical/spiral",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     multidetector/multislice",
"    </span>",
"    technology is used. High-resolution studies that require immobilization to avoid motion artifact (eg, temporal bone examination) are the exception. A newborn or young infant often can be examined during sleep (eg, after a feeding or at the usual nap-time).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     CT applications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of CT in pediatric neuroimaging has been redefined in the context of accessible and reliable ultrasonography and MRI. Ultrasonography is the procedure of choice for primary imaging or screening of the CNS in the newborn and young infant [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/11\">",
"     11",
"    </a>",
"    ], but has its limitations. When ultrasonography does not satisfy the clinical inquiry, or an acoustic window is not available, CT is used [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In other situations, MRI is the preferred imaging technique. However, MRI may not be readily available or feasible. CT is used in these situations, although it is less desirable. Because CT can be performed quickly and safely, imaging should never be delayed for a child with a suspected space-occupying intracranial lesion in order to obtain an MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'MRI applications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    CT often is the primary modality in acute or emergent situations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute trauma [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Acute neurologic deficit",
"     </li>",
"     <li>",
"      Encephalopathy",
"     </li>",
"     <li>",
"      Increased intracranial pressure",
"     </li>",
"     <li>",
"      Headache",
"     </li>",
"     <li>",
"      Unexplained or complicated acute episodic disorder (eg, seizure, apnea)",
"     </li>",
"     <li>",
"      Visual symptoms or signs [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Suspected CNS infection [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Shunted hydrocephalus with suspected shunt malfunction",
"     </li>",
"     <li>",
"      Suspected postoperative intracranial complication",
"     </li>",
"     <li>",
"      Head and neck masses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In these circumstances, the primary role of CT is to screen for acute or subacute hemorrhage (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51782 \" href=\"UTD.htm?27/8/27777\">",
"     image 3",
"    </a>",
"    ), edema, herniation, fractures, hypoxic-ischemic injury, focal infarction, hydrocephalus, tumor mass, or abnormal collection (eg, pneumocephalus, abscess, empyema).",
"   </p>",
"   <p>",
"    Other indications for using CT include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation of bony or air space abnormalities of the skull base, cranial vault, orbit, paranasal sinuses, facial bones, and temporal bone [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/33,34,37\">",
"       33,34,37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Bony evaluation of a localized spinal column abnormality (eg, trauma)",
"     </li>",
"     <li>",
"      Detection and confirmation of calcification in the brain (CT is the preferred modality for this indication)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Contrast enhanced CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In centers where MRI is readily available, the majority of head CTs are performed without contrast. Although intravenous contrast enhancement or cerebrospinal fluid (CSF) opacification may improve resolution [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1-3\">",
"     1-3",
"    </a>",
"    ], MRI is preferred to vascular- or CSF-enhanced CT in virtually all circumstances. The exceptions include CT angiography, evaluation of palpable masses in the head and neck, and follow-up of brain abscesses.",
"   </p>",
"   <p>",
"    As a general rule, when a contrast-enhanced CT examination of the brain is indicated, a non-enhanced CT examination should be performed first to avoid overlooking fresh blood and calcification. A possible exception to this rule is the long-term follow-up of a known enhancing intracranial collection.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intravenous contrast &mdash; Intravenous contrast enhancement is used to improve visualization for blood pool effect (eg, CT angiography or vascular malformations), or if the blood-brain barrier is disrupted (eg, infection, tumor). It is recommended for the evaluation of suspected or known vascular malformation, infarction, neoplasm, abscess, or empyema, and in patients with head and neck masses. Typically, an unenhanced brain scan should be performed before a contrast-enhanced scan in patients without a history of atopy or allergy to iodine. In patients with brain abscess, post-contrast only examinations can be used for follow-up.",
"      <br/>",
"      <br/>",
"      Vascular-enhanced CT may help in the evaluation of a mass or hemorrhage of unknown etiology and identify the membrane of a chronic subdural collection (eg, child abuse). By identifying the cortical veins, enhanced CT may distinguish prominent low-density subarachnoid collections (eg, benign extracerebral collections or benign external hydrocephalus of infancy) from low-density subdural collections (eg, chronic subdural hematomas or hygromas). It also may help differentiate infarction from neoplasm or abscess, serve as an indicator of disease activity (eg, in degenerative or inflammatory disease and vasculitis), or provide a guide to increase the yield of tissue in stereotactic or open biopsy.",
"     </li>",
"     <li>",
"      CSF contrast enhancement &mdash; CSF-contrast opacification of the ventricular or subarachnoid spaces (the latter by lumbar puncture) may further assist in evaluating or confirming CSF communication with lesions such as an arachnoid cyst or a porencephalic cyst.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Advanced display",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in computer display technology include image fusion (eg,",
"    <span class=\"nowrap\">",
"     MRI/SPECT,",
"    </span>",
"    <span class=\"nowrap\">",
"     CT/PET),",
"    </span>",
"    2D reformatting, 3D volumetric and reconstruction methods, segmentation, and surface rendering techniques. These high resolution display techniques are used for the following indications [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      CT angiography and venography",
"     </li>",
"     <li>",
"      To plan stereotactic radiotherapy and radiosurgery",
"     </li>",
"     <li>",
"      To plan craniofacial reconstructive surgery",
"     </li>",
"     <li>",
"      To plan surgical stabilization of craniocervical anomalies and scoliosis",
"     </li>",
"     <li>",
"      Real-time or stereotactic image guidance for interventional neuroradiologic and neurosurgical procedures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The introduction of higher multislice (up to 320) CT offers the possibility of 3D volume acquisition with a single rotation of the gantry. The detectors can cover up to 16 cm in a single scan performed in less than one second. For bony algorithms and contrast-enhanced studies of the brain, this offers the potential for substantial savings in radiation dosage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     MAGNETIC RESONANCE IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI is considered a relatively noninvasive imaging technology because it does not involve ionizing radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The MRI signal is derived from multiple parameters, including T1, T2, proton density, T2*, proton flow, proton relaxation enhancement, chemical shift, and molecular diffusion. This contrasts with ultrasonography and CT, in which the signal is essentially uniparametric (ie, acoustic reflectance and x-ray attenuation, respectively). MRI also uses many more basic imaging techniques than these other modalities (eg, spin echo, inversion recovery, gradient echo, echo planar, and chemical shift imaging methods). MRI provides multiplanar imaging with equivalent resolution in all planes without repositioning the patient. Bone does not interfere with soft tissue resolution, although metallic objects often produce signal void or field distortion artifacts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=see_link\">",
"     \"Principles of magnetic resonance imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MRI often provides more sensitive and specific imaging information about pediatric CNS abnormalities than ultrasonography or CT. MRI also has redefined the role of invasive procedures such as myelography, ventriculography, cisternography, and angiography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Limitations and safety considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contraindications to MRI are many and include implanted or attached electronic and ferromagnetic devices (eg, pacemakers, ferrous aneurysm clips). All individuals (eg, patients, personnel, parents) must undergo MRI safety screening and instructions before entering the MRI examination room. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=see_link\">",
"     \"Principles of magnetic resonance imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MRI is not as fast as ultrasonography or CT, and image quality is compromised easily by motion. Thus, sedation or anesthesia is required in most infants and younger children and occasionally in older patients, especially those with cognitive impairments [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    All personnel and all monitoring and support equipment must be safe for the magnet. Most resuscitation equipment is not magnet-safe and thus cannot be brought into the MRI scanning room. An unstable patient can undergo MRI if the clinical indication is urgent and no acceptable imaging alternative is available. However, magnet-safe monitoring equipment must be used, and, if resuscitation is required, the patient must be moved out of the MRI examination room to an appropriate site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     MRI applications",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI is the imaging modality of choice in numerous clinical situations, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Developmental delay (eg, static versus neurodegenerative encephalopathy) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Unexplained hydrocephalus [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/39\">",
"       39",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Neuroendocrine disorder and associated hypothalamic-pituitary abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      New onset seizures, especially focal seizures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75509 \" href=\"UTD.htm?31/8/31874\">",
"       image 4",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Intractable or refractory seizure activity and the evaluation for epilepsy surgery",
"     </li>",
"     <li>",
"      Pretreatment evaluation of neoplastic processes and follow-up of tumor response and treatment effects [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/42\">",
"       42",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Suspected infectious, postinfectious, and other inflammatory or noninflammatory encephalitides (eg, encephalitis, post-infectious demyelination, vasculitis) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/35,36,43\">",
"       35,36,43",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Migrational and other submacroscopic dysgeneses (eg, cortical dysplasia) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Neurocutaneous syndromes (eg, neurofibromatosis 1, tuberous sclerosis) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Orbital pathology",
"     </li>",
"     <li>",
"      Sensorineural hearing loss",
"     </li>",
"     <li>",
"      Vascular malformations and hemorrhage (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58964 \" href=\"UTD.htm?22/20/22849\">",
"       image 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75369 \" href=\"UTD.htm?39/10/40099\">",
"       image 6",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Ischemic and hemorrhagic stroke (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76709 \" href=\"UTD.htm?20/61/21471\">",
"       image 7",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Evaluation of the spinal column and spinal neuraxis (eg, atypical idiopathic scoliosis, spinal",
"      <span class=\"nowrap\">",
"       dysraphism/tethered",
"      </span>",
"      cord (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef63551 \" href=\"UTD.htm?16/17/16658\">",
"       image 8",
"      </a>",
"      ), traumatic cord injury, infectious spondylitis, neoplastic processes) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/46-48\">",
"       46-48",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Vascular disease and hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI often offers greater diagnostic specificity than CT or ultrasonography for delineating vascular and hemorrhagic processes (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58964 \" href=\"UTD.htm?22/20/22849\">",
"     image 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75369 \" href=\"UTD.htm?39/10/40099\">",
"     image 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    MR angiography (MRA) can provide a clear depiction of vascular structures and abnormalities without requiring the injection of contrast agents (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75369 \" href=\"UTD.htm?39/10/40099\">",
"     image 6",
"    </a>",
"    ). MRI with MRA can be used to differentiate arterial from venous occlusive disease. The combination of an abnormal signal in a venous sinus on brain MRI and the corresponding absence of flow on MR venography confirms the diagnosis of cerebral venous thrombosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7594?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology, clinical features, and diagnosis of cerebral venous thrombosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Using magnetic susceptibility sequences (eg, susceptibility-weighted imaging sequences), MRI can detect altered blood and blood products [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/49\">",
"     49",
"    </a>",
"    ]. MRI also provides more specific identification and staging of hemorrhage and clot formation (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58964 \" href=\"UTD.htm?22/20/22849\">",
"     image 5",
"    </a>",
"    ), but cannot be used to accurately date hemorrhagic extra-axial collections. Thus, MRI often is used for more definitive evaluation of hemorrhage and may clarify the need for conventional angiography.",
"   </p>",
"   <p>",
"    MRI may distinguish hemorrhagic infarction from hematoma in cases of an atypical or unexplained intracranial hemorrhage and can differentiate the types of vascular malformations, such as cavernous malformation versus arteriovenous malformation (AVM) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58964 \" href=\"UTD.htm?22/20/22849\">",
"     image 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75369 \" href=\"UTD.htm?39/10/40099\">",
"     image 6",
"    </a>",
"    ). In some cases of vascular malformation, MRA may obviate the need for conventional angiography in the follow-up of surgery, interventional treatment, or radiosurgery.",
"   </p>",
"   <p>",
"    MRI provides additional information about intracranial vascular anomalies such as vascular malformations or aneurysms that have been evaluated initially by CT or US. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identifying otherwise unsuspected prior hemorrhage by detection of hemosiderin",
"     </li>",
"     <li>",
"      Distinguishing an occult vascular malformation (eg, cavernous malformation) from a neoplasm (eg, glioma) when CT demonstrates a nonspecific focal high density that could be calcification or hemorrhage",
"     </li>",
"     <li>",
"      Differentiating benign infantile collections (eg, external hydrocephalus) from subdural hematomas (eg, in child abuse)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    MRI often provides definitive evaluation of muscular and cutaneous vascular anomalies. They include hemangiomas and vascular malformations that arise in parameningeal locations, such as the head and neck or paraspinal regions, and extend to involve the central nervous system (CNS) directly or are associated with other CNS vascular or nonvascular abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/37,50\">",
"     37,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4921931\">",
"    <span class=\"h3\">",
"     Pediatric stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric stroke has historically been underdiagnosed. However, there is increasing awareness of stroke in children. The etiologies of neonatal and childhood stroke are different from those of adult stroke, since atherosclerosis is usually not a factor in childhood stroke. Common risk factors for ischemic stroke in children include congenital and acquired cardiac lesions, vascular lesions, hematologic abnormalities, infection, and genetic conditions. Sickle cell disease is the most common cause of stroke in children. Abnormalities of the cerebral vasculature that predispose to arterial ischemic stroke include arterial dissection, focal (or transient) cerebral arteriopathy of childhood, fibromuscular dysplasia, moyamoya syndrome, and vasculitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27690?source=see_link\">",
"     \"Stroke in the newborn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23513?source=see_link\">",
"     \"Ischemic stroke in children and young adults: Etiology and clinical features\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In children without hemorrhage who have no contraindication, MRI with diffusion-weighted imaging (DWI) can confirm or refute the presence of acute ischemia. The time on the table for DWI is one minute. In practice, MRI with DWI can routinely be obtained without sedation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4921816\">",
"    <span class=\"h3\">",
"     Fetal MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;With an increase in high-risk pregnancies since the introduction of in-vitro fertilization, MRI has become a useful adjunct to ultrasound in the diagnosis of in-utero fetal abnormalities of the central nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/51\">",
"     51",
"    </a>",
"    ]. MRI has proven particularly useful in the examination of midline brain structures such as the corpus callosum, posterior fossa structures, and the dependent lateral ventricle. Advanced MRI techniques such as diffusion-weighted imaging, diffusion tensor imaging, and MR spectroscopy have been applied in-utero and may give valuable additional information about intrauterine insults such as stroke, while allowing for tracking of the normal development and pre-myelination of the cerebral white matter and cortical gray matter [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. There may be a place for MRI in &ldquo;noninvasive&rdquo; postmortem analysis following fetal demise to better understand the cause of death [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     MRI techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in MRI capabilities have further improved its sensitivity, specificity, and efficiency. Fast and ultrafast MRI techniques (fast spin echo, fast gradient echo, echo planar imaging) also have been developed to reduce imaging times, improve structural resolution, and provide functional resolution.",
"   </p>",
"   <p>",
"    These MRI techniques include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fluid attenuation inversion recovery (FLAIR)",
"     </li>",
"     <li>",
"      Short tau inversion recovery (STIR)",
"     </li>",
"     <li>",
"      Diffusion-weighted imaging (DWI), including diffusion tensor imaging (DTI)",
"     </li>",
"     <li>",
"      Perfusion-weighted imaging (PWI)",
"     </li>",
"     <li>",
"      Functional MRI (fMRI)",
"     </li>",
"     <li>",
"      Magnetic resonance spectroscopy (MRS)",
"     </li>",
"     <li>",
"      Magnetization transfer imaging (MTI)",
"     </li>",
"     <li>",
"      Higher field strength 3Tesla (3T) magnets",
"     </li>",
"     <li>",
"      MRI volumetrics",
"     </li>",
"     <li>",
"      Cerebrospinal fluid flow imaging and",
"      <span class=\"nowrap\">",
"       brain/spinal",
"      </span>",
"      cord motion imaging",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These are reviewed in greater detail in the following paragraphs.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      FLAIR, the fluid attenuation inversion recovery technique, attenuates the signal from flowing water (ie, cerebrospinal fluid) and increases the resolution of nonfluid water-containing lesions lying in close approximation to the cerebrospinal fluid-filled subarachnoid and ventricular spaces.",
"     </li>",
"     <li>",
"      STIR, short tau (or short T1) inversion recovery imaging, suppresses the fat signal and provides improved delineation of water-containing lesions in regions where fat dominates (eg, orbit, head and neck, spine).",
"     </li>",
"     <li>",
"      Diffusion-weighted imaging (DWI) uses echo planar or line-scan spin echo MRI techniques to provide information based upon differences in the rate of diffusion of water molecules [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/55-59\">",
"       55-59",
"      </a>",
"      ]. DWI detects the intracellular changes that may result from tissue injury by measuring the rate of diffusion, or apparent diffusion coefficient (ADC). The ADC is higher for free or pure water than for macromolecular-bound water and varies according to the microstructural or physiologic state of a tissue. Clinical applications of DWI include the evaluation of ischemia (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76709 \" href=\"UTD.htm?20/61/21471\">",
"       image 7",
"      </a>",
"      ), metabolic disorders, assessment of brain maturation, and characterizations of tumors. The diffusion of water decreases within minutes after an ischemic insult and falls progressively during the first hour. Bright signal is demonstrated with DWI at a time when conventional imaging is negative. The early signal is thought to reflect cytotoxic edema. In acute ischemia, ADC values remain decreased or restricted for a period of up to 10 days. In addition, certain tumors, including posterior fossa medulloblastoma, produce a restricted pattern of diffusion abnormality, probably as a result of the high nuclear to cytoplasmic ratio [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diffusion tensor imaging (DTI) is a refinement of the DWI technique. DTI provides microstructural mapping of normal and injured white matter tracts based upon fractional anisotropic changes (ie, differences related to orientation and development of white matter fibers). Fractional anisotropy (FA) is a measure of the restriction of motion of water in the brain normally constrained by axonal myelination. There is a known pattern of increasing FA in conjunction with decreasing ADC during premyelination and myelination of the normal infant brain. In addition to the quantitative parameters that can be calculated with DTI, tractography can be performed. Tractography connects the fibers with similar FA values to develop a 3D image of the fiber tracts. Certain metabolic disorders are associated with abnormal shifts of water and decreased diffusion; these changes can be detected with DTI, which may provide a means of tracking disease progression [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/61-64\">",
"       61-64",
"      </a>",
"      ]. DTI has a variety of applications in mapping the course, extent, and connectivity patterns of white matter structures [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/65\">",
"       65",
"      </a>",
"      ]. These may include surgical planning for patients with arteriovenous malformation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/66,67\">",
"       66,67",
"      </a>",
"      ] and defining anatomy in patients with central nervous system anomalies or injury [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/68-70\">",
"       68-70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Perfusion-weighted MRI (PWI) is based on the principle of dye dilution and can be used to evaluate cerebral perfusion through the application of a dynamic contrast-enhanced T2*-weighted MRI technique [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/71,72\">",
"       71,72",
"      </a>",
"      ]. Arterial spin tag labeling (ASL) techniques also have been developed; ASL utilizes the signal change from water endogenous to arterial blood as it flows from the neck to the brain [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/73\">",
"       73",
"      </a>",
"      ]. PWI offers a qualitative and quantitative assessment of normal and abnormal cerebrovascular dynamics, including relative cerebral blood volume, relative cerebral blood flow, mean transit time, and time to peak arrival of contrast. These measurements are complementary to conventional MRI. Applications of PWI include evaluation of ischemic cerebrovascular disease (eg, hypoxia-ischemia, moyamoya, sickle cell disease), differentiation of tumor progression from treatment effects, and brain activation imaging.",
"     </li>",
"     <li>",
"      Functional MRI (fMRI) is an advanced application of PWI that is used to localize brain activity [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/74\">",
"       74",
"      </a>",
"      ]. fMRI displays local or regional changes in cerebral blood flow that accompany the stimulation or activation of somatosensory, special sensory (eg, visual, auditory), motor, or cognitive centers. fMRI can provide important information regarding cognitive and behavioral disorders. It also may guide safer and more effective ablations for tumors, vascular malformations, and seizure foci.",
"     </li>",
"     <li>",
"      Magnetic resonance spectroscopy (MRS) offers a noninvasive in vivo approach to biochemical analysis [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/75-78\">",
"       75-78",
"      </a>",
"      ]. It provides quantitative information about cellular metabolites because signal intensity is directly related to the metabolite concentration. Cellular metabolites of interest include N-acetyl aspartate (NAA), which is a marker of axons and neurons; creatine, which is a measure of high energy phosphate products, such as ATP and ADP; and choline, which is a marker of cell membrane turnover. Efficiently obtaining single and multiple spectroscopic samples is possible using the high inherent sensitivity of hydrogen-1 to detect low concentration metabolites in healthy and diseased tissues. MRS may detect biochemical changes before morphological changes are apparent and, thus, provide insight into the follow-up assessment and prognosis of a variety of CNS processes.",
"      <br/>",
"      <br/>",
"      MRS is used primarily in the assessment of brain development and maturation, perinatal brain injury (",
"      <a class=\"graphic graphic_waveform graphicRef67971 \" href=\"UTD.htm?43/21/44383\">",
"       waveform 1",
"      </a>",
"      ), childhood central nervous system neoplasia and treatment effects, and metabolic and neurodegenerative disorders. As an example of the application of MRS, in the presence of a high grade malignant tumor such as a posterior fossa medulloblastoma or WHO grade 4 glioblastoma multiforme, NAA will be nearly completely absent owing to the destruction of normal underlying brain parenchyma, whereas choline will be markedly elevated owing to the increase in cell membrane turnover.",
"     </li>",
"     <li>",
"      Magnetization transfer imaging (MTI) suppresses background tissues and increases resolution for vascular flow enhancement (eg, MRA) and gadolinium enhancement (eg, to demonstrate tumor seeding).",
"     </li>",
"     <li>",
"      Higher field strength 3Tesla magnets (3T) are an important advance [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/79\">",
"       79",
"      </a>",
"      ]. With its higher signal-to-noise and improved spatial resolution, better anatomic imaging and more accurate MR spectroscopy, functional MRI, and diffusion tensor imaging can be anticipated. Special applications may include improved detection of structural abnormalities in previously diagnosed cryptogenic epilepsy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/80\">",
"       80",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Volumetric MRI uses differences in inherent tissue contrast to parse out gray matter from white matter from cerebrospinal fluid. Cortical and subcortical gray matter, white matter, and cerebrospinal fluid volumes can be calculated for different parts of the brain and a total intracranial volume measured by summation of all the parts. MRI volumetrics has furthered the understanding of normal brain development and pathologic mechanisms (eg, traumatic brain injury) with a view to developing therapeutic interventions [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/81\">",
"       81",
"      </a>",
"      ]. Correlation of volumetric findings with neuropsychologic testing (eg, for attention deficit hyperactivity disorder, autism spectrum disorders) is an active area of research, in hopes of providing better tools for diagnosis and prognosis.",
"     </li>",
"     <li>",
"      Cerebrospinal fluid flow imaging and",
"      <span class=\"nowrap\">",
"       brain/spinal",
"      </span>",
"      cord motion imaging. MRI techniques that are sensitive to motion can be used to evaluate vascular flow (eg, MRA) and perfusion. In addition, they can be used to demonstrate the effect of pulsatile cardiovascular flow on other fluid tissues (eg, cerebrospinal fluid) and on nonfluid tissues such as the brain and spinal cord. Using cardiac or pulse gating, these MRI techniques may be used to evaluate abnormalities of cerebrospinal fluid dynamics (eg, hydrocephalus, hydrosyringomyelia), as well as abnormalities of brain motion (eg, Chiari malformation), and spinal cord motion (eg, tethered cord) before and after surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1-3\">",
"       1-3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     ANGIOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited indications for cerebral, spinal, and head and neck angiography in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Contrast angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiography is usually performed on a digital subtraction unit (digital subtraction angiography, DSA). Possible indications for angiography include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation of pediatric stroke.",
"     </li>",
"     <li>",
"      Diagnosis of vasculitis.",
"     </li>",
"     <li>",
"      Confirmation of large vessel stenosis that may require antithrombotic therapy for the prevention of recurrent stroke or transient ischemic attacks.",
"     </li>",
"     <li>",
"      Evaluation of the vascular anatomy prior to neurosurgery or endovascular neurointerventional therapy. Examples include the preoperative evaluation of vascular malformations, and the use of six-vessel angiography (to visualize the bilateral external carotid, internal carotid, and vertebral arteries) prior to synangiosis surgery, such as dural inversion therapy for moyamoya disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7751?source=see_link\">",
"       \"Moyamoya disease: Prognosis and treatment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data regarding the incidence of complications during cerebral angiography in children are limited, but suggest that the complication rate is very low.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an earlier study of 3731 conventional cerebral angiograms in 1581 infants and children, the incidence of periprocedural embolization was 0.4 percent of all vessels and 0.9 percent (95% CI 0.5-1.5 percent) of all patients studied [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/82\">",
"       82",
"      </a>",
"      ]. The clinical consequences of embolization in this series were mild, as only one child had transient neurologic symptoms, and none had permanent deficits.",
"     </li>",
"     <li>",
"      In a modern era study of 241 consecutive cerebral digital subtraction angiograms performed in children ranging in age from one week to 18 years old, there were no intraprocedural complications (rate 0.0 percent, 95% CI 0.0-1.4 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/83\">",
"       83",
"      </a>",
"      ]. A fatal postprocedural posterior fossa varix rupture occurred in one child (0.4 percent, 95% CI 0.012-2.29 percent). No transient or permanent neurologic deficits were observed in any child.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As with other radiologic procedures, angiographic investigation should only be performed when the potential benefits outweigh the potential harms to the patient (ie, the results will influence management decisions). In addition, the lowest dose of radiation that is reasonably achievable should be used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     CT and MR angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT angiography (CTA) and magnetic resonance angiography (MRA) are noninvasive tests that are useful for the same indications as conventional contrast angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. These noninvasive techniques are continuously improving.",
"   </p>",
"   <p>",
"    A major advantage of CTA over conventional contrast angiography is the speed and ease by which it can be obtained, often immediately after diagnostic head CT when the patient is still in the scanner. In addition, CTA is usually more practical than MRA in emergent situations, given the constraints of acute patient management. Thus, CTA may be particularly useful for the assessment of a rapidly declining patient who needs emergent craniotomy for hematoma evacuation. However, emergent surgery should not be inordinately delayed if the rate of clinical deterioration does not permit sufficient time to obtain the CTA.",
"   </p>",
"   <p>",
"    Since CTA is quicker than MRA, it can usually be done without need for sedation in older children. However, MRA avoids exposure to ionizing radiation, and may be a better choice in younger children, who will generally need sedation regardless [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     NUCLEAR MEDICINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single photon emission computed tomography (SPECT) and positron emission tomography (PET) provide functional assessment of the pediatric CNS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/1,86\">",
"     1,86",
"    </a>",
"    ]. Although PET has the unique ability to monitor specific metabolic tracers (eg, oxygen utilization and glucose metabolism), the wider availability, relative simplicity, and rapid technical advancement of SPECT renders it more practical.",
"   </p>",
"   <p>",
"    SPECT and PET technologies have many clinical and investigative applications in children. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assessment of brain development and maturation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Focus localization in refractory childhood epilepsy (ictal and interictal perfusion SPECT, interictal PET) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/87\">",
"       87",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Assessment of tumor progression versus treatment effects in CNS neoplasia (perfusion and thallium SPECT, 18FDG-PET)",
"     </li>",
"     <li>",
"      Evaluation of occlusive cerebrovascular disease for surgical revascularization (perfusion SPECT)",
"     </li>",
"     <li>",
"      Diagnosis of brain death (perfusion SPECT)",
"     </li>",
"     <li>",
"      Use of brain activation techniques (eg, perfusion SPECT, PET) in the elucidation of childhood cognitive disorders",
"     </li>",
"     <li>",
"      Assessment of CSF kinetics (eg, in hydrocephalus or cerebrospinal fluid leaks)",
"     </li>",
"     <li>",
"      Spinal column screening (skeletal SPECT) in the evaluation of occult trauma (eg, stress fracture), infection (eg, discitis or osteomyelitis), and neoplastic processes (eg, osteoid osteoma) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/88\">",
"       88",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     SPECT scans",
"    </span>",
"    &nbsp;&mdash;&nbsp;SPECT uses gamma ray emitting radioisotopes and a gamma camera to record data that a computer uses to construct two- or three-dimensional images of active tissue regions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/89\">",
"     89",
"    </a>",
"    ]. When applied to neuroimaging, SPECT relies on an injection of radioactive tracer, which is rapidly taken up by the brain but does not redistribute.",
"   </p>",
"   <p>",
"    The most common tracers to image the CNS are 99mTc labeled hexamethylpropylene amine oxime (HMPAO) and ethyl cysteinate dimer (ECD). Uptake is nearly 100 percent complete within 30 to 60 seconds, reflecting cerebral blood flow at the time of injection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A significant limitation of SPECT is its poor resolution (approximately 1 cm) compared to that of MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/90\">",
"     90",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Magnetic resonance imaging'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     SPECT applications",
"    </span>",
"    &nbsp;&mdash;&nbsp;SPECT may be useful for the evaluation of central nervous system (CNS) tumors, lymphoma, and epilepsy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CNS tumors &mdash; SPECT has the potential to add valuable information to the diagnosis and management of certain types of CNS tumors. Radioactive tracers such as 99mTc-MIBI (sestamibi) are sensitive markers for brain tumors in children, particularly higher-grade astrocytomas [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/91\">",
"       91",
"      </a>",
"      ]. Tumor types that take up 99mTc-MIBI include brainstem glioma, fibrillary astrocytoma, other low-grade astrocytomas, and glioblastoma multiforme. 99mTc-MIBI scans demonstrate changes in these tumors over time and correlate with histologic grade. In contrast, tumors demonstrated on MRI that are",
"      <strong>",
"       not",
"      </strong>",
"      visualized on 99mTc-MIBI SPECT include craniopharyngioma, medulloblastoma, and optic glioma [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/91\">",
"       91",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CNS lymphoma &mdash; Thallium 201 (201-TI SPECT) is useful for the diagnosis of head and neck lymphoma. In particular, increased 201-TI uptake with co-localization of the lesion on MRI is highly specific for primary CNS lymphoma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/9/7321?source=see_link&amp;anchor=H6#H6\">",
"       \"AIDS-related lymphomas: Primary central nervous system lymphoma\", section on 'SPECT scanning'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neuroblastoma &mdash; 123-I- metaiodobenzylguanidine (MIBG) is a useful tracer in the diagnosis of childhood neural crest tumors such as neuroblastoma, which can arise anywhere throughout the sympathetic nervous system. The uptake of 123-I-MIBG tracer within the tumor and its biodistribution can be used to determine if treatment with 131-I-MIBGm is warranted. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15609?source=see_link&amp;anchor=H17#H17\">",
"       \"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma\", section on 'Radiologic evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Epilepsy &mdash; SPECT can be utilized in the diagnosis of seizures and is particularly important in surgical candidates. Ideally, both ictal and interictal SPECT should be obtained to localize the seizure focus; subtraction examinations can be performed off-line once the images are processed. Because cerebral blood flow changes are extremely rapid during the ictal phase, ictal injections should be performed within the first five to 10 seconds of seizure onset to obtain accurate localization. Timely injections during the ictal phase remain the main limitation of SPECT in children with epilepsy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/92\">",
"       92",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Ictal SPECT scans can be used to localize the epileptic focus in patients with epilepsy. Focal increased perfusion via SPECT occurs in up to 90 percent of patients with temporal lobe epilepsy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/89\">",
"       89",
"      </a>",
"      ]. Ictal patterns vary, but the most common pattern is unilateral temporal hyperperfusion with relatively decreased perfusion in other cortical areas in the ipsilateral and contralateral hemisphere. SPECT localization of epileptic focus has been reported in 70 to 90 percent of patients with frontal lobe epilepsy. Ictal SPECT studies also are useful in studying seizure spread. In temporal lobe epilepsy, ipsilateral basal ganglia hyperperfusion may be seen. In extra-temporal lobe epilepsy, the pattern of spread is more complex. In mesial frontal seizures, for example, the areas of activation often involve ipsilateral or bilateral basal ganglia and the contralateral cerebellar hemisphere.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     PET scans",
"    </span>",
"    &nbsp;&mdash;&nbsp;In positron emission tomography (PET), the detection and tomographic imaging of dual-photon positron emitting radionuclides serves as a functional imaging modality [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/89\">",
"     89",
"    </a>",
"    ]. PET neuroimaging is based on the assumption that areas of high radioactive uptake are associated with brain activity. The flow of blood to different parts of the brain, which is generally believed to be correlated with brain activity, is measured using radioactive tracers, such as 15-oxygen (15-O), 18-fluorothymidine (18-F) or fluorodeoxyglucose (FDG). For practical reasons, FDG is the preferred tracer [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     PET applications",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET imaging may be useful for the evaluation of central nervous system (CNS) tumors, lymphoma, epilepsy, encephalitis, and other pediatric disorders affecting the CNS.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CNS tumors &mdash; In children, PET and",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      (which permits more accurate anatomic localization with sequential imaging on the same machine) are increasingly used in the diagnosis of CNS pathology and head and neck tumors. FDG-PET is used to localize CNS tumors and to assess response to therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/94,95\">",
"       94,95",
"      </a>",
"      ]. FDG-PET with MRI coregistration and image fusion on",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      scanners results in better tumor localization and differentiation between benign and malignant pathology. The degree of FDG uptake in CNS tumors correlates with World Health Organization malignancy grade [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/89\">",
"       89",
"      </a>",
"      ]. Even with this correlation between tumor",
"      <span class=\"nowrap\">",
"       hotspot/brain",
"      </span>",
"      index and mitotic activity, there remains considerable overlap between high-grade and low-grade pediatric tumors. In addition, certain benign tumors are known to have high FDG uptake. These include pilocytic astrocytoma, choroid plexus papilloma, and the pleomorphic xanthoastrocytoma. The use of new PET tracers in CNS tumors, including radiolabeled amino acids, 11-C-choline and 18-F-choline, appear promising in differentiating benign from malignant neoplasms. Tumor proliferation imaging with radiolabeled nucleoside analogs to assess DNA synthesis also holds promise [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/94,95\">",
"       94,95",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lymphoma &mdash; The role of PET in childhood lymphoma is undergoing evaluation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/93,96\">",
"       93,96",
"      </a>",
"      ]. In adults, FDG-PET has been successful in the staging of lymphoma, evaluation of treatment, and differentiation between post-therapy changes versus",
"      <span class=\"nowrap\">",
"       persistent/recurrent",
"      </span>",
"      disease. Similar to 67Gallium citrate, FDG uptake tends to be greater in higher- than in lower-grade lymphoma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/6/32874?source=see_link\">",
"       \"Overview of Hodgkin lymphoma in children and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link\">",
"       \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/19/30007?source=see_link\">",
"       \"Monitoring of the patient with classical Hodgkin lymphoma during and after treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Epilepsy &mdash; PET is an important diagnostic tool in childhood epilepsy, and has proven to be particularly useful for preoperative localization of the epileptic focus. The majority of PET studies in children are obtained between seizures, largely because of the practical difficulties inherent with ictal studies. When PET is concordant with the results of electroencephalography, it is superior to CT or MRI alone. Although MRI is highly sensitive in detecting seizure foci and other lesions in temporal lobe surgical candidates, PET may be indicated when the MRI is normal. FDG-PET parallels the results of MR spectroscopy in epileptic foci and non-epileptic foci throughout the brain. Other tracers, such as 11C-flumazenil have also been used in PET, with alpha-11C-methyl-L-tryptophan showing promise for localization of seizure foci in patients with tuberous sclerosis [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/92,95\">",
"       92,95",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Encephalitis &mdash; PET also is used to aid in the diagnosis of differing types of encephalitis [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/95\">",
"       95",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Rasmussen's encephalitis is characterized by diffuse unilateral cerebral hypometabolism on FDG-PET, which corresponds to cerebral atrophy on MRI.",
"     </li>",
"     <li>",
"      HIV-1 infected children born to seropositive mothers may also benefit from FDG-PET, which can identify functional cerebral abnormalities that precede clinical symptoms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other applications &mdash; PET may be helpful in neurofibromatosis type I (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link\">",
"       \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"      </a>",
"      ) and has potential research applications for other pediatric brain diseases, including Sturge-Weber syndrome, Rett syndrome, neurodegeneration with brain iron accumulation type 1 (formerly Hallervorden-Spatz disease), sickle cell encephalopathy, traumatic brain injury, movement disorders [",
"      <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/97\">",
"       97",
"      </a>",
"      ], and neuropsychiatric disorders including attention deficit hyperactivity disorder, anorexia nervosa, and bulimia nervosa.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     MULTIMODAL IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Integration of neuroimaging techniques, (eg, PET and CT scans or PET and MRI scans) is increasingly used in the diagnosis of CNS pathology. Work has been performed to integrate PET scanning with MRI techniques such as DTI to look at the white matter connectivity and examine the integrity of white matter tracts that connect cortical brain regions with altered metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?22/40/23178/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4921696\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most important applications of ultrasonography (US) in the neuroimaging of children are (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Ultrasonography'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Ultrasound applications'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fetal and neonatal screening",
"     </li>",
"     <li>",
"      Bedside examination of a critically ill infant who is too unstable to be examined in the radiology department",
"     </li>",
"     <li>",
"      Rapidly determining whether a mass is cystic, solid, or vascular, differentiating subarachnoid collections (eg, benign external hydrocephalus) from subdural collections (eg, chronic subdural hematoma), assessment of vascularity, vascular flow, increased intracranial pressure, or edema (eg, measuring resistive index)",
"     </li>",
"     <li>",
"      Real-time guidance and monitoring during diagnostic or therapeutic interventional neuroradiologic procedures (eg, transcatheter endovascular ablation of vein of Galen vascular malformation) and surgical procedures (eg, craniotomy and laminectomy)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CT often is the primary modality in acute or emergent situations. In these circumstances, the primary role of CT is to screen for acute or subacute hemorrhage, edema, herniation, fractures, hypoxic-ischemic injury, focal infarction, hydrocephalus, tumor mass, or abnormal collection (eg, pneumocephalus, abscess, empyema). These situations include (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Computed tomography'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'CT applications'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Acute trauma",
"     </li>",
"     <li>",
"      Acute neurologic deficit",
"     </li>",
"     <li>",
"      Encephalopathy",
"     </li>",
"     <li>",
"      Increased intracranial pressure",
"     </li>",
"     <li>",
"      Headache",
"     </li>",
"     <li>",
"      Unexplained or complicated acute episodic disorder (eg, seizure, apnea)",
"     </li>",
"     <li>",
"      Visual symptoms or signs",
"     </li>",
"     <li>",
"      Suspected CNS infection",
"     </li>",
"     <li>",
"      Shunted hydrocephalus with suspected shunt malfunction",
"     </li>",
"     <li>",
"      Suspected postoperative intracranial complication",
"     </li>",
"     <li>",
"      Head and neck masses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other indications for using CT include evaluation of the skull, orbit, sinuses, and facial bones, evaluation of a localized spinal column abnormality, and detection and confirmation of calcification in the brain. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'CT applications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In centers where MRI is readily available, the majority of head CTs are performed without contrast. Although intravenous contrast enhancement or cerebrospinal fluid (CSF) opacification may improve resolution, MRI is preferred to vascular- or CSF-enhanced CT in virtually all circumstances. The exceptions include CT angiography, evaluation of palpable masses in the head and neck, and follow-up of brain abscesses. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Contrast enhanced CT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MRI is the imaging modality of choice in numerous clinical situations, including (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Magnetic resonance imaging'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Developmental delay (eg, static versus neurodegenerative encephalopathy)",
"     </li>",
"     <li>",
"      Unexplained hydrocephalus",
"     </li>",
"     <li>",
"      Neuroendocrine disorder and associated hypothalamic-pituitary abnormalities",
"     </li>",
"     <li>",
"      New onset seizures, especially focal seizures",
"     </li>",
"     <li>",
"      Intractable or refractory seizure activity and the evaluation for epilepsy surgery",
"     </li>",
"     <li>",
"      Pretreatment evaluation of neoplastic processes and follow-up of tumor response and treatment effects",
"     </li>",
"     <li>",
"      Suspected infectious, postinfectious, and other inflammatory or noninflammatory encephalitides",
"     </li>",
"     <li>",
"      Migrational and other submacroscopic dysgeneses",
"     </li>",
"     <li>",
"      Neurocutaneous syndromes",
"     </li>",
"     <li>",
"      Orbital pathology",
"     </li>",
"     <li>",
"      Sensorineural hearing loss",
"     </li>",
"     <li>",
"      Vascular malformations and hemorrhage",
"     </li>",
"     <li>",
"      Ischemic and hemorrhagic stroke",
"     </li>",
"     <li>",
"      Evaluation of the spinal column and spinal neuraxis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MRI often offers greater diagnostic specificity than CT or ultrasonography for delineating vascular and hemorrhagic processes. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Vascular disease and hemorrhage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CT angiography (CTA) and magnetic resonance angiography (MRA) are noninvasive tests that are useful for the same indications as conventional contrast angiography. These indications include (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Angiography'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Evaluation of pediatric stroke",
"     </li>",
"     <li>",
"      Diagnosis of vasculitis",
"     </li>",
"     <li>",
"      Confirmation of large vessel stenosis that may require antithrombotic therapy for the prevention of recurrent stroke or transient ischemic attacks",
"     </li>",
"     <li>",
"      Evaluation of the vascular anatomy prior to neurosurgery or endovascular neurointerventional therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Single photon emission computed tomography (SPECT) and positron emission tomography (PET) provide functional assessment of the pediatric central nervous system (CNS). Although PET has the unique ability to monitor specific metabolic tracers (eg, oxygen utilization and glucose metabolism), the wider availability, relative simplicity, and rapid technical advancement of SPECT renders it more practical. SPECT and PET technologies have many clinical and investigative applications in children. They include (see",
"      <a class=\"local\" href=\"#H22\">",
"       'Nuclear medicine'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Assessment of brain development and maturation",
"     </li>",
"     <li>",
"      Focus localization in refractory childhood epilepsy",
"     </li>",
"     <li>",
"      Assessment of tumor progression versus treatment effects in CNS neoplasia",
"     </li>",
"     <li>",
"      Evaluation of occlusive cerebrovascular disease for surgical revascularization",
"     </li>",
"     <li>",
"      Diagnosis of brain death",
"     </li>",
"     <li>",
"      Use of brain activation techniques in the elucidation of childhood cognitive disorders",
"     </li>",
"     <li>",
"      Assessment of CSF kinetics",
"     </li>",
"     <li>",
"      Spinal column screening in the evaluation of occult trauma, infection, and neoplastic processes",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Barkovich A. Pediatric Neuroimaging, Lippincott-Raven, Philadelphia 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/2\">",
"      Abdelhalim AN, Alberico RA. Pediatric neuroimaging. Neurol Clin 2009; 27:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/3\">",
"      Ketonen LM, Valanne L. Neuroimaging of pediatric diseases. Semin Neurol 2008; 28:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/4\">",
"      Lowe LH, Bailey Z. State-of-the-art cranial sonography: Part 1, modern techniques and image interpretation. AJR Am J Roentgenol 2011; 196:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/5\">",
"      Dubois J, Patriquin H. Doppler sonography of head and neck masses in children. Neuroimaging Clin N Am 2000; 10:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/6\">",
"      Wax JR, Pinette MG. Nonmedical fetal ultrasound--why all the noise? Birth 2006; 33:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/7\">",
"      Gressens P, H&uuml;ppi PS. Are prenatal ultrasounds safe for the developing brain? Pediatr Res 2007; 61:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/8\">",
"      Chen CY, Chou TY, Zimmerman RA, et al. Pericerebral fluid collection: differentiation of enlarged subarachnoid spaces from subdural collections with color Doppler US. Radiology 1996; 201:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/9\">",
"      Lowe LH, Bailey Z. State-of-the-art cranial sonography: Part 2, pitfalls and variants. AJR Am J Roentgenol 2011; 196:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/10\">",
"      Burrows PE, Robertson RL. Neonatal central nervous system vascular disorders. Neurosurg Clin N Am 1998; 9:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/11\">",
"      Barnes PD, Taylor GA. Imaging of the neonatal central nervous system. Neurosurg Clin N Am 1998; 9:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/12\">",
"      Byrd SE, Seibert JJ. Transcranial Doppler imaging in pediatric abnormalities in older children. Neuroimaging Clin N Am 1999; 9:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/13\">",
"      Saqqur M, Dean N, Schebel M, et al. Improved detection of microbubble signals using power M-mode Doppler. Stroke 2004; 35:e14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/14\">",
"      Barr LL, McCullough PJ, Ball WS Jr, et al. Quantitative sonographic feature analysis of clinical infant hypoxia: a pilot study. AJNR Am J Neuroradiol 1996; 17:1025.",
"     </a>",
"    </li>",
"    <li>",
"     Fundamentals of Diagnostic Radiology, 2nd, Brant WE, Helms CA.  (Eds), Lippincott Williams &amp; Wilkins, Philadlphia 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/16\">",
"      Hopkins KL, Davis PC, Sanders CL, Churchill LH. Sedation for pediatric imaging studies. Neuroimaging Clin N Am 1999; 9:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/17\">",
"      Donnelly LF, Emery KH, Brody AS, et al. Minimizing radiation dose for pediatric body applications of single-detector helical CT: strategies at a large Children's Hospital. AJR Am J Roentgenol 2001; 176:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/18\">",
"      Seemanov&aacute; E, Jarol&iacute;m P, Seeman P, et al. [Increased risk of malignancies in heterozygotes in families of patients with Nijmegen breakage syndrome]. Cas Lek Cesk 2006; 145:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/19\">",
"      Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001; 176:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/20\">",
"      Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/21\">",
"      Hall P, Adami HO, Trichopoulos D, et al. Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ 2004; 328:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/22\">",
"      Griffiths PD, Morrison GD. Computed tomography in children. BMJ 2004; 329:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/23\">",
"      Donnelly LF. Reducing radiation dose associated with pediatric CT by decreasing unnecessary examinations. AJR Am J Roentgenol 2005; 184:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/24\">",
"      Brody AS, Frush DP, Huda W, et al. Radiation risk to children from computed tomography. Pediatrics 2007; 120:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/25\">",
"      Shah NB, Platt SL. ALARA: is there a cause for alarm? Reducing radiation risks from computed tomography scanning in children. Curr Opin Pediatr 2008; 20:243.",
"     </a>",
"    </li>",
"    <li>",
"     Radiation dose issues in multi-slide CT scanning. ImPact techonology update no. 3. www.impactscan.org/msctdose.htm (Accessed on July 10, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/27\">",
"      Boone JM, Geraghty EM, Seibert JA, Wootton-Gorges SL. Dose reduction in pediatric CT: a rational approach. Radiology 2003; 228:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/28\">",
"      Goske MJ, Applegate KE, Boylan J, et al. The Image Gently campaign: working together to change practice. AJR Am J Roentgenol 2008; 190:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/29\">",
"      Medina LS, Pinter JD, Zurakowski D, et al. Children with headache: clinical predictors of surgical space-occupying lesions and the role of neuroimaging. Radiology 1997; 202:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/30\">",
"      Barnes PD. Editorial: Imaging in the pediatric patient with headache. Int Pediatr 2002; :17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/31\">",
"      Barnes PD, Robson CD. CT findings in hyperacute nonaccidental brain injury. Pediatr Radiol 2000; 30:74.",
"     </a>",
"    </li>",
"    <li>",
"     Kleinman, PK, Barnes, PD. Head trauma. In: Imaging of child abuse, 2nd ed, Kleinman, PK (Ed), Mosby Year Book Publishers, St Louis 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/33\">",
"      Barnes PD, Robson CD, Robertson RL, Poussaint TY. Pediatric orbital and visual pathway lesions. Neuroimaging Clin N Am 1996; 6:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/34\">",
"      Davis PC, Hopkins KL. Imaging of the pediatric orbit and visual pathways: computed tomography and magnetic resonance imaging. Neuroimaging Clin N Am 1999; 9:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/35\">",
"      Rajnik M, Ottolini MG. Serious infections of the central nervous system: encephalitis, meningitis, and brain abscess. Adolesc Med 2000; 11:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/36\">",
"      Hedlund GL, Boyer RS. Neuroimaging of postnatal pediatric central nervous system infections. Semin Pediatr Neurol 1999; 6:299.",
"     </a>",
"    </li>",
"    <li>",
"     Mukherji, SK (Ed). Pediatric head and neck imaging. Neuroimaging Clin N Am, WB Saunders, Philadelphia 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/38\">",
"      Young Poussaint T, Barnes PD. Imaging of the developmentally delayed child. Magn Reson Imaging Clin N Am 2001; 9:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/39\">",
"      Boaz JC, Edwards-Brown MK. Hydrocephalus in children: neurosurgical and neuroimaging concerns. Neuroimaging Clin N Am 1999; 9:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/40\">",
"      Poussaint TY, Gudas T, Barnes PD. Imaging of neuroendocrine disorders of childhood. Neuroimaging Clin N Am 1999; 9:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/41\">",
"      Blaser SI, Jay V. Disorders of cortical formation: radiologic-pathologic correlation. Neuroimaging Clin N Am 1999; 9:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/42\">",
"      Edwards-Brown MK, Jakacki RI. Imaging the central nervous system effects of radiation and chemotherapy of pediatric tumors. Neuroimaging Clin N Am 1999; 9:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/43\">",
"      States LJ, Zimmerman RA, Rutstein RM. Imaging of pediatric central nervous system HIV infection. Neuroimaging Clin N Am 1997; 7:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/44\">",
"      Braffman B, Naidich TP. The phakomatoses: Part I. Neurofibromatosis and tuberous sclerosis. Neuroimaging Clin N Am 1994; 4:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/45\">",
"      Braffman B, Naidich TP. The phakomatoses: Part II. von Hippel-Lindau disease, Sturge-Weber syndrome, and less common conditions. Neuroimaging Clin N Am 1994; 4:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/46\">",
"      Appignani BA, Jaramillo D, Barnes PD, Poussaint TY. Dysraphic myelodysplasias associated with urogenital and anorectal anomalies: prevalence and types seen with MR imaging. AJR Am J Roentgenol 1994; 163:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/47\">",
"      Barnes PD, Brody JD, Jaramillo D, et al. Atypical idiopathic scoliosis: MR imaging evaluation. Radiology 1993; 186:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/48\">",
"      Kim FM, Poussaint TY, Barnes PD. Neuroimaging of scoliosis in childhood. Neuroimaging Clin N Am 1999; 9:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/49\">",
"      Tong KA, Ashwal S, Holshouser BA, et al. Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol 2004; 56:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/50\">",
"      Robertson RL, Robson CD, Barnes PD, Burrows PE. Head and neck vascular anomalies of childhood. Neuroimaging Clin N Am 1999; 9:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/51\">",
"      Griffiths PD, Widjaja E, Paley MN, Whitby EH. Imaging the fetal spine using in utero MR: diagnostic accuracy and impact on management. Pediatr Radiol 2006; 36:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/52\">",
"      Widjaja E, Geibprasert S, Mahmoodabadi SZ, et al. Alteration of human fetal subplate layer and intermediate zone during normal development on MR and diffusion tensor imaging. AJNR Am J Neuroradiol 2010; 31:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/53\">",
"      Widjaja E, Geibprasert S, Blaser S, et al. Abnormal fetal cerebral laminar organization in cobblestone complex as seen on post-mortem MRI and DTI. Pediatr Radiol 2009; 39:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/54\">",
"      Whitby EH, Variend S, Rutter S, et al. Corroboration of in utero MRI using post-mortem MRI and autopsy in foetuses with CNS abnormalities. Clin Radiol 2004; 59:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/55\">",
"      Bydder GM, Rutherford MA. Diffusion-weighted imaging of the brain in neonates and infants. Magn Reson Imaging Clin N Am 2001; 9:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/56\">",
"      Phillips MD, Zimmerman RA. Diffusion imaging in pediatric hypoxic ischemia injury. Neuroimaging Clin N Am 1999; 9:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/57\">",
"      Robertson RL, Ben-Sira L, Barnes PD, et al. MR line-scan diffusion-weighted imaging of term neonates with perinatal brain ischemia. AJNR Am J Neuroradiol 1999; 20:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/58\">",
"      Gadian DG, Calamante F, Kirkham FJ, et al. Diffusion and perfusion magnetic resonance imaging in childhood stroke. J Child Neurol 2000; 15:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/59\">",
"      Huppi PS, Inder TE. Magnetic resonance techniques in the evaluation of the perinatal brain: recent advances and future directions. Semin Neonatol 2001; 6:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/60\">",
"      Erdem E, Zimmerman RA, Haselgrove JC, et al. Diffusion-weighted imaging and fluid attenuated inversion recovery imaging in the evaluation of primitive neuroectodermal tumors. Neuroradiology 2001; 43:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/61\">",
"      Trouard TP, Heidenreich RA, Seeger JF, Erickson RP. Diffusion tensor imaging in Niemann-Pick Type C disease. Pediatr Neurol 2005; 33:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/62\">",
"      Barker PB, Horsk&aacute; A. Neuroimaging in leukodystrophies. J Child Neurol 2004; 19:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/63\">",
"      Peng SS, Tseng WY, Chien YH, et al. Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment. AJNR Am J Neuroradiol 2004; 25:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/64\">",
"      Gropman A. Imaging of neurogenetic and neurometabolic disorders of childhood. Curr Neurol Neurosci Rep 2004; 4:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/65\">",
"      Lazar M, Alexander AL, Thottakara PJ, et al. White matter reorganization after surgical resection of brain tumors and vascular malformations. AJNR Am J Neuroradiol 2006; 27:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/66\">",
"      Itoh D, Aoki S, Maruyama K, et al. Corticospinal tracts by diffusion tensor tractography in patients with arteriovenous malformations. J Comput Assist Tomogr 2006; 30:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/67\">",
"      Kikuta K, Takagi Y, Nozaki K, et al. Early experience with 3-T magnetic resonance tractography in the surgery of cerebral arteriovenous malformations in and around the visual pathway. Neurosurgery 2006; 58:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/68\">",
"      Rollins N. Semilobar holoprosencephaly seen with diffusion tensor imaging and fiber tracking. AJNR Am J Neuroradiol 2005; 26:2148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/69\">",
"      Lee SK, Kim DI, Kim J, et al. Diffusion-tensor MR imaging and fiber tractography: a new method of describing aberrant fiber connections in developmental CNS anomalies. Radiographics 2005; 25:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/70\">",
"      H&uuml;ppi PS, Murphy B, Maier SE, et al. Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics 2001; 107:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/71\">",
"      Tzika AA, Massoth RJ, Ball WS Jr, et al. Cerebral perfusion in children: detection with dynamic contrast-enhanced T2*-weighted MR images. Radiology 1993; 187:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/72\">",
"      Ball WS Jr, Holland SK. Perfusion imaging in the pediatric patient. Magn Reson Imaging Clin N Am 2001; 9:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/73\">",
"      Licht DJ, Wang J, Silvestre DW, et al. Preoperative cerebral blood flow is diminished in neonates with severe congenital heart defects. J Thorac Cardiovasc Surg 2004; 128:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/74\">",
"      Martin E, Marcar VL. Functional MR imaging in pediatrics. Magn Reson Imaging Clin N Am 2001; 9:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/75\">",
"      Moore GJ. Proton magnetic resonance spectroscopy in pediatric neuroradiology. Pediatr Radiol 1998; 28:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/76\">",
"      Tzika AA, Vigneron DB, Ball WS Jr, et al. Localized proton MR spectroscopy of the brain in children. J Magn Reson Imaging 1993; 3:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/77\">",
"      Wang Z, Zimmerman RA, Sauter R. Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR Am J Roentgenol 1996; 167:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/78\">",
"      Hunter JV, Wang ZJ. MR spectroscopy in pediatric neuroradiology. Magn Reson Imaging Clin N Am 2001; 9:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/79\">",
"      Zimmerman RA, Bilaniuk LT, Pollock AN, et al. 3.0 T versus 1.5 T pediatric brain imaging. Neuroimaging Clin N Am 2006; 16:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/80\">",
"      Griffiths PD, Coley SC, Connolly DJ, et al. MR imaging of patients with localisation-related seizures: initial experience at 3.0T and relevance to the NICE guidelines. Clin Radiol 2005; 60:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/81\">",
"      Wilde EA, Hunter JV, Newsome MR, et al. Frontal and temporal morphometric findings on MRI in children after moderate to severe traumatic brain injury. J Neurotrauma 2005; 22:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/82\">",
"      Pettersson H, Fitz CR, Harwood-Nash DC, et al. Iatrogenic embolization: complication of pediatric cerebral angiography. AJNR Am J Neuroradiol 1981; 2:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/83\">",
"      Burger IM, Murphy KJ, Jordan LC, et al. Safety of cerebral digital subtraction angiography in children: complication rate analysis in 241 consecutive diagnostic angiograms. Stroke 2006; 37:2535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/84\">",
"      Alberico RA, Barnes P, Robertson RL, Burrows PE. Helical CT angiography: dynamic cerebrovascular imaging in children. AJNR Am J Neuroradiol 1999; 20:328.",
"     </a>",
"    </li>",
"    <li>",
"     Barkovich, AJ. Techniques and methods in pediatric neuroimaging. In: Pediatric neuroimaging, 4th ed, Lippincott Williams &amp; Wilson, Philadelphia 2005. p.8.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/86\">",
"      Kim S, Salamon N, Jackson HA, et al. PET imaging in pediatric neuroradiology: current and future applications. Pediatr Radiol 2010; 40:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/87\">",
"      Gulati S, Bal CS, Kalra V. Single-photon emission computed tomography (SPECT) in childhood epilepsy. Indian J Pediatr 2000; 67:S32.",
"     </a>",
"    </li>",
"    <li>",
"     Treves, ST. Pediatric nuclear medicine, 2nd ed, Springer-Verlag, New York 1995.",
"    </li>",
"    <li>",
"     Brant, WE, Helms, CA (Eds). Fundamentals of Diagnostic Radiology Second Edition, Lippincott Williams &amp; Wilkins, Philadelphia 1999.",
"    </li>",
"    <li>",
"     Ott RJ. Single photon emission computed tomography. www.nupecc.org/iai2001/report/B22.pdf (Accessed on June 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/91\">",
"      Kirton A, Kloiber R, Rigel J, Wolff J. Evaluation of pediatric CNS malignancies with (99m)Tc-methoxyisobutylisonitrile SPECT. J Nucl Med 2002; 43:1438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/92\">",
"      Kuzniecky RI, Knowlton RC. Neuroimaging of epilepsy. Semin Neurol 2002; 22:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/93\">",
"      Rhodes MM, Delbeke D, Whitlock JA, et al. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. J Pediatr Hematol Oncol 2006; 28:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/94\">",
"      Borgwardt L, H&oslash;jgaard L, Carstensen H, et al. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. J Clin Oncol 2005; 23:3030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/95\">",
"      Hahn K, Pfluger T. Has PET become an important clinical tool in paediatric imaging? Eur J Nucl Med Mol Imaging 2004; 31:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/96\">",
"      Depas G, De Barsy C, Jerusalem G, et al. 18F-FDG PET in children with lymphomas. Eur J Nucl Med Mol Imaging 2005; 32:31.",
"     </a>",
"    </li>",
"    <li>",
"     Personal communication, JV Hunter.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/40/23178/abstract/98\">",
"      Eluvathingal TJ, Chugani HT, Behen ME, et al. Abnormal brain connectivity in children after early severe socioemotional deprivation: a diffusion tensor imaging study. Pediatrics 2006; 117:2093.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6156 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-210.101.131.232-8FC26C7E2B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23178=[""].join("\n");
var outline_f22_40_23178=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4921696\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ULTRASONOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Safety issues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Ultrasound applications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Ultrasound techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PLAIN RADIOGRAPHS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      COMPUTED TOMOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Safety considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Radiation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Sedation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CT applications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Contrast enhanced CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Advanced display",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      MAGNETIC RESONANCE IMAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Limitations and safety considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MRI applications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Vascular disease and hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4921931\">",
"      - Pediatric stroke",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4921816\">",
"      - Fetal MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      MRI techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      ANGIOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Contrast angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      CT and MR angiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      NUCLEAR MEDICINE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SPECT scans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - SPECT applications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PET scans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - PET applications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      MULTIMODAL IMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4921696\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6156\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6156|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/45/4818\" title=\"diagnostic image 1\">",
"      Germinal matrix hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/16/6404\" title=\"diagnostic image 2\">",
"      Doppler ultrasound of the basilar artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/8/27777\" title=\"diagnostic image 3\">",
"      CT subdural hemorrhage and cerebral edema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/8/31874\" title=\"diagnostic image 4\">",
"      MRI of temporal lobe glioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/20/22849\" title=\"diagnostic image 5\">",
"      MRI cavernous vascular malformation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/10/40099\" title=\"diagnostic image 6\">",
"      MRA of cerebral AVM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/61/21471\" title=\"diagnostic image 7\">",
"      MRI basal ganglia capsular infarct",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/17/16658\" title=\"diagnostic image 8\">",
"      MRI of tethered spinal cord and lipoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6156|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?43/21/44383\" title=\"waveform 1\">",
"      MRS of hypoxic-ischemic brain injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/9/7321?source=related_link\">",
"      AIDS-related lymphomas: Primary central nervous system lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/60/23497?source=related_link\">",
"      Ataxia-telangiectasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19162?source=related_link\">",
"      Back pain in children and adolescents: Overview of causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/11/31930?source=related_link\">",
"      Cerebrovascular complications of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=related_link\">",
"      Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33770?source=related_link\">",
"      Clinical features; evaluation; and diagnosis of adolescent idiopathic scoliosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15609?source=related_link\">",
"      Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7594?source=related_link\">",
"      Etiology, clinical features, and diagnosis of cerebral venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=related_link\">",
"      Evaluation of cervical spine injuries in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=related_link\">",
"      Evaluation of the child with back pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23513?source=related_link\">",
"      Ischemic stroke in children and young adults: Etiology and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/19/30007?source=related_link\">",
"      Monitoring of the patient with classical Hodgkin lymphoma during and after treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7751?source=related_link\">",
"      Moyamoya disease: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/27/439?source=related_link\">",
"      Nijmegen breakage syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/6/32874?source=related_link\">",
"      Overview of Hodgkin lymphoma in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17032?source=related_link\">",
"      Principles of computed tomography of the chest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=related_link\">",
"      Principles of magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27690?source=related_link\">",
"      Stroke in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37065?source=related_link\">",
"      Treatment and prognosis of adolescent idiopathic scoliosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_40_23179="Causes of unintentional death";
var content_f22_40_23179=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F79294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F79294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Leading causes of unintentional-injury deaths, United States, 1998",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Motor Vehicle",
"       </td>",
"       <td>",
"        43,501",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Falls",
"       </td>",
"       <td>",
"        16,274",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Poisoning*",
"       </td>",
"       <td>",
"        10,255",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drowning",
"       </td>",
"       <td>",
"        4,406",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Choking",
"       </td>",
"       <td>",
"        3,515",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"2\" rowspan=\"1\">",
"        Deaths",
"and injuries in the home",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        29,500",
"fatalities and 7,100,000 disabling injuries in 2000. This represents a",
"5 percent increase over 1999 figures.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        In the home,",
"there is a fatal injury every 18 minutes and a disabling injury every 4",
"seconds.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        The four",
"leading fatal events are solid and liquid poisonings, falls, fires and",
"burns, and suffocation by ingested object.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Includes solid and liquid poisoning only. The leading causes of fatal unintentional injuries in 1998 (latest available figures) are the same top four since 1970. \"Suffocation by ingested object\" has supplanted \"fires and burns\" as the fifth leading cause of death.",
"    </div>",
"    <div class=\"reference\">",
"     National safety Council. Report on Injuries in America, 2001 (file://www.nsc.org/library/rept2000.htm#recs).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23179=[""].join("\n");
var outline_f22_40_23179=null;
var title_f22_40_23180="Manifestations of hypothermia";
var content_f22_40_23180=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of accidental hypothermia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mild",
"       </td>",
"       <td class=\"subtitle1\">",
"        Moderate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurologic",
"       </td>",
"       <td>",
"        Confusion, slurred speech, impaired judgment, amnesia",
"       </td>",
"       <td>",
"        Lethargy, hallucinations, loss of pupillary reflexes,",
"EEG abnormalities",
"       </td>",
"       <td>",
"        Loss of cerebrovascular regulation, decline in EEG",
"activity, coma, loss of ocular reflexes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiovascular",
"       </td>",
"       <td>",
"        Tachycardia, increased cardiac output, and systemic",
"vascular resistance",
"       </td>",
"       <td>",
"        Progressive bradycardia (unresponsive to atropine),",
"decreased cardiac output, BP, atrial and ventricularar rhythmias, J",
"(Osborn) wave on EKG",
"       </td>",
"       <td>",
"        Decline in BP and cardiac output, ventricular",
"fibrillation (&lt;28&deg;C; 82.4&deg;F) and asystole",
"(&lt;20&deg;C; 68&deg;F)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respiratory",
"       </td>",
"       <td>",
"        Tachypnea, bronchorrhea",
"       </td>",
"       <td>",
"        Hypoventilation, decreased oxygen consumption and CO2",
"production, loss of cough reflex",
"       </td>",
"       <td>",
"        Pulmonary edema, apnea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal",
"       </td>",
"       <td>",
"        Bladder atony, cold diuresis",
"       </td>",
"       <td>",
"        Cold diuresis",
"       </td>",
"       <td>",
"        Decreased renal perfusion, oliguria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Musculoskeletal",
"       </td>",
"       <td>",
"        Increased shivering",
"       </td>",
"       <td>",
"        Decreased shivering (&lt;32&deg;C;",
"89.6&deg;F) muscle rigidity",
"       </td>",
"       <td>",
"        Patient may appear dead, \"pseudo-rigor mortis\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic",
"       </td>",
"       <td colspan=\"1\">",
"        Increased metabolic rate,",
"hyperglycemia",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Decreased metabolic rate, hyper- or hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hematologic",
"       </td>",
"       <td colspan=\"1\">",
"        Increase in hematocrit, decreased",
"platelet count and white blood cell count, bleeding diathesis, DIC",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal",
"       </td>",
"       <td>",
"        Ileus, pancreatitis, gastric stress ulcers, hepatic",
"dysfunction",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BP: blood pressure; C02: carbon dioxide; DIC: disseminated intravascular coagulation;&nbsp;EEG: electroencephalogram.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Hanania, NA, Zimmerman, JL. Accidental hypothermia. Critical Care Clinincs 1999; 15:235. Copyright &copy; 1999 WB Saunders Company.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23180=[""].join("\n");
var outline_f22_40_23180=null;
var title_f22_40_23181="Levels of prevention";
var content_f22_40_23181=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F60717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F60717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Levels of prevention",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 176px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Primary prevention prevents disease from occurring. Secondary prevention detects and cures disease in the asymptomatic phase. Tertiary prevention reduces complications of disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fletcher RF, Fletcher SW. Prevention. In: Clinical Epidemiology - The Essentials, 4th ed. Lippincott Williams &amp; Wilkins, Baltimore, 2005. Copyright &copy; 2005 Lippincott Williams and Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23181=[""].join("\n");
var outline_f22_40_23181=null;
var title_f22_40_23182="Mechanisms for urate secretion by the proximal tubule";
var content_f22_40_23182=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F83925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F83925&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 495px\">",
"   <div class=\"ttl\">",
"    Mechanisms for urate secretion by the proximal tubule",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 475px; height: 388px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Urate enters the cell at the basolateral membrane via exchange with alpha-ketoglutarate, mediated by OAT1 and OAT3. At the apical membrane, urate is secreted via MRP4, ABCG2, NPT1 (SLC17A1), and/or NPT4 (SLC17A3). SLC13A1 is a sodium-dependent transporter that drives basolateral urate uptake.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23182=[""].join("\n");
var outline_f22_40_23182=null;
var title_f22_40_23183="Dental plate aspiration";
var content_f22_40_23183=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F80136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F80136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dental plate fragment",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Encased in the left main stem bronchus following facial trauma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles Marquette, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_40_23183=[""].join("\n");
var outline_f22_40_23183=null;
